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1. Contribution to the publications 
1.1 Contribution to Paper I 
A Biomimetic, Copolymeric Membrane for Cell-Stretch Experiments with 
Pulmonary Epithelial Cells at the Air-Liquid Interface  
Ali Doryab, Mehmet Berat Taskin, Philipp Stahlhut, Andreas Schröppel, Darcy E. Wag-




In this paper, we presented a novel membrane technology for culturing lung epithelial 
cells under air-liquid interface (ALI) and dynamic (cyclic stretch) conditions. The funda-
mental concept and the manufacturing method of the BETA (Biphasic Elastic Thin for 
Air-liquid culture conditions) membrane are described. The copolymeric biphasic mem-
brane consisting of poly(ε-)caprolactone (PCL) and gelatin with tunable physicomechan-
ical and biological properties guided by the characteristics of the alveolar basement 
membrane of the lung. As validation of the membrane, we used the newly developed 
CIVIC (Cyclic In VItro Cell-stretch) cell-stretch bioreactor to study the cellular responses 
due to cyclic stretch with respect to the formation of F-actin cytoskeleton and tight junc-
tion, cell apoptosis, inflammatory response (IL-8) activity, and apparent permeability of 
an alveolar epithelial cell-layer. We also investigated the cellular uptake of particles 
(nano- and microparticles) by alveolar epithelial cells cultured at the ALI under more 
physiologically relevant conditions (cyclic mechanical stretch and medium flow) as com-
pared to static conditions.  
 
CONTRIBUTION 
The fundamental biphasic membrane concept was developed by my supervisor (Otmar 
Schmid) and me. The two materials (PCL and gelatin) were selected by my supervisor 
(Otmar Schmid) and me based on a thorough review of currently available porous, elastic 
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membranes used for in vitro cell-stretch models of the alveolar barrier, which we recently 
published (see paper IV in the Appendix (Doryab et al., 2019)). My supervisor and I de-
signed the experiments. I conducted all of the experiments, recorded the data and pro-
vided an initial analysis. I designed and manufactured the BETA membrane involving an 
extensive optimization process. I implemented a design of experiment (DoE) approach 
using the response surface methodology (RSM)– central composite design (CCD), to co-
optimize physicomechanical properties of the membrane. I characterized the physical 
(thickness, wettability, and porosity), mechanical (elastic modulus, modulus of resilience, 
and stretchability) properties, and lung epithelial cells (A549 and 16HBE14o−) cytocom-
patibility (cell viability and attachment) of the membrane. For the membrane characteri-
zation, I performed scanning electron microscopy (SEM), energy dispersive x-ray spec-
troscopy (EDS)/SEM, focused ion beam (FIB)/SEM, and Fourier transform infrared spec-
troscopy (FT-IR). I did a uniaxial tensile test to measure the mechanical properties of the 
membranes. I also measured the water contact angle (WCA) of the membranes to study 
their surface wettability. Moreover, I quantified the porosity (and the pore size) of the 
membranes using both the liquid displacement method and quantification of the SEM 
images (in phase II). 
In addition to the membrane fabrication, I technically optimized the MALI (Moving Air-
Liquid Interface) bioreactor system that now it is referred to as CIVIC (Cyclic In VItro Cell-
stretch) mainly with respect to the real-time monitoring of the stiffness (elastic modulus) 
of the membrane during the cell-stretch experiment. More details of the optimization of 
the CIVIC and MALI bioreactor systems were published in paper II and III, respectively. 
I also performed all the cell experiments under both static and cell-stretch conditions, 
including seeding and growing lung epithelial cells (A549 and 16HBE14o−) on the BETA 
membrane and Transwell® insert, following by cell proliferation and cell viability assay 
(WST1). Furthermore, I analyzed biological endpoints using different methods, including 
immunofluorescence, confocal laser scanning microscopy (CLSM; both qualitative and 
quantitative via processing and quantification of images), SEM, qualitative elemental and 
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chemical microanalysis using EDS/SEM, FIB/SEM tomography for site-specific analysis, 
in vitro functional analysis (Trans-epithelial electrical resistance (TEER) measurement 
and apparent permeability), and measurement of pro-inflammatory IL-8 release. Moreo-
ver, I conducted particle (nanoparticle and microparticle) studies and investigated cell 
uptake of particles. I performed all the Immunofluorescence staining (F-actin, ZO-1, col-
lagen I, cell nuclei, and particles), and CLSM image acquisition. I also processed and 
quantified all the CLSM, SEM and SEM/FIB images using FIJI (NIH) and IMARIS soft-
ware. 
Together with my supervisor, the analysis was refined and the data were interpreted. I 
also carried out all the statistical analysis using GraphPad Prism and Minitab software.  
My supervisor and I designed all of the figures. I generated all of the figures and prepared 
a complete first draft of the manuscript, which was then revised by my supervisor. His 
requested modifications were implemented by me and I then uploaded the manuscript 
to the journal webpage. I assisted my supervisor with the writing of the point-by-point 
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1.2 Contribution to Paper II 
 
A Bioinspired In Vitro Lung Model to Study Particokinetics of Nano-/Micro-
particles under Cyclic Stretch and Air-Liquid Interface Conditions 
 
Ali Doryab, Mehmet Berat Taskin, Philipp Stahlhut, Andreas Schröppel, Sezer Orak, 
Carola Voss, Arti Ahluwalia, Markus Rehberg, Anne Hilgendorff, Tobias Stöger, Jürgen 





In this paper, we described more precisely the optimization of the CIVIC (Cyclic In VItro 
Cell-stretch) lung bioreactor system as compared to the original so-called MALI bioreac-
tor (see paper III (Appendix)), which is able to mimic culture conditions for pulmonary 
epithelial cells at the air-liquid interface (ALI) experiencing cyclic stretch with aerosol 
delivery. The modifications are mainly related to improved geometry, material stability 
(silicone-free), (BETA) membrane fixation, and pressure sealing, and the real-time mon-
itor the stretch-related parameters (amplitude, frequency, and elastic modulus of the 
membrane). Moreover, we presented further BETA membrane characterizations. We 
also tried but failed to improve the biomimetic features of the BETA membrane by chang-
ing the mixing ratio of copolymer (PCL/gelatin) composition. We also investigated the 
role of physiologic cyclic mechanical stretch on uptake of nano- (100 nm) and micropar-
ticles (1000 nm) by A549 epithelial cells cultured at ALI and trans-epithelial transport of 
particles across the epithelial cell barrier. 
 
CONTRIBUTION 
My supervisor and I designed the experiments. I conducted all of the experiments, rec-
orded the data, and provided an initial analysis. Together with my supervisor, the analy-
sis was refined and the data were interpreted. I carried out all the statistical analysis 
using GraphPad Prism. My supervisor and I designed all of the figures. I made all of the 
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figures and prepared a complete first draft of the manuscript, which was then revised by 
my supervisor. His requested modifications were implemented by me and I then up-
loaded the manuscript to the journal webpage. I assisted my supervisor with the writing 
of the point-by-point rebuttal letter and the revision of the manuscript. 
More specifically, I modified the BETA membrane in terms of its chemical composition, 
permeability, elasticity (elastic modulus and stretchability), and bioactivity. In paper I, we 
determined the optimum concentration of the membrane compound (poly(ε-)caprolac-
tone and gelatin). In this paper, we explored a higher range for component concentration 
to further optimize the membrane. I performed atomic force microscopy (AFM), scanning 
electron microscopy (SEM), energy dispersive x-ray spectroscopy (EDS)/SEM, focused 
ion beam (FIB)/SEM, uniaxial tensile test, water contact angle measurement, and liquid 
displacement test (porosity) to analyze the physicomechanical properties of the mem-
brane.  
I developed the MALI (Moving Air-Liquid Interface) bioreactor system that now it is re-
ferred to as CIVIC. Since the working volume of the CIVIC bioreactor is in the range of 
“milliliter”, we can then refer to this bioreactor as a “millifluidic” system (as compared to 
smaller-scale, microfluidic systems). In this version, the millifluidic system was modified 
to improve its efficiency and handling. The modifications include designing and manu-
facturing the new membrane holder and the vacuum sealing, changing the material of 
the bioreactor (silicone-free), and the new membrane for culturing cells at ALI. I also 
performed all of the cell experiments including seeding and growing cells (A549 and 
16HBE14o−) on the BETA membrane and Transwell® insert, following by cell prolifera-
tion and cell viability assays (WST1 and LDH assays), Immunofluorescence, confocal 
laser scanning microscopy (CLSM), and SEM. I also measured the TEER of the estab-
lished epithelial cell layer as a functional analysis. I also processed and quantified all the 
CLSM, SEM and SEM/FIB images using FIJI (NIH) and IMARIS software. Moreover, I 
conducted particle and particokinetic studies. I investigated the role of physiologic cyclic 
mechanical stretch on cellular uptake and transepithelial transport of nanoparticles (100 
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nm) and microparticles (1000 nm). I exerted qualitative and quantitative CLSM to study 
the cellular uptake and transepithelial transport of particles. I performed all the Immuno-
fluorescence staining (F-actin, E-cadherin, ZO-1, cell nuclei, and particles), CLSM image 
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1.3 Contribution to Paper III 
 
Development of a Dynamic In Vitro Stretch Model of the Alveolar Interface 
with Aerosol Delivery 
Daniele Cei#, Ali Doryab#, Anke-Gabriele Lenz, Andreas Schröppel, Paula Mayer, Ge-
rald Burgstaller, Roberta Nossa, Arti Ahluwalia, Otmar Schmid. 2021. Biotechnology and 
Bioengineering. 118 (2): 690–702. 
https://onlinelibrary.wiley.com/doi/10.1002/bit.27600 
(# share first authorship)  
 
SUMMARY 
In this paper, we described the engineering and computer-aided methods of design and 
performance characterization of a Moving Air-Liquid Interface (MALI) bioreactor for the 
study of aerosol deposition on a cyclically stretched, “breathing” in vitro model of the 
lung. As a proof of concept, we showed that lung epithelial cells (A549) can be mechan-
ically stimulated under air-liquid interface and physiologic stretch conditions without loss 
of cell viability. 
 
CONTRIBUTION 
As the shared co-first author of this research paper, I performed aerosol delivery meas-
urements in the MALI system for different nebulizer duty cycles. I also analyzed aerosol 
dosimetry and aerosol deposition (delivery) efficiency data and depicted the results in 
Figure 4. I also cultured A549 and 16HBE14o− on the commercial Bionate® electrospun 
membrane, which was the only membrane used in this paper. For evaluation of the cell 
viability, I performed all of the Immunofluorescence staining (F-actin and cell nuclei) and 
CLSM analysis (image acquisition and processing) of the A549 cells on the Bionate® 
membrane (Figure 7). I also evaluated the attachment of 16HBE14o− cells to the elec-
trospun membrane using SEM analysis (Supplementary Figure S9). Moreover, I pre-
pared Figure 5 and Supplementary Figure 8 (image processing). 
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I assisted my supervisor in writing the manuscript and analyzing data both for the initial 
submission and implementation of the reviewer-requested revision, which included the 
revised and supplementary information. Moreover, I assisted with writing the point-by-
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1.4 Contribution to Paper IV (Appendix) 
 
Evolution of Bioengineered Lung Models: Recent Advances and Chal-
lenges in Tissue Mimicry for Studying the Role of Mechanical Forces in Cell 
Biology 
Ali Doryab, Sinem Tas, Mehmet Berat Taskin, Lin Yang, Anne Hilgendorff, Jürgen Groll 
Darcy E. Wagner, Otmar Schmid. 2019. Advanced Functional Materials. 29 
(39):1903114. https://onlinelibrary.wiley.com/doi/abs/10.1002/adfm.201903114  
 
SUMMARY 
In this review paper, we summarized the role of mechanical stretch in lung biology, dis-
ease, and regeneration. Then, the key technical aspects of currently available in vitro 
cell-stretching devices with a focus on lung models (including lung-on-a-chip) were pre-
sented, which identifies the lack of suitable membranes for cell growth at the air-liquid 
interface as key aspect hampering progress in this field. Subsequently, the main physi-
ologic parameters of the native basal membrane of the alveolar-capillary tissue were 
defined as guidance for future membrane design. This paper offers a glimpse on future 
perspectives for evolving the cell-stretching membrane technology as a determinative 




Together with my supervisor, we determined the main direction of the manuscript. I pre-
pared a complete first draft of the manuscript, which was then revised by my supervisor. 
My supervisor and I designed all of the figures and I generated all of the figures/sche-
matics and his requested modifications were implemented by me and I then uploaded 
the manuscript to the journal webpage. I assisted my supervisor with the writing of the 
point-by-point rebuttal letter and the revision of the manuscript. 
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1.5 Contribution to other publications 
During my PhD project, I contributed to two side projects.  
In Bölükbas et al. (Advanced Therapeutics 2020), we showed the organ-restricted vas-
cular delivery (ORVD) enhances tumor cell-specific uptake of nanoparticles at cellular 
resolution. I assisted the lead authors with the organ-restricted vascular delivery (ORVD) 
by designing and manufacturing an ex vivo lung perfusion and ventilation system. We 
described the detail of the ex vivo lung perfusion system in (Bölükbas et al., 2019). 
In Costa et al. (British Journal of Pharmacology; under revision), we studied the regen-
erative potential of FDA-approved compounds for Wnt/β-catenin signaling in murine 
adult epithelial cell-derived lung organoids and in vivo model of chronic obstructive pul-
monary disease (COPD). We found that amlexanox, an approved drug with potential for 
COPD treatment, can rapidly translate into the clinics. I assisted the lead author with the 




2. Introductory summary  
Chronic respiratory diseases are one of the leading causes of death with almost no ef-
fective cure. The failure rate of successfully preclinically tested drug in clinical studies 
which is high probably, at least partially due to the lack of effectiveness of preclinical 
models. The failure of missing therapies might in part be owed to the inefficiency of the 
current in vivo and in vitro lung models to develop therapies since the mechanisms un-
derlying chronic lung diseases and their pathogenesis are poorly understood. Thus, over 
the last decades, numerous in vitro models for the lung –as an alternative for animal 
models– have been developed from simple monoculture to complex microfluidic co-cul-
ture models of the lung, often referred to as airway- or even lung-on-a-chip models; how-
ever, none of them could completely emulate the intricacy of the lung microenvironment 
and architecture, hampering the progress in finding the cures for lung diseases. We, 
therefore, intended to contribute to the development of more physiologically relevant and 
robust in vitro lung models for improving the translation of preclinical research into a 
more reliable prediction of clinical outcome in human studies.  
Here, we present a next generation of the cell-stretch bioreactor system for pulmonary/al-
veolar epithelial cells cultured at the air-liquid interface (ALI) –with potential applicability 
to multi-coculture models– equipped with an aerosolized drug delivery unit and a biomi-
metic copolymeric membrane, resembling the main physicomechanical characteristics 
of the alveolar basement membrane. The main emphasis of this dissertation lies on (i) 
technical improvements of the bioreactor with particular focus on real-time monitoring of 
stretch-related characteristic parameters (amplitude, frequency, and membrane stiff-
ness), (ii) introduction of the concept, design and manufacturing of a novel biphasic, 
elastic, and porous membrane for more biomimetic cell culture, and (iii) develop a bioin-
spired in vitro model for particokinetic study (nano-/microparticles) on pulmonary lung 
epithelial barrier under cyclic mechanical stretch and ALI culture conditions. With these 
technologies, we confirmed the well-known pivotal role of cyclic mechanical stretch on 
alveolar epithelial cell physiology for both physiologic and non-physiologic (over-) stretch 
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conditions, including the formation of F-actin cytoskeleton and tight junction integrity, 
activation of the inflammatory response (IL-8), and permeability. Moreover, particokinetic 
studies demonstrated that cyclic physiologic stretch can significantly affect cellular up-
take and transepithelial transport of nanoparticles. We believe this study presents a val-
uable step towards the improvement of the predictive value of advanced lung cell mod-
els. 
2.1 Definition of problem and aim of the study 
The lung is a vital organ in the human body with the main function of oxygen-carbon 
dioxide exchange between inhaled air and blood. The organ characteristics of the human 
lungs emphasize its critical function. The lung is the largest organ in the body, comprising 
only half of a liter of tissue, which is built to have a huge gas exchange surface area 
(100 m2) –ca. half of the size of a tennis court. This superior design i.e. limited space for 
locating the lung in the chest cavity with large epithelial tissue surface area, requires an 
extremely intricate structure (Weibel, 2009) (Figure 1A). The lung has a complex archi-
tecture partitioned into 23 generations of branching, encompassing from trachea (gen-
eration z = 0), bronchioles (z = 4), terminal bronchioles (z = 15) to alveolar ducts and 
sacs (z = 20-23) (Figure 1B) (Weibel, 1963). The respiratory bronchioles are further di-
vided into acinar airways (z= 16- 23), which is included of respiratory bronchioles (z = 
16-18), alveolar ducts (z = 19- 22), and alveolar sacs (z = 23). The alveoli have a complex 
3D structure where the gas exchange occurs via the large air-liquid interface (ALI) pre-
sented by the huge surface area of the alveolar tissue (Gil et al., 1979; Weibel, 1963). 
The tissue barrier separating air and blood consists of two cell layers, the alveolar epi-
thelium and the capillary endothelium (Figure 1A), attached to the alveolar basement 
membrane. This tissue layer is an ultrathin (alveolar-capillary barrier thickness is ≈ 1.1 
µm ± 0.1; harmonic mean), which also includes the basement membrane (ca. 0.1 µm) 
consisting of small fibrils of collagen and elastin and occasionally occurring fibroblasts 
(Weibel, 1970, 2009). The alveolar epithelium consists of the squamous type I cell, 
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covering 97% of the alveolar surface and providing the area for gas exchange, and the 
cuboidal type II cell (only ≈ 5%), a progenitor of type I cells, which are responsible for 
synthesis and secretion of surfactant and homeostasis (Castranova et al., 1988; Crapo 
et al., 1982). 
 
Figure 1. Lung morphology, cellular structure, and architecture (A) Schematic of the cellular 
composition of the human airway tree from bronchus to alveolus. In the alveoli, a thin layer (mem-
brane) of small fibrils of collagen and elastin (and rare fibroblasts) separates the epithelial and 
endothelial cell layers. (B) Schematic of airway branching in human lung, starting from the trachea 
(generation z=0), over bronchi and terminal bronchioles (Conducting airway; z=1-14), to alveolar 
ducts and sacs (Acinar airways; z=20-23). The anatomical size (diameter) decreases from cm 
(trachea) to nm (alveolar sacs). (C) The lung alveolar region consists of alveolar epithelial type I 
and II (airside) and epithelial side (in the blood side) with an ultrathin basement membrane (thick-
ness of gas exchange region is ca. 0.1 µm), which separates epithelial and endothelial cell layers. 
A thin layer of surfactant (<0.1 µm) covers the epithelial cells to lessen surface tension and hence 
prevent the collapse of the alveoli. A and C were reproduced with permission from (Doryab et al., 
2021b). Panel B was inspired by Weibel et al. ( (Weibel, 1963), reproduced with permission). 
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What makes the lung an extremely complicated organ to be modelled in vitro? In 
the gas exchange region of the lung (alveolar-capillary barrier, 1 µm thick), a micro-scale 
membrane (thickness of ca. 0.1 µm) separates alveolar epithelial cells (airside) from ca-
pillary endothelial cells (blood side) (Figure 1C). This membrane has extraordinary phys-
icomechanical properties including significant high stretchability and permeability while 
maintaining structural integrity, providing the delicate alveolar sac structure. 
This membrane/scaffold mostly consists of extracellular matrix (ECM) proteins. ECM is 
a fiber-like network of proteins and polysaccharides, which surrounds the cells. The im-
portant roles of ECM are structural support for cells and the transport of nutrients and 
biomolecules. Furthermore, ECM provides a unique microenvironment for cells, which 
can be highly variable depending on cell type and location. However, a simplified version 
of the ECM is typically employed in even the most advanced in vitro lung models, which 
acts as a passive cell-substrate only without reflecting special characteristics of the ECM 
(Doryab et al., 2019). In addition to the exceptional architecture of the lung tissue, which 
is difficult to recapitulate in vitro, pulmonary cells are exposed to a cyclic mechanical 
stretch-induced by breathing. The microenvironment of epithelial cells along with a phys-
iologic cyclic mechanical stretch at ALI provides a more realistic model of the lung than 
most currently available in vitro models of the lung. 
The complexity of imitating the main features of culture conditions for the lung cells has 
prevented researchers from bioengineering a more physiological in vitro model of the 
lung for studying respiratory disease under biomimetic conditions. As a result of the lack 
of proper in vitro lung models, there are currently no cures for chronic lung diseases –
only symptomatic therapies and lung transplantation for end-stage disease patients 
(Beasley et al., 2015; May and Li, 2015). The absence of therapeutic approaches is also 
contributing to the exponentially increasing expenditure involved in respiratory disease. 
For instance, in Germany only, the mean annual direct and indirect costs for chronic 
obstructive pulmonary disease (COPD) grades 1-4 was estimated as 115,581 € per pa-
tient in 2012 with an increase factor of 2.5-5.7 in annual healthcare costs (based on the 
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cohort of COSYCONET, 2,139 COPD patients) while the total cost for healthy people 
(for participants aged < 65 years only) was 7,983 € (Wacker et al., 2016). 
With the current project, we aimed to improve the predictive value of advanced lung cell 
models through improved membrane technology with more biomimetic features. In this 
project, an ultra-thin membrane (≤5 µm) has been developed, mimicking the main char-
acteristics of the cell-substrate in the alveolar epithelial cells. We characterized the phys-
ical and mechanical properties as well as bioactivity of the manufactured membrane. The 
findings showed that the membrane is permeable and stretchable enough to emulate the 
properties of the ECM of the lung. The membrane provides a biomimetic environment 
for cellular attachment and proliferation of lung epithelial cells by granting cell-responsive 
motifs such as arginine-glycine-aspartic (RGD) and stimulating the physiologic secretion 
of ECM proteins by the resident cells themselves. The developed membrane provides 
the basis for an advanced in vitro lung model for studying the implications of cyclic me-
chanical stretch (physiologic and non-physiologic) on cell physiology. 
Nanoparticles can serve as drug carriers for the targeted therapeutics in cancer therapy 
and delivery of proteins, protein-based materials, and antibiotics (Bölükbas et al., 2020; 
Pontes and Grenha, 2020). It has been shown that the mechanical forces such as cyclic 
stretch and shear stress induced by medium flow affect the cellular uptake and transport 
of nanoparticles across the biological barriers (Freese et al., 2014; Huh et al., 2010; 
Schmitz et al., 2019). The advanced biomimetic in vitro lung model enables us to study 
the effect of cyclic mechanical stretch on cell-nanoparticle interactions i.e. cellular uptake 
and transbarrier transport (particokinetics) of aerosolized nanoparticles on a pulmonary 
tissue barrier, which were cultured at ALI. 
2.2 Previous studies 
Animal models are playing a pivotal role in pre-clinical drug discovery and development 
since they allow us to study the biologically complicated responses of drugs in complex 
organisms under in vivo conditions by providing physiologic tissue-tissue and organ-
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organ interaction. Nevertheless, it has been estimated that up to 96% of the drug testing 
in preclinical animal models fails in clinical settings (patients) because of the lack of ef-
fectiveness and safety problems (Akhtar, 2015; Matthews, 2008). Unreliable extrapola-
tion from animals to humans is mainly due to the species differences in biological mech-
anisms (Pound and Ritskes-Hoitinga, 2018). 
Over the last decades, many efforts have been made to improve the biomimicry level of 
the in vitro models of the lung –as an alternative to animal models. Conventional in vitro 
lung cell models rely on static submerged culture conditions, where cells are completely 
covered with cell culture medium, preventing them from polarization and secretion of a 
protective lining fluid such as mucus or surfactant (Doryab et al., 2019). Lately, ALI cell 
culture systems mainly based on Transwell® technology have been introduced, where 
epithelial cells are cultured on a porous membrane (such as PET (polyethylene tereph-
thalate) and PC (polycarbonates)), with air on the apical side and cell culture medium on 
the basal side, offering more physiologic conditions. Under ALI conditions, epithelial cells 
can polarize and secrete the protective liquid layer such as surfactant (Birkness et al., 
1999; Gueven et al., 1996; Heise et al., 2011; Liu et al., 1995; Trepat, 2006; Trepat et 
al., 2004). Nevertheless, these membranes are rigid and are not able to mimic the struc-
tural integrity and high elasticity of the ECM (or cell-substrate) of the lung. 
The lung as a dynamic organ experiences cyclic mechanical stretch due to breathing 
activity, which is under both physiological and non-physiological conditions, playing a 
key role in the physiology of alveolar epithelial cells (Doryab et al., 2019). Numerous 
investigations have suggested that several stretch-induced biological endpoints can be 
activated/mediated during cell-stretch such as secretion of surfactant proteins, cell pro-
liferation, apoptosis, activation of pro/inflammatory responses, and permeability (Figure 
2). Among them, secretion of surfactant proteins by alveolar epithelial cells is one of the 
main stretch-activated endpoints via triggering of the transcription factor-dependent pro-
tein kinase (cAMP-PKA-dependent) signaling pathway and Ca2+–regulated mechanisms 
(Arold et al., 2009; Nakamura et al., 2000; Sanchez-Esteban et al., 1998; Scott et al., 
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1993; Wang et al., 2006; Wirtz and Dobbs, 1990). Mechanical stretch under physiologic 
and non-physiologic strain can stimulate extracellular signal-regulated protein kinases 1 
and 2 (ERK1/2), which are members of the mitogen-activated protein kinase (MAPK) 
family, meditating cell proliferation and apoptosis (Chaturvedi et al., 2007; Chess et al., 
2000; Edwards et al., 1999; Felder et al., 2019; Hammerschmidt et al., 2004; Kuhn et al., 
2017; McAdams et al., 2006; Savla and Waters, 1998; Stucki et al., 2015; Tschumperlin 
and Margulies, 1998). 
 
Figure 2.  Effects of (cyclic) mechanical stretch on lung epithelial cell physiology observed 
under in vitro conditions. The cell schematic has been reproduced with permission from 
(Doryab et al., 2019). 
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It has been also shown that the cyclic mechanical stretch can provoke pro-inflammatory 
(Rentzsch et al., 2017; Valentine et al., 2018) and inflammatory responses (Chang et al., 
2017; Copland and Post, 2007; Jafari et al., 2004; Ning and Wang, 2007; Schmitz et al., 
2019; Stucki et al., 2015; Vlahakis et al., 1999) in both physiologic or non-physiologic 
range in the lung alveolar epithelial cell.  
Furthermore, paracellular and transcellular transport of small molecules across the epi-
thelial cell barrier are increased under short term cell-stretch conditions at 37% ∆SA/SA 
(relative change in surface area, 10-60 min (Cavanaugh et al., 2006; Yehya et al., 2019)) 
or long-term cell-stretch (21-72h) at a physiologic amplitude and rate (≈8-10% linear or 
16-21% ∆SA/SA, at 0.2 Hz) (Stucki et al., 2015, 2018). The majority of these in vitro 
investigations used available commercial cell-stretch technologies (e.g. Flexcell® FX-
6000™ Tension System; Flexcell Intl. Corp., USA) (Figure 3), which are suitable for sub-
merged culture conditions only. 
More recently, several lung-on-a-chip technologies have been proposed most notably 
the ground-breaking work by the WYSS Institute of Harvard University, USA, which is 
able to coculture lung cells not only under cyclic stretch but also at ALI culture (Huh et 
al., 2010; Jain et al., 2018; Li et al., 2019; Si et al., 2020) (Figure 3). Typically, these 
microchip devices are comprised of polydimethylsiloxane (PDMS) apical and basal cell 
culture chambers that are separated by a thin porous membrane, on which cells are 
cultured (Doryab et al., 2016; Huh et al., 2010). Some of these platforms can also provide 
a relevant medium/blood flow to mimic both blood movement and breathing-induced me-
chanical stretch. These microfluidics systems or similar airway-on-chip are evidence of 
a great technological advancement as compared to the conventional 2D ALI culture mod-
els on static, rigid porous membrane to the extent that they recently are being considered 
as an alternative for animal models for the repurposing of FDA-approved drugs as pos-
sible therapeutics for Coronavirus disease 2019 (COVID-19) (Gard et al., 2020; Ingber, 





Figure 3. Advancement of cell stretch devices employed in studies on cell and tissue mod-
els of the lung (in vitro). Schematics have been reproduced with permission from (Doryab et al., 
2019). 
 
Despite these recent innovations, more investigations are required to address several 
critical drawbacks of these microfluidic devices. In these platforms, a porous/permeable 
PDMS-based membrane is employed as a cell-substrate (or ECM). PDMS is considered 
chemically inert and provides suitable mechanoelastic properties. However, PDMS is not 
cell-friendly since it has hydrophobic nature, which requires surface treatment prior to 
cell seeding such as chemical and physical modification or coating with ECM proteins 
(e.g. collagen) to allow for cell attachment and growth. This may be seen as an obvious 
flaw of ECM–coated PDMS membranes since the aggregation and/or dislodgment of 
cells from PDMS membranes frequently happens, especially for long-term culture and/or 
stretch conditions (Chuah et al., 2016). PDMS also absorbs lipophilic drugs (passive 
drug absorption) and adsorbs some natural biomolecules and pharmaceutical agents in 
the culture medium as a thin layer on the surface of the PDMS membrane, which can 
interfere with drug studies, mitigate cell viability and impair the predictive capacity of in 
vitro testing concerning clinical relevance. It has been shown that the level of passive 
drug absorption by the PDMS is comparable with fat absorption in some cases e.g. nic-
otine and cisplatin in human gut-liver-kidney chips modeling (Herland et al., 2020). 
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Hence, the performance of PDMS-based systems has to be tested for different drugs. 
Furthermore, PDMS can release cell-toxic substances (Carter et al., 2020; Regehr et al., 
2009), which may affect the cell physiology probably cell apoptosis. 
Lately, alternative synthetic/natural scaffolds have been fabricated with a thickness 
range of ≈20-200 µm and proper properties for lung cells mainly using electrospinning. 
These hybrid electrospun scaffolds showed promising results for adherence and prolif-
eration of lung cells. For instance, poly-L-lactic acid (PLLA)/ decellularized pig lung ECM 
(PLECM) (Young et al., 2017), poly(ε-caprolactone) (PCL)/ star-shaped polyethylene gly-
cols (sPEG) functionalized with biomolecules (Nishiguchi et al., 2017),  and  PCL/ gelatin 
(Higuita-Castro et al., 2017) have presented the advantage of employing natural poly-
mers in combination with synthetic polymers to obtain a membrane with superior physi-
comechanical properties. The stretchability of these scaffolds/membranes, however, has 
not been tested yet since these scaffolds were used only under static (unstretched) cell 
culture conditions. Besides, these alternative membranes are mainly rigid, which cannot 
mimic the stiffness of ECM and connective tissues in the alveolar region. This aspect is 
particularly important especially for mimicry of specific lung disease in the lab such as 
pulmonary fibrosis. Although enormous efforts have been invested in the development 
of a tunable membrane/scaffold for the lung epithelial cells, several key biomimetic fea-
tures are still missing, including thickness, stretchability, permeability, and stiffness. As 
mentioned above, each of these parameters directly or indirectly impacts on cell micro-
environment, causing adverse effects on cell functions. 
2.3 Overview of our approach 
The current Ph.D. project aimed to (i) manufacture and validate a biomimetic stretchable 
porous membrane highly conducive to the growth of pulmonary cells, (iii) optimize cell 
growth and viability under both static and dynamic conditions, (iii) study the effects of 
dynamic conditions on cell physiology, and (iv) investigate the effect of cyclic mechanical 
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stretch on cellular uptake and transbarrier transport (particokinetics) of aerosolized nano- 
and microparticle on a pulmonary tissue barrier. 
During this project, we have modified the cell-stretch Moving Air-Liquid Interface (MALI) 
bioreactor –which was originally developed as part of the Ph.D. thesis by Daniele Cei 
under the supervision of Otmar Schmid and Arti Ahluwalia (University of Pisa, Italy) (Cei, 
2015; Cei et al., 2021)– that is now referred to as CIVIC (Cyclic In VItro Cell-stretch) 
bioreactor. This millifluidic bioreactor system or “breathing” in vitro model of the lung was 
designed to mimic the culture conditions of the alveolar tissue barrier in the lung, for the 
study of the role of cyclic mechanical stretch on cell physiology under physiologic and 
pathophysiologic stretch conditions (Figure 5A). The CIVIC system also allows for aero-
solized delivery of liquid drugs (here: nano- and microparticle suspensions) and encom-
passes a medium flow/ perfusion to recapitulate blood movement associated with shear 
stress applied to the basal side of the cells. A recently added feature of the CIVIC system 
is the implementation of two pressure sensors to monitor the stretch profile (amplitude 
and frequency) and the elastic modulus of the membrane in real-time, which is a unique 
feature of this cell-stretch lung bioreactor. 
We equipped the CIVIC bioreactor system with a biphasic ultrathin BETA membrane 
(BETA: Biphasic Elastic Thin for Air-liquid culture conditions) for models of the alveolar 
air-blood barrier (European patent application was filed by INNO, HMGU on 24.11.2020) 
to overcome the limitations of PDMS (polydimethylsiloxane) or PET (polyethylene ter-
ephthalate) membranes, which are commonly used in ALI culture and/or cell-stretch sys-
tem (Figure 5A). 
The conceptual idea of the biphasic membrane was inspired by the two distinctly different 
membrane characteristics required during the two phases of in vitro cell-stretch experi-
ments with epithelial cells of the lung, namely (i) the initial phase of cell seeding and 
proliferation (under static and submerged conditions) and (ii) the culture of cells at ALI 
and cyclic mechanical stretch conditions (Figure 5B). During phase I, the membrane 
should be wettable and conducive to cell growth (surface hydrophilicity) to support initial 
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adhesion and cell growth. After the formation of a cell monolayer, the cells are air-lifted 
in phase II of cell culture, which requires a permeable membrane (low thickness with 
suitable porosity), allowing for contact with air from the apical side and transporting nu-
trient/growth factors supply to the cells through the pores of the membrane (from basal 
to apical side) (Figure 1C). After polarization of cells at ALI conditions, the cells are ex-
posed to a cyclic cell-stretch, demanding not only a porous but also a flexible/stretchable 
membrane to endure cyclic stretch. 
In addition to this bifunctional characteristic, a suitable membrane for culturing pulmo-
nary epithelial cells undergoing cell-stretch should meet a broad range of requirements 
including cytocompatibility, wettability, switchable permeability, and durability. We 
screened various polymers as candidate materials for stretchable and porous mem-
branes (See Table 4 of paper IV). Natural-derived polymers such as gelatin and collagen 
are greatly used for remolding in vitro tissue models due to their high bioactivity and 
cytocompatibility. Nevertheless, the application of natural-derived polymers in scaffold 
fabrication is limited due to (mainly) their low mechanical properties. The blends of nat-
ural and synthetic-derived polymers, however, have been shown tunable mechanical 
(elastic modulus and reversible strain) and physical (porosity, thickness, and wettability) 
properties (more detail can be found in section 4.3. Material Selection of paper IV). After 
evaluating various natural and synthetic-based polymers, we concluded that a hybrid 
copolymer (natural-synthetic) consisting of poly(ε-)caprolactone (PCL) and gelatin is the 
superior candidate for a biomimetic membrane used in pulmonary cell-stretching models 
with a combination of physicomechanical and cytocompatibility properties (Figure 4). 
Gelatin is a water-soluble and bioresorbable polymer, which is widely employed in the 
field of tissue engineering and regenerative medicine due to its high cytocompatibility, 
tunable biophysical properties, abundance of cell-responsive motifs, easy to access, and 
reproducibility. PCL is an FDA-approved biodegradable, biocompatible, and bioresorba-
ble polymer. By using gelatin as sacrificial material which initially fills the pores of the 
PCL membrane but is gradually dissolved during contact with cell culture medium, the 
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initial non-porous, stiff membrane gradually transitions into a porous elastic membrane, 
which matches the requirements during phase I and phase II of cell-stretch experiments 
as described above. In sum, a biomimetic membrane (BETA) was tailored to mimic the 
main physicomechanical characteristics similar to the ECM of the lung alveolar region 
(Figure 4) and to improve the cell adherence and proliferation of the lung epithelial cells. 
 
 
Figure 4. The state-of-the-art membrane for alveolar tissue. The candidate materials (both 
synthetic and natural-based) were screened based on their physical, mechanical, and bioactivity 
characteristics. The natural-synthetic copolymers are favorable candidates for suitable stretcha-
ble membranes, mimicking human alveolar tissue. A suitable membrane should have both biomi-
metic physicomechanical and bioactivity properties. These properties include stretch- and perme-
ability-related physiologic parameters as listed in the table, which was reproduced with permission 
from (Doryab et al., 2019). 
 
As an application of the BETA membrane and the CIVIC bioreactor system, we investi-
gated the role of cyclic mechanical stretch (both physiologic and non-physiologic) on the 
cell physiology such as F-actin and tight junction formation, cell layer permeability, and 
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inflammatory responses (IL-8) (Figure 5B). This revealed that tight junctions (ZO-1) are 
formed and oriented along the stretch direction under a physiologic stretch while non-
physiologic (over-)stretch may disrupt the tight junction formation. We also showed that 
the cyclic cell-stretch can increase the permeability of the cell layer as well as the release 
of IL-8. 
Exploiting more physiologically relevant cell models could affect cell–nanoparticle inter-
actions, altering the fate of nanoparticles after administration to the body i.e transbarrier 
transportation through biological barriers such as air-blood. In addition, the pharmacoki-
netics profiles of particles (e.g. time-resolved drug concentration in the blood after drug 
inhalation) are a mandatory part of clinical trials for regulatory approval of drugs. We, 
therefore, performed particle transport studies (nanoparticles (100 nm) and microparti-
cles (1000 nm)) under unstretched and physiologically stretched conditions. The data 
suggest that a physiologic stretch can increase cellular uptake and internalization/traf-
ficking of nanoparticles (100 nm), resulted in higher transcytosis.  
A summary of the advantages of the CIVIC and BETA technology as well as an overview 
of the main properties of the optimized BETA membrane and the effect of cyclic stretch 
on nanoparticle transport across an alveolar barrier model is presented in Figure 5. To 
the best of our knowledge, this is the first investigation of the effect of cyclic stretch on 
transbarrier transport of aerosolized particles deposited on an in vitro alveolar barrier 
model at ALI culture, closely resembling the conditions during inhalation of nanoparticles 
in the lung. Moreover, real-time monitoring of the stretch characteristics and the mem-
brane stiffness (elastic modulus) is an important measure of quality control during cell-
stretch experiments. 
The technological progress introduced by the CIVIC bioreactor system and the BETA 
membrane presents a significant advancement with respect to biomimicry of in vitro mod-
els of the lung, providing a more biomimetic model for more reliable translation of in vitro 
response studies into clinical outcome. Nevertheless, several challenges involved in the 
newly developed CIVIC bioreactor system equipped with the BETA membrane (see 
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Table 1), which demand further studies to develop the membrane and the bioreactor 
technology together with more thorough cellular and particokinetic analysis, improving 
the competence of the advanced in vitro lung cell models. 
 
Figure 5. The overview of the main results of this Ph.D. study. (A) (Left panel) Schematic 
depiction of the in vitro cell stretching bioreactor system (CIVIC), which was modified in this study. 
This bioreactor system mimics the culture conditions for pulmonary epithelial cells, including cyclic 
mechanical stretch and medium flow (in the basal chamber using perfusion). The platform incor-
porates pressure sensors to monitor stretch profile and measure the elastic modulus (stiffness) 
of the membrane in real-time (further details in Figure 1 of paper II). (Right panel) A biomimetic 
membrane (BETA) with relevant physicomechanical properties was designed and manufactured, 
which then integrated into the CIVIC system for studying the role of cyclic mechanical stretch 
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(both physiologic and non-physiologic) on the physiology of pulmonary epithelial cells and cell-
particle interactions. Reproduced with permission from (Doryab et al., 2021b). (B) Schematic de-
piction of a summary of the outcomes of the current study. (i) Selection of a PCL/gelatin mixing 
ratio providing optimum (biomimetic) properties of the BETA membrane (further details in Figures 
1-5 of paper I). (ii) Stretch-induced formation of ZO-1 tight junctions and polymerization of F-actin, 
and (iii) the enhanced internalization of nanoparticles (100 nm). (iv) The role of physiologic cell-
stretch on cell layer permeability, inflammatory responses (IL-8) (further details in Figure 6 of 
paper I), and the cellular uptake of nanoparticles (further details in Figure 7 of paper I and Figure 
4 of paper II). 
2.4 Concluding remarks 
In the present study, we developed a biomimetic in vitro model for the lung application 
consisting of a stretch-activated lung bioreactor system (CIVIC) and a bioinspired mem-
brane (BETA). Proliferation of two lung epithelial cells (A549 and 16HBE14o−) on the 
BETA membrane exhibited its excellent cytocompatibility at ALI culture. We showed the 
CIVIC bioreactor system can mimic the cell-stretch induced by breathing motions and 
shear stress stimulated by blood flow. For proof-of-concept experiments, we integrated 
the BETA membrane into the CIVIC system and investigated the effect of cyclic mechan-
ical stretch (physiologic and non-physiologic) on cell physiology at ALI, including cell 
proliferation/apoptosis, polymerization of the F-actin cytoskeleton, formation/disruption 
of ZO-1 tight junctions, the permeability of cell monolayer, and inflammatory response 
(IL-8). Moreover, the CIVIC bioreactor system enables us to study particle-cell interac-
tions at ALI conditions. We then studied the role of cell-stretch on cellular uptake and 
transport of particles (100 nm and 1000 nm) across an alveolar barrier model at ALI 
culture. The results demonstrated the advantages of the novel in vitro cell-stretch model 
for investigation of the role of mechanical stretch on the pulmonary epithelial cell model, 
which could pave the way for more biomimetic in vitro models of the lung, providing more 
robust translation into clinical outcome. Nevertheless, more studies are required to un-
derstand the role of cyclic mechanical stretch on key pathways mediated by stretch such 
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as Yes-associated protein (YAP)/Transcriptional co-activator with PDZ-binding motif 
(TAZ). The membrane, however, could be further modified to support the proliferation of 
primary cells and to improve physicomechanical properties (such as thickness and stiff-
ness) in the range of physiologic level. 
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Table 1. Advantages and challenges of the next generation of the in vitro model based on the BETA membrane and CIVIC bioreactor system. 
Advantages Challenges/ Future Studies 
BETA Membrane  
The stiffness/ elastic modulus of the BETA membrane is 0.78±0.24 
MPa (phase II, day 6) (Doryab et al., 2021b), which is lower than the 
commonly used PDMS membranes with Young’s modulus of ≈1–3 
MPa (Wang et al., 2014). 
 
It is still ≈100-fold larger than that of alveolar tissue with 3 – 6 kPa (Bou 
Jawde et al., 2020; Polio et al., 2018). 
The BETA membrane could withstand cyclic mechanical stretch up 
to 25% (linear) up to 48 h (the maximum time tested in paper I), 
which embraces the physiologic mechanical strain (linear (1D) strain 
4%–12% (normal breathing-deep inspiration and heavy exercise) 
and pathological conditions (20 % linear) in the lung (Forrest, 1970; 
Fredberg and Kamm, 2006; ICRP, 1994; Roan and Waters, 2011; 
Waters et al., 2012). 
 
The role of cyclic stretch (24 h for cell physiology/response; 2 h for parti-
cokinetics) on cellular physiology and particle transportation/uptake were 
studied. A longer period of cell-stretch (more than 24 h) is required. 
The BETA membrane is thin (≤ 5 µm) compared to the available 
membranes for lung application at ALI (≈10 µm). 
It is still ≈100-fold larger in thickness; therefore, a thinner membrane is 
required to cover the thickness of the total alveolar-capillary barrier: 1.1 
µm ± 0.1 (Weibel, 1970, 2009). 
 
The BETA membrane is permeable (9.9x10-6 cm s-1 for FITC-dex-
tran 4 kDa and 15.3% 3D porosity) with through pores (an equivalent 
area diameter of 4.5 ±1.7 µm). 
 
A thinner membrane is required to circumvent the artifact effect of the 
membrane during the permeability experiments. 
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Two types of lung epithelial cell lines (A549 and16HBE14o−) were 
grown successfully on the BETA membrane. 
- It is necessary to use primary lung cells (or at least immortalized primary 
cells) to investigate the bioactivity of the BETA membrane. 
- loss of barrier integrity for A549 cells (2 h physiologic stretch) indicates 
a better cell model is required for transport studies. 
 
The copolymer (PCL/gelatin) represents a great combination of bio-
physicomechanical properties suitable for culturing lung epithelial 
cells at ALI culture 
 
It does not represent the fiber-like structure and molecular composition 
of the innate basement membrane. 
The Millifluidic CIVIC Bioreactor  
The millifluidic CIVIC bioreactor utilizes positive pressure to me-
chanically stretch a cell-covered elastic membrane, allowing for pre-
cise selection of stretch amplitude during the cell-stretch experi-
ment. 
The maximum positive pressure (2.5 kPa) is similar to mechanical venti-
lation at the intensive care unit of a hospital (normal: 1.5 – 2.0 kPa, 2.5 
kPa acceptable peak value) (Hall, 2016) but higher than exerted onto the 
lung tissue during normal exhalation (0.1 – 0.5 kPa). 
 
The CIVIC bioreactor system could cover the entire clinically rele-
vant amplitude range (5% linear (Cei et al., 2021), 10-17% linear 
(Doryab et al., 2021a, 2021b)) compared to human breathing pat-
terns. 
 
Further studies are required to decipher the role of non-physiologic cell 
stretch on cellular physiology in complex lung cell models (coculture and 
triple coculture). 
The medium perfusion rate used in the CIVIC system mimics a blood 
perfusion rate of 400 µL min-1 with the ratio of area and perfusion 
rate of 1.25 m2/(L min-1)-1. 
- The ratio of area and perfusion rate of the CIVIC is considerably lower 
than that of the lung (20 m2/(L min-1)-1 = 100 m-2/(5 L min-1)). 
- The flow rate of the lung (6.4 L min-1) can be established in the CIVIC 




The CIVIC bioreactor system is able to apply simultaneously cell 
stretch (mimicking breathing motions) and perfusion (mimicking 
blood flow). 
 
More studies are required to understand the role of blood perfusion on 
cell-stretched experiments. 
Particokinetic Studies  
The efficiency of aerosolized substance delivery is ca. 50% (only 
liquids; no dry powder) with the delivered dose of 0.5 µL cm-2 min-1, 
which is corresponding to typical drug inhalation times of ca. 3 min 
–delivery rate (0.1 min (metered-dose inhalers) to 15 min (nebulizer) 
in clinics) and efficiency (10 – 30%) similar to clinical conditions. 
- Enhanced cellular uptake of nanoparticles, but not of microparticles (2 
h physiologic stretch) –strong inverse size dependence of transport is 
consistent with in vivo data (Kreyling et al., 2013). 
- More in-depth investigations on cellular uptake of particles based on 
particle physicochemical characteristics such as material, size, shape, 
and surface charge are required. 
Chapter 1 
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2.5 Chapter 1: Design and manufacturing of a biomimetic 
membrane for pulmonary epithelial cells 
In this chapter, we report the design and manufacturing of a bioinspired BETA (Biphasic 
Elastic Thin for Air-liquid culture conditions) membrane, mimicking key features of the 
alveolar-capillary barrier of the human lung. The BETA is a biphasic copolymeric thin 
membrane consisting of poly(ε-)caprolactone and gelatin with appropriate surface wet-
tability, porosity and stretchability (up to 25% linear strain) for culturing lung epithelial 
cells under cell-stretch conditions at ALI. Moreover, we investigated the role of physio-
logic and non-physiologic cyclic mechanical stretch (at ALI culture) on cell viability, for-
mation of F-actin cytoskeleton and tight junction, apparent permeability (barrier integ-
rity), and activity of inflammatory response (IL-8). We also showed that cyclic physiologic 
stretch can enhance the cellular uptake of nanoparticles.  
The method for fabricating BETA membrane has been filed for European patent appli-
cation. This study was published in Advanced Functional Materials (Doryab et al., 
2021b) and reprinted with permission from the corresponding publishers. Copyright © 
2020. The Authors. Advanced Functional Materials published by Wiley-VCH GmbH.  
Chapter 2 
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2.6 Chapter 2: Particokinetic study under cyclic stretch and 
air-liquid interface conditions 
In this chapter, we describe the technical details of the CIVIC (Cyclic In VItro Cell-stretch) 
bioreactor system with particular emphasis on the new or refined aspects as compared 
to the MALI system. The CIVIC incorporates in-line two pressure sensors for real-time 
monitoring of the stretch profile (amplitude) and the elastic modulus of the (cell-covered) 
membrane during cell-stretch experiments. The latter has the potential of real-time mon-
itoring of the stiffness of the cells grown on the membrane, which could be used for real-
time sensing of fibrotic modifications of the cell layer. The CIVIC system is PDMS-free 
to prevent any unwanted leaching/release of silicone into the culture medium. We stud-
ied the role of physiologic cyclic mechanical stretch on cellular uptake and transepithelial 
transport of nanoparticles (100 nm) and microparticles (1000 nm), which demonstrated 
that the cyclic physiologic mechanical stretch can enhance the cellular uptake and tran-
sepithelial translocation of only nanoparticles. 
 The method for investigating cells attached to the biocompatible composite membrane 
(BETA) have been filed for European patent application. This study was published in 
Frontiers in Bioengineering and Biotechnology (Doryab et al., 2021a) and reprinted with 
permission from the corresponding publishers. Copyright © 2021. The Authors. Under 
the terms of the Creative Commons Attribution License (CC BY). 
Chapter 3 
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2.7 Chapter 3: An in vitro lung model with aerosol delivery 
In this chapter, we explain the engineering design, computational modeling, and empir-
ical performance of a Moving Air-Liquid Interface (MALI) bioreactor system for the study 
of aerosol deposition on lung epithelial cells (A549) cultured at Air-Liquid Interface (ALI) 
under cyclic mechanical stretch. The main chamber was designed to recapitulate the 
ALI conditions using apical (air) and basal (cell culture media) compartments separated 
by an elastic porous membrane for cell growth. The membrane can be stretched by 
oscillating airflow in the apical chamber to apply a cyclic mechanical strain to cells. Fur-
thermore, highly efficient liquid aerosol deposition (ca. 51.5%) can be accurately mod-
eled using finite element methods. As a proof of concept, we showed that A549 cells 
can be mechanically stimulated under ALI and physiologic stretch conditions without 
loss of cell viability. 
This study was published in Biotechnology and Bioengineering (Cei et al., 2021) and 
reprinted with permission from the corresponding publishers. This publication reprinted 
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Chronic respiratory diseases are among the leading causes of death 
worldwide, but only symptomatic therapies are available for terminal 
illness. This in part reflects a lack of biomimetic in vitro models that 
can imitate the complex environment and physiology of the lung. 
Here, a copolymeric membrane consisting of poly(!-)caprolactone and 
gelatin with tunable properties, resembling the main characteristics of 
the alveolar basement membrane is introduced. The thin bioinspired 
membrane (!' µm) is stretchable (up to !'% linear strain) with 
appropriate surface wettability and porosity for culturing lung epithelial 
cells under air–liquid interface conditions. The unique biphasic concept 
of this membrane provides optimum characteristics for initial cell growth 
(phase I) and then switch to biomimetic properties for cyclic cell-stretch 
experiments (phase II). It is showed that physiologic cyclic mechanical 
stretch improves formation of F-actin cytoskeleton filaments and tight 
junctions while non-physiologic over-stretch induces cell apoptosis, 
activates inflammatory response (IL-&), and impairs epithelial barrier 
integrity. It is also demonstrated that cyclic physiologic stretch can 
enhance the cellular uptake of nanoparticles. Since this membrane offers 
considerable advantages over currently used membranes, it may lead the 
way to more biomimetic in vitro models of the lung for translation of in 
vitro response studies into clinical outcome.
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The lung is one of the vital organs in the 
body that is responsible for gas exchange 
between air and blood during breathing. 
Although the prevalence of lung diseases 
such as chronic obstructive pulmonary 
disease (COPD) is rising, few causal thera-
pies are available for respiratory diseases 
due to the complex internal structure and 
functions of the lung tissue, which cannot 
easily be recreated in the lab.[!] The availa-
bility of preclinical models of lung disease 
for reliable prediction of clinical outcome 
is recognized as an important bottleneck 
for the development of new drugs against 
lung diseases.["] Consequently, significant 
e#orts are undertaken to enhance the 
biomimetic level of currently available in 
vitro models of lung diseases.[$,%]
The main purpose of the lung is to 
allow for an e&cient supply of oxygen to 
and removal of carbon dioxide from the 
red blood cells (erythrocyte). From the tra-
chea, the gas is directed through a com-
plex branching network of conducting 
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/%".%""!/adfm.!"!""'$"$.
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airways into the alveolar region, where gas exchange takes 
place (Figure! !A). For e"cient gas exchange, a micro-scale 
alveolar-capillary tissue barrier (minimum thickness of !#!µm) 
is required, which essentially consists of an ultrathin base-
ment membrane (!$.#!µm) covered with a confluent layer of 
alveolar type-I and type-II (ATI and ATII, respectively) epithelial 
cells on the apical (air-facing) side and a confluent layer of 
endothelial cells on the blood side (Figure! #B,C).[%,&] The main 
functions of this basement membrane include structural sup-
port for resident cells as well as transport of nutrients and 
biomolecules between blood and lung tissue.[&] Thus, the base-
ment membrane of the alveolar region needs to be sti' enough 
Figure %. Manufacturing of the BETA membrane. A) A #D reconstruction of the whole murine lung tissue obtained with light sheet fluorescence 
microscopy (LSFM) depicting trachea, bronchi, small (terminal) bronchioles (I), distal bronchial tree (II) and #D honeycomb structure of the 
alveolar region as observed with confocal microscopy on precision cut lung slices (III). B) Transmission Electron Microscopy (TEM) image of 
alveolar-capillary region, depicting the alveolar epithelium, capillary endothelium, basement membrane as part of the air–blood barrier, and eryth-
rocyte. Panels of (A,B) reproduced with permission.[$] Copyright !"%&, John Wiley and Sons. C) Schematic of lung alveolar region, showing the 
air-liquid (blood) interface (ALI) in vivo. An ultrathin basement membrane ("% µm),'which separates epithelial and endothelial cell layers (liquid 
side). A thin layer of surfactant, which is secreted by type II alveolar epithelial cells, is sitting on the top of epithelial cells to reduce surface tension 
at ALI in the alveolar region. D) Schematic of in vitro ALI culture models under static and stretch conditions. Cells are seeded on a porous/flexible 
membrane and air-lifted after forming a confluent cell layer. E) Schematic of the membrane fabrication consisting of poly(!-)caprolactone (PCL) 
and gelatin using spin-coating. F) Photograph of the fabricated membrane and a %-euro coin, showing that it is transparent enough for cell imaging 
technologies such as live cell imaging and confocal microscopy. G) Depiction of the two phases of the membrane. Phase I: After the spin-coating 
of a PCL-gelatin mixture, a uniform, non-porous PCL-gelatin membrane is produced, which consists of PCL with embedded “islands” of gelatin 
serving as adhesion point for cells facilitating subsequent cell proliferation. Spin-coating of a gelatin-PCL mixture results in an initially non-porous 
PCL-gelatin membrane, where the “islands” of gelatin allow the epithelial cells to grow into a confluent cell monolayer. Phase II: Gradually gelatin 
is dissolved away by cell culture medium. This opens pores for the nourishment of the cells under ALI conditions, which enhances not only mem-
brane permeability but also elasticity. H) A cross-sectional view of the manufactured membrane. Scale bar is ('µm. I) SEM image (top view) of the 
membrane during phase I and phase II. The scale bar is %"" µm.
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for supporting the delicate honeycomb structure of the alveolar 
sacs and yet provide su!cient elasticity to allow for a breathing-
induced cyclic stretch at low energy consumption.
Current membrane technologies employed in in vitro lung 
models focus on structural support for the cells, but are too 
thick and lack elasticity as compared to basement membranes 
of the lung.[",#] Standard cell culture models are grown in multi-
well polycarbonate plates under submerged culture conditions, 
i.e., the cells are completely covered with cell culture media. 
More advanced, complex, multi-cell, physiologically structured 
cell cultures of the lung epithelium for studying normal home-
ostasis and regeneration or co-cultured with disease-specific 
e$ector cells (e.g., fibroblasts for pulmonary fibrosis) are com-
mercially available from both healthy donors and patients.[%] 
These advanced in vitro models are cultured in Transwell 
inserts under air-liquid interface (ALI) conditions and exposed 
to aerosolized drugs under dose-controlled conditions.[&–'(] On 
the other hand, these inserts culture the cells on perforated, 
sti$ polyethylene terephthalate (PET) membranes (more rarely 
polycarbonate or polytetrafluoroethylene (PTFE) membranes 
are used), which do not mimic the elastic ECM and cyclic 
stretch conditions in a “breathing” lung, which has been shown 
to play a key role in the development of chronic lung diseases 
such as pulmonary fibrosis.['']
Several cell-stretch devices have been described in the litera-
ture, but only a few devices are commercially available and all 
of them utilize submerged cell cultures.[#] On the other hand, 
newly designed microfluidic systems for stretch-activated ALI 
culture conditions have been described '( years ago but–in 
spite of significant e$orts–are just reaching the marketplace 
and are not widely used, yet.[')] Most of these cell-stretch 
devices rely on membranes made out of poly(dimethylsiloxane) 
(PDMS) since they are considered chemically inert and pro-
vide suitable mechano-elastic properties.['),'*] However, they do 
have disadvantages, which hamper the progress of cell-stretch 
technologies. PDMS membranes are hydrophobic requiring 
pre-conditioning of the membrane (e.g., coating with ECM 
proteins) to enhance wettability and cell adhesion. Achieving 
a confluent monolayer of epithelial cells on a coated-PDMS 
membrane is a major challenge since the aggregation and/or 
dislodgment of cells from the PDMS surface due to protein 
dissociation often occurs especially for long-term culture condi-
tions and under stretch conditions.['+] Moreover, PDMS adsorbs 
some drugs and proteins/growth factors contained in the cell 
culture media and leaching of uncured PDMS oligomers into 
the culture media can influence cell physiology.['"] Thus, an 
appropriate membrane providing both optimum cell culture 
conditions and physicomechanical properties inspired by the 
microenvironment of alveolar epithelium is still missing, which 
presents a major obstacle for the development of biomimetic in 
vitro cell-stretch models of the lung.
Polymeric systems (natural and synthetic-based) are widely 
used to manufacture suitable sca$olds with biomimetic fea-
tures for soft tissue applications including lung due to their 
diversity in chemical groups, allowing for remarkable physical 
and mechanical properties.[#,'#,'%]
In this study, we introduce a biphasic copolymeric mem-
brane consisting of gelatin and poly(!-)caprolactone (PCL) 
chosen for their cell-conducive and mechano-elastic properties 
to mimic the microenvironment of alveolar epithelial (AT) cells 
with respect to important functional features such as mechan-
ical, biophysical, and bioactive properties. This Biphasic Elastic 
Thin for Air-liquid culture conditions (BETA) membrane facili-
tates cell adhesion and proliferation without pre-treatment 
of the membrane and it provides su!cient porosity and bio-
mimetic elasticity as required for in vitro cell-stretch applica-
tions under ALI culture conditions. The hybrid membrane is 
integrated into a stretch-activated lung bioreactor, which allows 
us to investigate the e$ect of cyclic mechanical stretch on cell 
physiology and the transport of nanoparticles across an alveolar 
barrier model. We also present novel methods for real-time 
monitoring of cyclic stretch and measuring the elastic modulus 
of membrane during cell-stretch experiments.
!. Results and Discussion
!.&. The Biphasic Membrane Concept
Mimicking the lung in vitro models of the alveolar barrier often 
culture a confluent monolayer of epithelial cells under static 
ALI conditions, where air-exposed epithelial cells are growing 
on a rigid perforated membrane, which is in contact with cell 
culture medium on the basal side for the nourishment of the 
cells (Figure,'D). Only recently, static ALI culture models have 
been adapted to allow for cyclic stretch conditions, mimicking 
the mechano-elastic strain exerted during the breathing activity 
of the lung (Figure,'D).
During the growth of these static or dynamic ALI cell cul-
ture models, two main phases can be distinguished; i) an initial 
phase of cell adhesion, proliferation, and growth of alveolar epi-
thelial cells into a )D and confluent cell monolayer. Since this 
is done under submerged cell culture conditions (with cell cul-
ture medium in the apical compartment), the membrane does 
not have to be perforated, yet (phase I). ii) Once a confluent 
cell layer is formed the cell culture is air-lifted (i.e., cell culture 
medium is withdrawn from the apical compartment) and left 
for acclimatization allowing the cells to polarize and secrete 
protective lining fluid['&] prior to performing the actual cell cul-
ture experiments under physiologic ALI conditions (phase II), 
i.e., a perforated membrane is required for this phase.
Consequently, the “ideal” membrane is tailored toward 
sequentially meeting the two di$erent sets of specifications 
corresponding to those two phases of cell culture conditions. 
For phase I (initial cell growth), the “ideal” membrane is bio-
active (i.e., conducive to cell adhesion and growth), wettable 
and non-porous (prevents cells to migrate into/through the 
membrane) to facilitate the formation of a planer, confluent 
epithelial (and endothelial) cell layer under submerged cul-
ture conditions. On the other hand, after air-lifting of the 
cells (phase II), the membrane should be porous/permeable 
enough to allow for su!cient exchange of nutrients, growth 
factors, and cell signaling molecules between cells and basal 
cell culture medium,['-] mimic elasticity/sti$ness of the ECM 
of the lung[)(,)'] and be resilient to cyclic stretch while being 
in contact with cell culture medium (Figure, 'D). Moreover, 
the membrane should be as thin as possible (!(.', µm in 
the lung) minimum interference of the membrane with cell 
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experiments and analytical tools such as microscopy requires 
the membrane to be as thin as possible (basement membrane 
of lung: !."# µm), optically transparent, chemically inert (no 
leaching of membrane materials into cell culture medium) 
and non-adsorptive toward drugs, proteins, and growth factors 
contained in the cell culture medium. The most widely used 
current membrane technology tries to accomplish this by 
using an elastic but hydrophobic material (e.g., PDMS), which 
requires pre-treatment prior to cell seeding such as chemical 
and physical modification or coating with ECM proteins (i.e., 
collagen (or gelatin), fibronectin, and laminin). Moreover, 
the membrane is always porous as required for phase II, but 
the pore size is limited to "–$# µm to prevent epithelial (or 
endothelial) cells from migrating into or through the mem-
brane during phase I.
Here we pursue a di%erent, biphasic membrane approach, 
which sequentially adapts the membrane properties to meet 
the di%erent requirements of the two phases of cell culture 
conditions during cell-stretch experiments under ALI con-
ditions. We fabricated this biphasic stretchable membrane 
(BETA) by spin-coating of a copolymer emulsion consisting of 
PCL and gelatin into a thin (!&#µm) membrane (Figure#"E–I). 
Since PCL and gelatin are immiscible in the solvent used 
here, the spin-coated membrane initially consists of poorly 
wettable PCL with “islands” of wettable gelatin due to phase 
separation (Figure# "I). The amide groups of gelatin form 
hydrogen bonds with water molecules in phase#I, improving 
surface wettability of the initially smooth and nonpo-
rous membrane. Moreover, gelatin contains the tripeptide 
Arg-Gly-Asp (RGD) cell adhesion motif that ligates several 
integrins and mediates cell attachment.[''] As cells prolif-
erate, they secrete their own ECM allowing them to gradually 
migrate into the poorly wettable PCL regions and eventually 
forming a confluent cell layer. Moreover, water-soluble gelatin 
serves as a sacrificial polymer which is gradually dissolved in 
cell culture medium, inducing porosity in the originally non-
porous membrane as required for phase II (Figures# "I,!A,B 
and Figure# S", Supporting Information). In addition, selec-
tive removal of the relatively sti% gelatin (as compared to 
the elastic PCL) increases the elasticity of the membrane to 
a value typically observed for lung tissue (see Section# '.'). 
Hence, the biphasic membrane concept introduced here lev-
erages the specific properties of a hybrid membrane for the 
controlled transformation of an initially relatively sti%, non-
porous, wettable membrane, which is ideal for the formation 
of a planar confluent epithelial barrier under submerged cul-
ture conditions (phase I), into a porous, elastic and stretch-
able membrane as required for the cell-stretch experiments 
under ALI culture conditions (phase II).
!.!. Selection and Characterization of Optimum Membrane
The ideal mixing ratio of the copolymer emulsion (PCL, gel-
atin) for spin-coating of the membrane was experimentally 
determined with a design of experiment (DoE) approach using 
the response surface methodology (RSM) which examines up 
to 'nd order e%ects of PCL and gelatin concentration on mul-
tiple biophysical and mechanical properties of the membrane. 
Based on our recently published review paper on physiologic 
properties of basement membranes of the lung[(] and the mem-
brane requirements listed above, we selected target values of 
elastic modulus (Young’s modulus; &–"!#MPa with !"!% linear 
strain), surface wettability (water contact angle WCA !)!°) and 
porosity/permeability (su*cient for nutrient exchange; good 
cell viability in phase II) as well as cytocompatibility (good cell 
proliferation) as most relevant parameters for optimization of 
the copolymer mixing ratio.
To this end, we fabricated nine spin-coated PCL/gelatin thin 
(!& µm)#membranes in di%erent PCL and gelatin mixing ratios 
(Table "). All of them formed a uniformly distributed, com-
plex, $D interconnected gelatin network within a PCL matrix 
as evidenced by the distribution of gelatin islands (disc-shaped 
structures) on SEM images of the membrane (Figure# 'A and 
Figure#S'A, Supporting Information) and the observed cell via-
bility under ALI conditions. However, PCL/gelatin mixing ratio 
a%ects pore size and pore-covered area fraction, which influ-
ences cell adhesion, growth, and viability.
The membranes have WCA and porosity in a range of ('." ± 
&.'#! WCA ! +!.( ± '.,#[°]#and +.+! ± ".!$#! P#! '+.)" ± ".'"#[% 
of area], respectively (Table#" and Figure#'C,D). During "'- h of 
contact with cell culture medium, '!–-&% of the gelatin is dis-
solved and the membranes have an elastic (Young’s) modulus 
in a range of (.'& ± !.-"#! E#! "-.", ± !.$!# [MPa] depending 
on PCL/gelatin mixing ratio (Figure# 'E) where a membrane 
with higher PCL concentration is sti%er (lower Young’s mod-
ulus) and capable to absorb more energy without plastic defor-
mation (Ur#! $'#kPa for !).&% PCL; (&–"&-#kPa for "!% PCL) 
(Figure#'F). For the assessment of cytocompatibility, we seeded 
an alveolar type II-like epithelial cell line (A&-,) on the mem-
brane. Real-time WST-" metabolic activity showed that there 
is no general cytotoxicity for any of the membranes (meta-
bolic activity increases with time; Figure# 'G). On the other 
hand, cells formed a confluent monolayer only on membranes 
with pores smaller than the size of an individual cell ("+#µm), 
i.e., especially for low gelatin concentration ((%), but also for 
higher gelatin concentration, if the PCL concentration was low 
(&%) (Figure#S$, Supporting Information).
WCA and porosity depend linearly on both PCL and gelatin 
concentrations (Figure #A,B), while the elastic modulus of the 
membrane is a%ected by both one-way mixing ratio and two-
way interaction of PCL and gelatin concentrations (Figure#$C). 
Applying the DoE approach to the experimental data listed in 
Figure# ' (and Table# ") revealed that the polymer blend con-
sisting of ,.$&% PCL and (.$-% gelatin [w/v solvent] provides 
the optimal membrane properties with respect to co-optimiza-
tion of elastic modulus, wettability, and porosity (Figure#$D,E).
To validate the fitted model, five membranes with an 
“optimum” PCL/gelatin mixing ratio (,.$&% PCL and (.$-% gel-
atin) were fabricated and experimentally examined with respect 
to these parameters. The WCA was found to be (+.+ ± &.$°#which 
is in-between the limiting values of "",.' ± -.'°#and -(.+ ± +."° 
measured for PCL and gelatin, respectively (Figure $A). 
The 'D fractional porosity of the membrane area (in phase II) 
was determined as ,.- ± !.'%#with an area-weighted diameter 
distribution of -.& ± ".)#µm#(mean ± SD) (Figure#-B). The elastic 
modulus of the membrane in phase I and II was ,.!" ± ".,&#and 
".+- ± !.((# MPa,# respectively with an extended reversible 
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deformation region up to !"% (linear) (Figure# $C). These 
results showed no statistically significant di%erences between 
model-predicted and experimentally determined parameters 
(WCAexp vs WCApred, p-value = &.'($; Porosityexp vs Porositypred, 
p-value = &.)*); Eexp vs Epred, p-value = &."'*).
These five “optimum” membranes (+.("% PCL and ,.($% 
gelatin) were experimentally examined in more in-depth. A 
)D fatigue test was conducted to measure the behavior of the 
membrane under continued cyclic stretch with an amplitude of 
)!% linear strain (sinusoidal cyclic stretch) and a frequency of 
&.((#Hz (!& cpm). No hysteresis or creep was observed for the 
maximum test period ($ h), indicating that the BETA membrane 
can endure cyclic mechanical stretch without any plastic defor-
mation or rupture (Figure#$D). Moreover, (D Young’s modulus 
of the membrane was measured in the bioreactor during cell cul-
turing after day ) ().(( ± &.)$#MPa),#day ( ().)+ ± &.!)#MPa),#and 
Figure !. Structural, biophysical and mechanical characterization of the fabricated membranes following a co-optimization strategy. SEM analysis of 
the fabricated membranes in A) phase I and B) phase II by various combination of PCL (P) and gelatin (G) mixing ratio (Table#$), indicating that higher 
PCL and lower gelatin concentration result in a narrow-distributed porosity with smaller pore size, which is in favor of ALI culture application. Scale 
bar is !"#µm. C) Surface wettability of the membrane quantified by WCA. D) Generated porosity after removal of gelatin in phase II quantified by SEM 
images is a function of the mixing ratio of PCL (p-value !".!) and gelatin (p-value !"."%). E) Elastic modulus of the membranes measured by the $D 
tensile stress test (phase I). F) The modulus of resilience (Ur) calculated by the area underneath the stress–strain curve up to yield (elastic region). 
G) WST-$ metabolic activity at days !, &, ', and ( of cell culturing. Data were baseline-corrected by the OD value of the Corning Costar Transwell cell 
culture inserts (PET, $!-well, $.$ cm!; ".&#µm pore). Three replicate samples were used for each analysis (n#= %, mean#±#SEM).
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day ! (".#$ ± ".%&' MPa),' revealing that (D Young’s modulus 
continues to moderately decrease by about a factor of % between 
day ) and day !. It is noteworthy that at day !, (D Young’s mod-
ulus (".#$ ± ".%&'MPa)' is more than %-fold lower than the cor-
responding )D value ().$& ± ".!!'MPa), i.e. the BETA membrane 
is somewhat more elastic under actual cell culture conditions 
(with cells in place) than determined by standard )D elastic 
modulus testing without cells (Figure' &E). The BETA mem-
brane at day !, which will be used for cell-stretch experiments, 
remained elastic for &$ h of (D cyclic stretch (under submerged 
conditions) with no deformation, rupture, and creep. Thus, this 
membrane is suitable for cell-stretch experiments for at least up 
to &$'h, which covers the typically used experimental periods for 
in vitro cell-stretch experiments.
FTIR analysis of the chemical composition of the BETA 
membrane in the transition between phase I and phase II 
showed clear evidence for the removal of gelatin from the 
membrane (Figure' &F). The characteristic peaks of PCL were 
approximately observed at %*)#' cm!) (asymmetric CH%), 
%$+"'cm!) (symmetric CH%), )#%%'cm!) (C!O), )%*('cm!) (C–O 
and C–C), )%(* cm!) (asymmetric C–O–C), and ))!%' cm!) 
(symmetric C–O–C). The FTIR spectrum of the pure gelatin 
film shows absorption peaks at (%*" cm!) (N–H stretching of 
amide A), )!%* cm!) (amide'I), and )+(* cm!) (amide II).[%(,%&] 
All of the characteristic bands of PCL and gelatin were detect-
able on the membrane before immersion in culture media. 
Some shifting of bands is observed due to interaction between 
the ester group of PCL and an amine group of gelatin.[%(] After 
incubation in cell culture medium (phase II), the FT-IR spec-
trum of porous PCL/gelatin membrane shows only charac-
teristic bands of PCL, indicating that gelatin has been largely 
washed away (Figure' S%B, Supporting Information). The 
optimum membrane also performed well with respect to cell 
adherence and growth. A+&* epithelial cells formed a confluent 
monolayer on the membrane (Figure !A,B) with a transepi-
thelial electrical resistance (TEER) of )(! ± %('" cm% (under 
static culture). This relatively low barrier integrity is typical for 
A+&* cells (Figure' &H). Hence, we also tested a bronchial epi-
thelial cell line ()!HBE)&o!) known to be capable of forming 
a tighter barrier. Similar to the A+&* cells, )!HBE)&o! cells 
also form a uniform confluent monolayer on the membrane 
(Figure'+C and Figure'S&A, Supporting Information), reaching 
the full barrier integrity as evidenced by the (maximum) TEER 
value of &+% ± ++'"'cm% after ! days (Figure' &H), which is in 
agreement with data reported in the literature.[%+] The observed 
gradual build-up of a confluent )!HBE)&o! cell layer is also 
consistent with the proliferation assay reaching its maximum 
value on day' # (Figure' &G). A summary of the characteristics 
of the optimum membrane is given in Figure' &I. All of these 
values are in agreement with the target values specified above.
!.(. Improvements over Conventional Membranes
The properties of the (optimum) BETA membrane reported 
above provide a significant advancement over currently used 
membranes for ALI cell culture models of the lung, namely 
PET and PDMS for static and stretch-activated ALI cell culture 
models, respectively. PET membranes are sti, (Young’s mod-
ulus of #%–('GPa) but relatively conducive to cell adherence. 
On the other hand, PDMS is elastic and allows for cyclic cell-
stretch, but it is not conducive to cell growth due to its hydro-
phobic nature (WCA $ )"+°). The BETA membrane presented 
here combines conduciveness to cell growth with biomimetic 
elasticity and resilience to cyclic stretch for at least &$ h (longest 
time period investigated here). The currently used PET and 
PDMS membranes are typically at least )"'µm thick and use 
fixed-sized )–('µm pores to provide su-cient permeability for 
nourishment of cells under ALI culture conditions and to pre-
vent inadvertent migration of epithelial cells from the apical to 
the basal side (or vice versa for endothelial cells) during phase 
I.[!] However, )–('µm pores are too small to allow for innate 
cell migration such as infiltration of neutrophils from the blood 
to the luminal side of the lung epithelium during inflamma-
tory events. The BETA membrane introduced here is not only 
thinner (<+'µm) but also allows for larger pores during the cell 
culture experiments (no pores initially; during phase II: &.+'± 
).#' µm (mean ± SD) corresponds to a range of ).)–#.*' µm), 
Table &. Range of PCL/Gelatin mixing ratios and experimental responses entering the design of experiment (DoE) approach to obtain the most 
biomimetic membrane properties by response surface methodology (RSM) based on Central Composite Design (CCD) arrangement.
Parameters PCL [%w/v] GGG Gelatin [%w/v] WCA [°] Po Porosity [%] E [MPa]
Levels !# "  # !#  "  #
[$%,$$] % &.% #" $  ' #"
Run
# %  $ '".$ ± $.$ !!.!' ± #.'! #(."! ± #.")
! #"  $ $'." ± #".( '.'" ± #."( #".'* ± #."(
( % #" &#.% ± %.! !'.&# ± #.!# #*.!" ± ".("
* #" #" &!.) ± #!.$ #%.#* ± *.%( $.!% ± ".*#
% %  ' $).) ± $.' !'.&" ± ".%( #(.'% ± #.$%
$ #"  ' $!.# ± ##.$ !!.(* ± %.#! '.!# ± #.)*
& &.%  $ &*.' ± #!.% #(.*" ± *.&& #".'% ± ".'!
' &.% #" &!.* ± '.* !!.!) ± #.#% ).)% ± #.)*
) &.%  ' &(.' ± '.% !%.%( ± &.%& ).!! ± ".*$
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which reduces inadvertent artifacts of the membrane itself and 
is likely to allow for trans-membrane migration of migratory 
cells such as neutrophils (was not investigated here). In addi-
tion to these micron-sized pores, the phase II membrane has 
also numerous much smaller secondary pores (<!""# nm) as 
evidenced by focused ion beam-scanning electron microscopy 
(FIB-SEM) tomography (Figure# $E). It is also evident from 
Figure# $E, that the voids left by the sacrificial gelatin provide 
a connected %D network of pores suitable for nutrient supply 
under ALI cell culture conditions. The primary pores are 
often occupied with cells since this is where the sacrificial gel-
atin provided the most suitable substrate for cell attachment 
Figure '. Multi-parameter optimization of PCL-gelatin mixing ratio of the BETA membrane (based on data presented in Figure#!). A) Surface plot of membrane 
wettability (WCA) for the technically feasible range of PCL and gelatin mixing ratios explored in Figure#!. Both gelatin (p-value !"."$$) and PCL (p-value !"."%&) 
concentrations a'ect WCA and thus cell attachment. Second-order polynomial regression analysis revealed WCA = %().) + ).&P – !(.(G – ".)P*P + %.*G*G + 
".%P*G; R! = ".+). B) Contour plot of porosity (P) versus PCL and gelatin mixing ratio, indicating a linear dependence of porosity on both PCL and gelatin 
concentration (Porosity = –*!.) – (.,P + !%.)G + ".%P*P – %.$G*G + ".!P*G; one-way PCL (p-value <"."() and gelatin (p-value <"."(); R! = ".+*)). C) Interac-
tion plot of PCL and gelatin mixing ratio on the elastic modulus (E = %*.( – %.$P + %.(G + ".!P*P + "."!G*G – ".$P*G; R! = ".++), showing that both one-way 
PCL (p-value !"."""%; gelatin p-value !".""%) and two-way interaction of PCL and gelatin concentration alter the membrane elasticity. D) The optimization plot, 
which was provided by the response optimizer demonstrating the composite desirability. E) Weights for WCA, porosity, and elastic modulus were considered 
as %, representing equal importance. Overlaid contour plot of membrane response parameters namely elastic modulus (E), water contact angle (WCA), and 
porosity (P) to select an optimum region of mixing ratios by co-optimization of all relevant variables and responses, reaching the target values (see Section#!.!). 
The design of experiment (DoE) was applied using Minitab %, software (Minitab Inc., State College, PA, US). The variables were optimized and the significance 
of the coe-cients was evaluated through the coe-cient of determination of the R-squared (R!) (ability to explain variance) by ANOVA at a +(% confidence level. 
The experiments were performed with three replicate membranes for each mixing ratio, which were analyzed in a randomized order, to avoid systematic bias.
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Figure #. Characterization of the optimized membrane. A) Violin plot of WCA of the membrane compared to the pristine PCL and pristine gelatin 
films. B) Quantification of porosity of the membrane after day # of incubation in cell culture medium (phase II). The pores account for $.%±".!%&of 
the membrane surface area and equivalent area diameter of %.' ±(.)&µm.&Scale bar is (""&µm. C) (D stress–strain curves of the membrane before 
(phase I) and after inducing porosity (phase II; #d in cell culture medium) showing a %.$-fold increase in elastic modulus after washing out gelatin. 
D) Segmented fatigue test using sinusoidal cyclic (D stretch at (!% linear strain at ".**&Hz for % h. E) Time-dependence of *D Young’s modulus of the 
membrane incubated with cell culture medium in the bioreactor, showing that the elastic modulus of the membrane increases between day ( and day 
# by !*"% (phase II). F) FT-IR spectra of pristine gelatin and PCL, PCL/gelatin blend (phase I), porous PCL/gelatin (phase II) and PCL/gelatin mem-
brane after cell culture (# d incubation). The FT-IR spectrum of the membrane with cells (green curve) and without cells (black curve) in wavenumber 
of i) (*""–()"" cm"( ii) and !+""–*""" cm"(. G) Time series of cell viability measured by WST-( assay of A'%$ and (#HBE(%o" cells on the membrane. 
H) Time series of TEER measurements (barrier tightness) of A'%$ and (#HBE(%o" cells on the membrane. Maximum barrier tightness (confluency) 
is reached after # to ) days of LLC. K) Schematic of the optimum membrane ($.*'% PCL, #.*%% gelatine) showing its unique bio-physicomechanical 
properties. Data are reported as the mean ± SD. n&# '; *P&<&"."', **P&<&".""( by one-way ANOVA with Tukey test.
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(Figure! "F). Considering that the innate basement membrane 
of the alveolar region is ultra-thin (!#.#"!µm), has a substan-
tial fraction of nanopores (<$."!nm in diameter) and few larger 
pores (<%##!nm), but is fibrous in nature allowing super-micron 
sized cells to “squeeze” through under certain conditions (e.g., 
neutrophil influx into the lung during inflammation).[$&] The 
BETA membrane is more biomimetic than conventional engi-
neered membranes, but is still not perfectly representing the 
basement membrane of the alveolar tissue.
It is also noteworthy that both A"%' and (&HBE(%o" lung cells 
secrete their own ECM on the BETA membrane, which contrib-
utes to the biomimetic nature of the microenvironment of the 
cells (Figure!"D) and even more pronounced for (&HBE(%o" cells 
(Figure!S%B, Supporting Information). ECM secretion is further 
evidenced by FT-IR analysis of the decellularized membrane, 
which reveals new bonds and shifted FT-IR peaks at wavenum-
bers of (%&', (%&(, $)%), $'(", and $'"" cm"( when compared to 
pristine membranes (Figure! %F-i,ii). Since ECM is a mixture of 
proteins, lipids, and glycosaminoglycans (GAGs), it is di*cult to 
unambiguously assign a specific functional group to each char-
acteristic peak. However, it has been shown that these peaks can 
correspond to nucleic acid, ECM proteins, and lipids.[$+] We also 
found some fibrillar structures of ECM on A"%' decellularized 
membranes (Figure! "D). These results, as well as the immu-
nohistochemical identification of ECM proteins such as type I 
collagen (Figure !B), indicate that epithelial cells do not only 
proliferate well on the BETA membranes, they also shape their 
microenvironment by secreting their own ECM components.
Figure (. Ultrastructural, morphological and tomographic analysis of cell-membrane interactions. A) SEM image of A#$% cells adhering to the surface 
of the membrane during proliferation on the (optimum) membrane. Scale bar is &"'µm. B) CLSM orthogonal (XY) view and side views of YZ (right) 
and XZ (bottom), depicting a confluent monolayer of A#$% cells (cell seeding density: &.# # &"#'cells cm"!, ( days LLC culture) and C) &(HBE&$o" cells 
(cell seeding density: ! # &"#'cells cm"!; incubation: ( days under LLC and & day under ALI conditions) on the membrane. &(HBE&$o" cells form tight 
junctions between cells. Cell nucleus (blue, DAPI), cytoskeleton (green, F-actin), and ZO-& tight junction (red). Scale bar is &"'µm. D) SEM analysis 
of the membrane after removal of A#$% cells (".&% SDS) reveals that cells deposit their own ECM (pseudocolored in green) on the BETA membrane. 
Scale bar is &"'µm. E) Schematic depiction of the focused ion beam (FIB)-SEM tomography for site-specific analysis. FIB-SEM image of the membrane 
in phase II (without cells). The green dotted lines show the cross-section of the membrane. Red and blue arrows illustrate the primary and secondary 
pores, respectively. Dashed red arrows show the interconnectivity of the pores in the structure. The scale bar is &'µm. F) FIB-SEM z-stack image of 
the cross-section of the membrane populated with A#$% cells, showing the cells (blue dotted line) located on the membrane (green dotted line) as a 
monolayer (left panel) and situated in the micron-sized primary pores (middle and right panel) occasionally even contacting adjacent cells via the )D 
pore network. Scale bar is &'µm.
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Figure '. The e#ect of cyclic mechanical stretch on the cytoskeleton, deposited-ECM, tight junction formation, and barrier integrity. A) Schematic of the 
in vitro cyclic cell-stretch bioreactor system used in this study. A small positive pressure (maximal $% above ambient pressure) is applied to the apical 
side of the membrane, resulting in membrane deformation, which is associated to the volume displacement of cell culture medium into the media 
reservoir can be monitored via the pressure sensor (P!) in the medium reservoir. B) Fluorescent CLSM images (obtained for optimum gain/pinhole 
settings of CLSM) of A%$& cells grown on the (optimum) BETA membrane under static ('d LLC and 'd LLC plus !$ h ALI) and dynamic/ALI (!(% and 
)%% !SA for !$ h) culture conditions (n*= %). Cells under cyclic strain (!(% !SA) formed more F-actin (green) and collagen I (red). Non-physiologic 
high levels of strain ()%% !SA) disrupted the cytoskeleton (no increase in F-actin). On the other hand, deposited collagen I is polymerized under both 
static and dynamic ALI culture as compared to LLC conditions. Cell nuclei stained with DAPI (blue). Scale bar is !"*µm. These trends are confirmed 
by quantitative fluorescence analysis (total fluorescence intensity of z-stack–obtained for a given reference gain/pinhole CLSM setting–normalized to 
the number of cell nuclei) of C) F-actin and D) collagen I in panel B under dynamic ALI and static (LLC and ALI) culture conditions. E) Qualitative 
(optimum CLSM settings) and F) quantitative CLSM analysis of ZO-( tight junction formation of A%$& cells (reference CLSM settings normalized to the 
number of cells/nuclei) under physiologic and non-physiologic cyclic mechanical stretch (ALI) conditions (n*= $). For each experimental setting, five 
representative images (z-stacks) were recorded at independent fields of view (region of view: !(!.%%*µm x !(!.%%*µm) for each sample. Nuclei (DAPI, 
blue) and ZO-( (red). G) The number of cells (nuclei) per area were quantified to investigate the dependence of cell viability under static and stretch 
conditions. H) Apparent permeability (Papp) of a confluent A%$& cell monolayer under static (LLC and ALI) and cyclic cell-stretch (!(% !SA and )%% 
!SA) conditions with respect to FITC-Dextran ($*kDa). Pristine membranes (without cells; white bars) at day " and $ under static and stretch conditions 
were used as control (n*" $). I) IL-+ release of pIL+-Luc-A%$& cells after stimulating with TNF-alpha ((%*ng mL#(). LLC without TNF-alpha stimulation 
was used as a control (n*" $). Data are reported as the mean ± SD; *P*<*"."%, **P*<*".""( and ****P*<*".""""( by one-way ANOVA with Tukey test.






!""#$"$ (%% of %&) © !"!" The Authors. Advanced Functional Materials published by Wiley-VCH GmbH
This is important for cell culture studies since it is likely that 
the secretion of ECM modulates the interaction between the 
cell cytoskeleton and the membrane/ECM, which are linked by 
transmembrane receptors so-called integrins that regulate AT 
cell migration and proliferation.[!"] Z-stack FIB-SEM analysis 
shows the spreading of A#$% cells on the membrane, formation 
of ECM inside pores, and cell-cell interaction via interconnected 
pores (Figure&#F and Movie S', Supporting Information). Trans-
mission electron microscopy (TEM) study of the human alveolar 
wall has shown that alveolar epithelial cells (both type I and II) 
and human alveolar fibroblasts make contact through gaps in 
the epithelial basement membrane. In addition, fibroblasts may 
directly connect the endothelium to the epithelium via apertures 
in the basement membrane.[!%] Mimicry of these aspects may be 
possible with the BETA membrane presented here.
Furthermore, alveolar epithelial cells such as primary rat 
alveolar epithelial type II (rATIIs) and human alveolar epithelial 
type-II like cells (A#$%) are responsive to membrane sti(ness 
and surface architecture, where softer membranes enhance 
actin cytoskeletal distribution and diminish tight junction for-
mation[!),!',*)] and sti(er membranes increase the formation 
of F-actin cytoskeleton (Figure& S#, Supporting Information), 
which is consistent with other studies.[*',*!] These studies sig-
nify the importance of the membrane mimicking the sti(ness 
of the basement membrane of the lung. The membrane under 
wet conditions has Young’s modulus of ).+" ± ).!$&MPa,&which 
complies with the average of Young’s modulus of a single alve-
olar wall (!).*)&MPa).[**] As the lungs are under continuous 
expansion and contraction, and the membrane stretch should 
remain reversible for at least a few hours, which has been 
shown to be required for adaptation of cells to cyclic stretch, to 
the entire lifetime of the cell culture model (here several days). 
We have shown that the biphasic membrane remains elastic 
under physiologic cyclic mechanical stretch up to ')% linear 
strain for ! days (largest investigated time period).[,]
!.#. Cyclic Mechanical Stretch Regulates Pulmonary  
Cell Physiology
Cyclic mechanical stretch induces several biological endpoints 
and activates several pathways involved in the physiology of 
lung epithelial cells.[,] Here, we implement our (optimum) 
BETA membrane in the cyclic in vitro cell-stretch (CIVIC) bio-
reactor, which was designed for culturing of in vitro lung cell 
models under cyclic mechanical stretch with the possibility 
of delivering aerosolized substances to the cells, to investi-
gate cellular responses to cyclic stretch under ALI conditions 
(Figure&,A). It is noteworthy that during physiologic cell stretch 
experiments cells ALI conditions remain intact remain, i.e., 
cells do not detach from the membrane and no medium is 
seeping onto the apical surface. Its unique feature of moni-
toring the pressure in the apical chamber (P') and the pressure 
in the medium reservoir (P!) allows for not only for real-time 
monitoring of amplitude and frequency of cyclic cell stretch 
during the entire cell-stretch experiment but also of Young’s 
modulus of the membrane. A#$% epithelial cells were grown on 
the membrane to reach confluency and then cyclically stretched 
(tri-axial (*D), !) cpm ().**&Hz)) for !$ h under physiologic 
(!'% "SA (surface area); ')% linear) and non-physiologic (*#% 
"SA; ',.#% linear) conditions using the CIVIC cell-stretch bio-
reactor system.
While quantitative confocal laser scanning microscopy 
(CLSM) analysis showed that the culture condition itself (ALI 
versus submerged) does not a(ect F-actin expression, cell-
stretch stimulated actin accumulation under physiologic stretch 
conditions (!'% "SA strain), but not under overdistension con-
ditions (*#% "SA strain) (Figure& ,B,C). In contrast, secretion 
of the ECM protein collagen I was stimulated for ALI condi-
tions, but not a(ected by cyclic mechanical stretch regardless of 
amplitude (Figure&,B,D). We also found that physiologic stretch 
induces ZO-' tight junction formation, while non-physiologic 
stretch (*#% "SA) causes a loss of cells (Figure&,G) and a dis-
ruption of the integrity of the cell monolayer (Figure&,E,F and 
Figure&S,, Supporting Information). ZO-' tight junctions were 
intensified especially at cell–cell junctions, revealing that cyclic 
physiologic stretch enhances tight junction formation/arrange-
ment (Figure&,E). Moreover, pathologic stretch (*#% "SA) dam-
aged the cell layer as evidenced by the reduced number of cells 
possibly due to apoptosis (Figure&,G).
We then studied the paracellular transport of small mole-
cules to evaluate the role of mechanical stretch on barrier 
integrity. Figure& ,H shows the apparent permeability (Papp) 
of FITC-dextran ($& kDa) under stretch conditions compared 
to static conditions. The permeability of FITC-dextran under 
submerged (static), ALI (static), ALI !'% "SA (dynamic) 
and ALI *#% "SA (dynamic) conditions was measured as 
".$" ± *.,% # ')$,, ".'" ± !.#$ # ')$,,& ',.)* ± ).%! # ')$,&and 
'".$$ ± '.+$ # ')$,& cm& s$', respectively. Apparent permeability 
analysis indicated that the translocation of ($& kDa) molecules 
across the cell barrier under ALI conditions is significantly 
increased under stretch for !$ h compared to static conditions 
(!'% "SA vs ALI, p&< ).)*;& *#% "SA vs ALI, p&< ).)').& It is 
also important to note that the membrane itself has larger per-
meability under physiologic stretch (',.)' ± ).,# # ')$,&cm&s$') 
than under static conditions (".'" ± !.#$ # ')$,&cm&s$'), which 
is likely due to expanding pores (!'.')-fold larger for !'% "SA) 
and convective dextran transport during the cyclic stretch. 
Assuming that the transport resistance (!'/Papp) of the mem-
brane and the cell barrier are additive, the membrane-corrected 
permeability of the stretched layer of A#$% cells can be deter-
mined as #%.# # ')$, and ')%.% # ')$ ,&cm&s$' for !'% "SA and 
*#% "SA stretch, respectively (Equation ('))
( )/app app total app membrane app total app membranecellP P P P P( )= ! "  (')
This indicates that for non-physiologic stretch (*#% "SA), the 
A#$% barrier integrity is impaired. It is also instructive to con-
sider Papp values (for $&kDa dextran) for A#$% cells cultured on 
standard Transwell inserts under static conditions. Typical litera-
ture values range between !.# # ')$, and ') # ')$,&cm&s$',[*$,*#] 
but only very few studies also report Papp of the membrane 
without cells. From Frost et al !)'% (Figure # of[*$]), one can 
calculate Papp for the membrane ('.+) # ')$# cm s$' for '!-well 
Transwell insert; pore size ).$ µm) and the membrane with cells 
(+.#" # ')$, cm s$') yielding Papp = '.*, # ')$# cm s$' for A#$% 
cells. This is about ,-fold lower than the value we found for A#$% 
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on BETA membrane under physiologic stretch. Thus, cyclic 
stretch apparently enhances the permeability of A!"# cells, but 
we cannot rule out that the large di$erence in membrane elastic 
modulus (!%&&&-fold higher as compared to PET) also has an 
e$ect on A!"# permeability. This e$ect cannot be assessed from 
our data since there is no significant di$erence between Papp of 
the membrane with and without cells (Figure'(H). However, for 
a PDMS membrane under static conditions in a lung-on-a-chip 
device, Papp of A!"# cells was found to be !.( " %&#('cm's#% (as 
derived from Papp of the membrane with ().! " %&#('cm's#%) and 
without A!"# cells (".! " %&#('cm's#%).[*"]
We conclude that our results are in general agreement with 
previously reported results, which validates our BETA mem-
brane for cell-stretch experiments. Formation of actin as one 
of the main components of the anchored cytoskeleton that is 
necessary for the maintenance of epithelial barriers can be 
stimulated by stretch due to an increase in intracellular cal-
cium ion levels that influences epithelial permeability.[*(–*+] 
Tight junctions are cell-cell adhesion complexes in epithelial 
cells that carry out important functions, including control-
ling paracellular and transcellular transport, maintaining 
cellular polarity, and regulating a variety of intracellular sig-
nals.[*#,"&] Crucial tight junction proteins in the alveolar epi-
thelium are occludin, ZO-%, and claudin-".[*+] Among them, 
ZO-% influences the structure and function of the alveolar 
epithelial barrier and acts as a connection between transmem-
brane tight junction proteins and the actin cytoskeleton.[*+] It 
has been shown that a physiological stretch of +% linear did 
not a$ect the integrity of a cell monolayer and ZO-% forma-
tion.[%)] On the other hand, a cyclic non-physiologic stretch 
during mechanical ventilation is playing a pivotal role in dis-
ease development (e.g., acute respiratory distress syndrome 
(ARDS)) via increasing protein permeability, inhibiting tight 
junction proteins, and disarrangement of actin filaments.[*+,"%] 
Cavanaugh'et'al. showed that the overall expression of ZO-% is 
negatively a$ected by a high level of stretch (*,% $SA) in rat 
AT-type II cells.["%] Song' et' al. also showed that the mechan-
ical overdistension (*,% $SA strain) causes a disconnection 
of claudin " and , from ZO-% in precision-cut lung slices 
(PCLS).[")]
Changes in the arrangement of actin cytoskeleton and 
interaction between F-actin and the tight junction complexes 
modulate the paracellular permeability.[*+–"&] Similar to our 
finding for "' kDa dextran, it has been reported that cyclic 
mechanical stretch increases the transport of FITC-sodium 
(&."'kDa) in the %(HBE%"o# cell line and primary AT cells.[%),"*] 
The apparent permeability for RITC-dextran (,&'kDa) is also 
increased under a physiological stretch of +% linear strain.[%)] 
High amplitude strain increases the translocation of micro-
molecules across the alveolar epithelium, which can partly 
happen through calcium- and actin-dependent mechanisms[*,] 
or by paracellular signaling pathways such as stretch-associ-
ated superoxide release.[""]
Albeit stretch-induced enhanced barrier permeability is 
an important factor for in vitro pharmacokinetic studies, the 
majority of the research in this field has been carried out under 
non-physiologic submerged or static ALI conditions.[),"!] There 
is very little data on the e$ect of cyclic stretch on the perme-
ability of in vitro barrier models of the lung.
!.'. Inflammatory Response Can Be Activated by Stretch
Interleukin-+ (IL-+) plays a key role in the pathogenesis of 
inflammatory lung diseases such as ARDS.["(] It has been 
shown that cyclic stretch promotes IL-+ gene expression 
and protein release in A!"# cells.[",] We used IL-+ release as 
a marker of deformation-induced inflammatory signaling 
induced by cyclic stretch. Here, we seeded the IL+-Luc-A!"# 
reporter cell line on the membrane["+] and IL-+ promoter 
activity was measured using the luciferase assay. IL-+ release 
of the cells cultured under cyclic stretch of *!% $SA for )" h 
was significantly higher than under physiologic stretch ()%% 
$SA; p-value <&.&"),'static conditions under both ALI (p-value 
<&.&&*)' and liquid-liquid culture (LLC) conditions (p-value 
<&.&%),' indicating that non-physiologically high stretch (*!% 
$SA) activates inflammatory responses (Figure' (I). Again 
these results agree with previous studies that reported no sig-
nificant increase in IL-+ secretion by A!"# and primary human 
alveolar epithelial cells under physiologic mechanical strain 
(%&–%!% $SA strain)["*,"#] and intense mechanical stretch (*&% 
$SA strain) induced inflammatory mediators such as IL-+ in 
A!"# cells.[",]
!.(. Cellular Uptake of Nano- and Microparticles under Stretch
The e$ect of cell-stretch on the mechanisms of cellular uptake 
and paracellular transport of nanoparticles (NPs) is very di--
cult to study under in vivo conditions. While in vitro studies 
under static ALI conditions have been performed, to the best 
of our knowledge, this has not been investigated for cell-stretch 
conditions, yet. The e$ect of cyclic stretch on particle uptake 
was only performed under physiologic conditions ()%%'$SA) 
since non-physiologically high deformation of the cell layer 
(*!% $SA) not only disrupts the tight junctions but also 
reduces cell viability and loss of cells. While the loss of cells 
and disruption of tight junctions is expected to substantially 
enhance transepithelial translocation of particles (Figure'(E,F), 
reduced cell viability (Figure'(G) inhibits all cellular processes 
including cellular uptake. Since such a severely injured alveolar 
cell barrier does not exist in patients, cellular uptake and tran-
sepithelial transport of particles were not measured for *!% 
$SA stretch conditions.
Ultrafine ambient NPs (less than %&&–*&&' nm in diam-
eter) are often implicated as particularly hazardous due to 
their enhanced surface area per mass which has been associ-
ated with both acute and chronic lung disease.[!&,!%] Moreover, 
NPs smaller than !%&&'nm have a relatively high probability of 
translocation from the lung to blood circulation (transbarrier 
transport)[!)] which may induce adverse health e$ects in the 
secondary target organ (e.g., liver, heart),[!*] but it also makes 
inhaled nanosized particles attractive as drug carriers for both 
pulmonary and systemic drug delivery.[!"]
We chose two sizes (NP: %&&' nm diameter; microparticle 
(MP): %&&&'nm) of amine-modified polystyrene (PS-NH)) par-
ticles to investigate the size-dependent e$ect of physiologic 
cyclic stretch on cellular uptake dynamics of particles under 
ALI culture conditions (Figure !A). An aqueous suspension 
of monodisperse particles (PS-NH); %&& and %&&&' nm) was 
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nebulized within a few minutes onto the cells under static/ALI 
and physiologic cell-stretch/ALI conditions. The exposure 
process itself does not substantially change the nominal 
particle diameter. Albeit nebulization increased the nominal 
particle diameter by about !"% likely due to agglomeration 
(see Figure#S$, Supporting Information), this does not signifi-
cantly a%ect our comparison of cellular uptake of nano- versus 
micron-sized particles. Moreover, the cell-delivered particle 
Figure $. Cell uptake of nano- and microparticles under static and stretch conditions. A) Workflow for particle study. A#$% cells (cell density: 
! ! &"#'cells cm"!) were seeded on the membrane. The cells were cultured under LLC for $ days and after obtaining a confluent cell monolayer, cells were 
air-lifted and maintained as ALI culture for & day. Amine-modified polystyrene (PS-NH!) nano- and microparticles (&"" and &"""'nm diameter, respec-
tively) are then nebulized onto the cells (within a few minutes) either with the nebulizer of the bioreactor (for cell-stretch conditions) and the VITROCELL 
CLOUD ( system (static conditions). After ! h, the cells were fixed and prepared for CLSM analysis. B) (top) SEM analysis of microparticle (MP) distri-
bution (Red arrow, &"""'nm) on A#$% lung cells. Scale bar is !"'µm. (bottom) Detection of MPs (by carbon) using SEM/EDS analysis. Scale bar is &"'µm. 
C) Schematic depiction of internalization nanoparticles into a cell under static and stretched conditions based on results from panel D. D) )D recon-
struction CLSM images of nano- and microparticles after ! h under static and physiologic stretch (!&% #SA) conditions. (left) The perspective (by 
IMARIS) and XZ (by Fiji) view of CLSM images based on the results of the z-stack and cross-section. (middle) XZ view of CLSM image shows only the 
NPs (red) and cell nucleus (blue). (right) Surface rendering of CLSM images by IMARIS. These images reveal retention of the MPs near the apical (top) 
side of the cells for both static and dynamic conditions. Nanoparticles also reside near the apical side of the cell layer under static conditions, but get 
internalized deeply across the cell membrane and reside in close proximity with actin filaments. Nuclei (DAPI, blue), PS-NH! (red), and F-actin (green).
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dose of !."#µg cm!$ was chosen to avoid multi-layered stacking 
of the particles (agglomeration) by low fractional area coverage 
of the cells (here: %&% and %% for "&&#and "&&&#nm particles, 
respectively). After ! h of particle exposure (deposited dose: 
!."#µg cm!$), no cytotoxicity (WST-" assay) was detected (data 
not shown) under these conditions. SEM analysis also pre-
sented no cell detachment after the nebulization of particles 
(Figure# 'B). Hence, cells were viable enough for reliable cel-
lular uptake measurements.
Localization of particles on the A()* cell layer showed that 
after ! h under static conditions, the particles of both sizes 
("&& and "&&&# nm) are located on top of the cell layer often 
attached to F-actin (Figure# 'D and Movies S!–S%, Supporting 
Information), which is in line with previous studies.[((,(+] Under 
physiological cell-stretch conditions (!"% "SA strain), the same 
situation was observed for "&&&#nm particles. However, "&&#nm 
NPs were found to e,ciently penetrate the cell layer reaching 
the subcellular compartments in the vicinity of the nucleus and 
again attaching to the actin filament structure (Figure# 'D and 
Movie S), Supporting Information).
The knowledge of the e-ect of stretch on NP internalization 
in the lung is controversial. In support of our results, Hu#et#al. 
showed that physiological mechanical stretch ("&% linear 
strain) enhanced cellular uptake (A()*) and internalization of 
"&&# nm PS-NH! NPs under ALI conditions.["%] On the other 
hand, Schmitz# et# al. reported that physiologic cyclic stretch 
("(% "SA strain) did not increase cellular uptake (A()*) of 
!(#nm SiO! NPs under LLC conditions.[)*]
For pulmonary epithelial cells, particle uptake primarily 
occurs via endocytosis, which is limited to particle sizes 
smaller than #(&&#nm.[(',(.] This explains the lack of uptake of 
"&&&# nm particles under both static and cyclic stretch condi-
tions (Figure# 'D). Passive para– or transcellular di-usion into 
and across the cell barrier was ruled out as relevant uptake 
mechanism by demonstrating that transcellular transport of 
"&&#nm particles was inhibited almost completely at low tem-
perature () °C) conditions (data not shown), which implies that 
an energy-consuming, active cellular mechanism like endocy-
tosis governs cellular uptake. In contrast to previous studies, 
"&&#nm NPs were also found to be attached to the cell surface 
without penetrating deeper into the cells.[(.] Only after cyclic 
stretch, NPs were abundantly taken up and internalized by 
A()* cells (Figure#'C). As all previous studies were performed 
on extremely sti- plastic multi-well plates, this surprising 
lack of NP uptake under static conditions may be evidence for 
the impact of membrane elasticity on cellular function and 
response.
!.$. Advantages of BETA Membrane
Most in vitro cell culture experiments with alveolar epithe-
lial cells cultured under physiologic ALI conditions are per-
formed either on standard PET Transwell inserts (no stretch) 
or on stretchable PDMS membranes. Alternatively, natural 
polymers such as collagen and decellularized ECM (derived 
from pig lung) in combination with synthetic polymers such 
as poly-/-lactic acid["'] showed an improvement in the physical 
characteristics of hybrid sca-olds used for lung applications.
Here we presented a biphasic copolymeric membrane con-
cept (PCL/gelatin) which provides optimized conditions for 
the two di-erent phases of toxicological or pharmacological 
studies with alveolar barrier models, namely the cell growth 
(phase I) and cyclic stretch (phase II). The spin-coated PCL/
gelatin membrane (*.%(% PCL and +.%)% gelatin [w/v solvent]) 
demonstrated various improved biomimetic features as com-
pared to conventional porous membranes (sti-: PET; elastic: 
PDMS) such as low interference with transbarrier transport 
processes, biomimetic elasticity, while maintaining the struc-
tural integrity of the membrane even under cyclic stretch, and 
ease-of-handling.
The bio-inspired membrane manufactured here is ultrathin 
(thickness $ (#µm), mimicking the total alveolar-capillary bar-
rier thickness ("." µm ± &.", harmonic mean). The prerequi-
site for low interference with transbarrier transport processes 
is i) low membrane thickness ($(#µm is similar to "."#µm of 
alveolar-capillary tissue (harmonic mean) while PET and PDMS 
membranes are typically >"&#µm),# ii) large pore size of up to 
.#µm ().(#± ".'#µm (mean± SD) as compared to <#% µm),#and 
iii) large porosity (*.)# ± &.!%, instead of %.(# % or &.(% for 
PET membranes with % and &.)# µm pores, respectively (e.g., 
Corning specification sheet). This results in an apparent per-
meability (for )# kDa FITC-dextran) of ..". ± !.() % "&!+ and 
"+.&% ± &.*! % "&!+# cm# s!" under static and dynamic (stretch) 
conditions, respectively, as compared to ).& ± (.( % "&!+#cm#s!" 
typically reported for PET and PDMS membranes.[%)] In addi-
tion to the reduced interference of our membrane with trans-
barrier molecule/particle transport, it is conceivable that up to 
.#µm pores (instead of typically %#µm pores for epithelial cells 
on PET or PDMS membranes) will facilitate the important fea-
tures of migration of neutrophils from the basal/blood into the 
luminal compartment (airside), which is a hallmark of pulmo-
nary inflammation.
Another important aspect of cell functionality is the elastic 
modulus of the membrane. The BETA membrane has Young’s 
modulus of &.'.# ± &.!)# MPa, which is very similar to alve-
olar tissue of the lung (&.%&# MPa) and much smaller than 
typical Young’s modulus of PDMS membranes (!.+" ± &.&!–
%.(*±&.""#MPa# for "&:"–(:" base: agent mass ratio).[(*] In addi-
tion to the high elasticity, the membrane is resilient to fatigue 
under cyclic stretch for at least up to ). h, which covers the typ-
ically used experimental periods for in vitro cell-stretch experi-
ments and maintains structural integrity not only for small 
microfluidic lung chips (<mm!), but also for millifluidic (>cm!) 
membranes similar to +- well, "!-well, and !)-well Transwell 
inserts. The translucent nature of the manufactured membrane 
makes it suitable for all optical imaging modalities. Its condu-
civeness to cell growth does not require physical or chemical 
functionalization or protein coating of the membrane to stimu-
late cell adherence and growth.
'. Outlook
The development of even more biomimetic in vitro models of 
biological organs and barriers is essential for their prediction 
capacity for human/clinical outcomes with respect to protection 
and restoration of health. The biphasic copolymer membrane 
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designed here is capable of closely mimicking several key fea-
tures of the alveolar-capillary barrier of the human lung.
In this proof-of-concept study with an alveolar type-II like 
(A!"#) and bronchial ($%HBE$"o!) epithelial cell line, we were 
able to confirm stretch-induced functional changes of these 
cells reported in the literature. These features include remod-
eling of the actin cytoskeleton and enhanced barrier function 
associated with higher levels of tight junction proteins (ZO-$) 
and permeability (Papp) under physiologic stretch conditions 
(&$% "SA strain, '.(()Hz), while non-physiologic stretch ((!% 
"SA strain, '.(()Hz) induced apoptosis, provoked inflammatory 
responses (IL-*) and disrupted actin cytoskeleton, and barrier 
integrity. Application of this cell stretch model to aerosolized 
particles showed that & h of physiologic cyclic stretch enhances 
cellular uptake of NPs ($'')nm), but not of MPs ($''')nm). The 
latter indicates that cyclic stretch does not extend the size limit 
of !'')nm for endocytic uptake by epithelial cells to $''')nm.
The BETA membrane introduced here should be tested with 
advanced cell culture models such as immortalized primary 
alveolar epithelial cells (hAELVi) and it could be integrated with 
microfluidic lung-on-a-chip devices to extend their biomimetic 
features with respect to membrane elasticity, ease of cell growth 
and reduced membrane thickness. All of these features com-
bined could pave the way for significantly improved in vitro tox-
icity, drug and pharmacokinetics testing of inhaled substances.
#. Experimental Section
Membrane Fabrication: Poly(!-caprolactone) (PCL: Sigma-Aldrich, 
Mn #"$ """), and gelatin (Type A from porcine skin, Sigma) were 
dissolved in TFE ((!,!,!-trifluoroethanol) with #%%% purity, Roth) and 
stirred until the emulsion was homogenous. The copolymer emulsion 
of PCL/gelatin was then added to a homemade spin-coater (!"""$rpm) 
to produce a dense skin layer (Figure$ &E–G). The fabricated film was 
subsequently dried under vacuum ('"" mbar) to obtain a uniform layer. 
The film was then fixed between two polycarbonate holders to create 
apical and basal chambers. Membranes were sterilized before cell 
culture experiments with phosphate bu(ered saline (PBS), ethanol #"% 
and UV exposure. The film thickness depends on spinning speed, initial 
viscosity, and evaporation rate.[)"] The manufacturing process was 
optimized to obtain an ultrathin membrane $*$µm) (Figure$&H). Design 
of experiment (DoE) approach using the response surface methodology 
(RSM)–the central composite design (CCD)–was applied (Minitab &# 
software, Minitab Inc., State College, PA, US) to find the optimal mixing 
ratio of PCL and gelatin (Table$ &). The significance and the e(ect size 
of variables (concentration of PCL and gelatin) and the corresponding 
linear and quadratic interactions on the response variables (WCA, 
porosity, and elastic modulus) were evaluated based on the coe+cient 
of determination (R-squared). Analysis of variance (ANOVA) was 
used to evaluate whether the model is statistically significant at %*% 
confidence level.
Membrane Characterization: The morphology of the membranes was 
observed by scanning electron microscopy (SEM, Zeiss Crossbeam 
',", Carl Zeiss AG, Oberkochen, Germany) at an operating voltage of 
!$ kV. To evaluate cell attachment, the samples were fixed in )% v/v 
glutaraldehyde (Sigma-Aldrich) and subsequently post-fixed with &% 
OsO, ((Plano, Wetzlar, Germany)) and &.*% K,Fe(CN)) (Sigma) in ".& - 
CAC bu(er for & h (, °C). The samples were then dehydrated in gradient 
ethanol solutions followed by HDMS (hexamethyldisilazane, Sigma-
Aldrich) for &*$min and subsequently mounted onto aluminum stubs, 
sputter-coated with platinum, and imaged by SEM. ECM materials were 
pseudocolored in SEM images using the GNU Image Manipulation 
Program (GIMP !.&".#) (http://www.gimp.org/).
Focused ion beam (FIB)-SEM tomography (Zeiss Crossbeam ',", 
Carl Zeiss AG, Oberkochen, Germany) in sectional series (!,.*$ nm 
interval) was used to study the internal structures of samples at high 
resolution ('" kV;$ &"" and '"" pA). The images were aligned using 
NIH Fiji (Registration tool) and then reconstructed by IMARIS software 
(version %."; Bitplane, Zurich, Switzerland) and NIH Fiji.
Energy dispersive X-ray spectroscopy (EDS, X-maxN, Oxford 
instruments) analysis with acceleration voltage of # kV$was also used to 
provide qualitative elemental and chemical microanalysis.
To calculate the porosity and the pore diameter size of the 
membranes, &! independent fields per sample of SEM images quantified 
by NIH Fiji macro (Threshold, make binary, watershed and analyze 
particles).
The water contact angle (WCA) of the membranes was determined 
with the sessile drop method using an automated contact angle system 
OCA!" with an image processing system. Deionized water droplets of 
&$µL were deposited via a syringe at a velocity of & µL s!&. The drop shape 
was recorded with a high-speed framing camera and measurements 
were performed * s after droplet addition. Five measurements per 
sample type were performed.
Fourier transform infrared spectroscopy (FT-IR; Nicolet iS &" FTIR 
Spectrometer (Thermo Fisher Scientific, Waltham/Massachusetts, USA) 
was used to analyze the structural properties and chemical changes of 
the membranes. All spectra were recorded with '! scans per sample in 
the attenuated total reflection (ATR) mode in the wavelength range of 
,""!,""" cm!&.
The mechanical properties of the membranes were characterized 
using a dynamical mechanical testing instrument (BOSE **"" system, 
ElectroForce, Eden Prairie, MN, USA) with a load capacity of !! N. Film 
strips membrane (&"%&"$mm) were stretched at a rate of "."&$mm$ s!& 
until rupture. Sample thickness was measured using the cross-section 
area of the membranes using SEM. Tensile strength and maximum 
elongation at the elastic region were calculated. Young’s modulus was 
calculated as the slope of the most linear region of the stress–strain 
curves in the elastic region. The modulus of resilience (Ur, kPa) which is 
the area under the strain-stress curve in the elastic region was calculated 
using the Area Below Curves macro, Sigma Plot &!.".
Static Cell Culture: Immortalized human alveolar epithelial type-II 
like A*,% cell line was cultured and maintained in Dulbecco’s Modified 
Eagle Medium: Nutrient Mixture F-&! (DMEM/F&!, &:& v/v, Gibco) 
supplemented with &"% FCS (Gibco), &% v/v Pen/Strep (&"" U mL!&, 
Gibco), &% L-glutamine (!$% &"!' -, Gibco), and !-phospho-L-ascorbic 
acid (".&$% &"!' -, Sigma). For cell proliferation study, cell suspension 
with a cell density of &%&"*$cells cm!! was seeded on a pre-wetted and 
sterilized membrane (e(ective growth area: &.' cm!). Cells first were 
cultured under liquid–liquid conditions (LLC, ) days) and then were air-
lifted for ALI conditions (!, h).
Bronchial epithelial &)HBE&,o! cells were also used for cell model 
barrier studies such as cell monolayer integrity and TEER measurements. 
&)HBE&,o! cells (cell seeding density: ! % &"*$cells cm!!) were cultured 
on the membranes () days under LLC and & day under ALI conditions) 
in MEM medium (Gibco) supplemented with &"% FCS (Gibco), &% v/v 
Pen/Strep (&"" U mL!&, Gibco).
Cell viability was measured by WST&-assay. Each membrane was 
incubated with & mL$diluted WST& reagent (Roche, Mannheim, Germany) 
(&:&*) at '. °C. After &*$ min, &*"$ µL supernatant was transferred to 
%)-well plate (, times for each membrane) and was measured in a plate 
reader (Magellan Tecan) at ,*" nm.$All the results were normalized to 
the mean value of blank.
Dynamic Cell Culturing: The CIVIC system was used to apply cyclic 
stretch to cells grown on the BETA membrane under ALI culture 
conditions. The CIVIC system is a modified version of the previously 
described MALI system,[)&,)!] which has been improved for technical 
performance mainly related to material stability, membrane fixation, 
and pressure sealing. While the geometry of the bioreactor system was 
not changed over the previously described version, some parts were 
modified to improve the airtightness of the bioreactor chamber and ease 
of handling. All of the elements, which are in contact with the culture 
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medium, were manufactured with polycarbonate (PDMS-free materials) 
to prevent leaching of PDMS to the culture medium. The upgraded 
polycarbonate holder enables to prevent the membrane sliding and 
leakage of the culture medium during the cell-stretching experiment. 
Briefly, the main chamber of the bioreactor consists of an apical (air) 
and a basal (cell culture media) compartment separated by a membrane 
for cell growth (Figure#$A). Cell culture medium circulates through the 
basolateral surface of the membrane using a peristaltic pump to mimic 
the blood flow (%""# µL min!&) while cyclic pressure pulses induced 
by oscillating airflow in and out of the apical chamber subjects the 
membrane (and the cells) to a uniform cyclic triaxial strain in surface 
area ("SA). The CIVIC is equipped with a clinically relevant vibrating 
mesh nebulizer (Aeroneb Pro/Lab, Aerogen Inc, Galway Ireland) for 
aerosolized substance delivery to the cells. Typically, &"#µL of liquid is 
nebulized and deposited with a deposition e'ciency of (!% onto the ALI 
cultured cells within #&#min. This patented ALICE Cloud technology has 
become commercially available as VITROCELL Cloud MAX (VITROCELL 
Systems, Waldkirch, Germany).[$&,$!]
The elastic modulus of the membrane was measured using 
the bioreactor system during cell culturing. Two pressure sensors 
(MPX("(", Freescale Semiconductor, Munich, Germany) were devised 
in the apical compartment of the bioreactor (P&) and the headspace 
of the reservoir chamber (P!) as depicted in Figure# $A. During cell-
stretch, the membrane expands and pushes the culture medium of the 
basal chamber into the medium reservoir. This compresses the air in 
the reservoir chamber ("V, mL), which can be measured by increased 
pressure in the reservoir ("P# = P!# ! P"), where P" is the pressure in 
both air volumes (ambient air pressure, typically P"#= )*#kPa) when the 
membrane is relaxed and V" is the corresponding volume of air in the 
medium reservoir (+"# mL). Assuming the membrane motion can be 
approximated by a spherical cap geometry, the corresponding membrane 
displacement ("V, mL) is associated with the radius (a: &!.$#mm) and 
axial deflection of the membrane ("h, cm) (Equations (!) and (+)). The 
elastic modulus (E, kPa) of the membrane (Young’s modulus) can then 
be calculated from Equation (%).[$+]
To study the role of mechanical stretch on cell physiology, A(%) cells 
were seeded on the membrane under dynamic/LLC culture conditions. 
After *"% of cell confluence, the cells were air-lifted (ALI conditions) 
and a cyclic mechanical stretch of !&% "SA (or &"% radius) and +(% 
"SA (&$.(% linear) strain at the ".++#Hz was subsequently applied to 
cells to mimic physiologic and non-physiologic conditions, respectively 
(Equation (())
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Immunofluorescence: Cells were fixed in %% paraformaldehyde 
(Sigma-Aldrich) for !"# min at room temperature (RT). After washing 
two times with PBS, cells were permeabilized by ".+% Triton X-&"" 
(Sigma-Aldrich) in PBS, &"#min at RT. To prevent any unspecific antibody 
binding, a blocking bu,er ((% BSA and ".&% TritonX-&"") was added for 
&"#min. The cells were then incubated overnight at % °C with anti–ZO-& 
monoclonal (mouse, &:&""; Invitrogen), anti-collagen type & polyclonal 
(rabbit, &:&""; Rockland) antibodies. After washing with PBS, cells 
incubated for & h in RT with secondary antibody Alexa Fluor ((( goat 
anti-mouse IgG (&:(""; Invitrogen) and Alexa Fluor %** donkey anti-
rabbit IgG (&:(""; Invitrogen). The F-actin cytoskeleton and cell nuclei 
were stained with Phalloidin ()% (&:%") and %$,$- diamidin-!-phenylindol 
(DAPI) at & µg mL!& in (% BSA, ".&% TritonX-&"" in PBS, respectively. 
After rinsing three times with blocking solution, the membranes were 
embedded in Glycergel (DAKO Schweiz AG, Baar, Switzerland). All cell 
images were acquired using the confocal laser scanning microscope 
(LSM-&", Carl Zeiss; Oberkochen, Germany), coupled to the Zen!"") 
software. Images were further processed using the +D reconstruction 
IMARIS software (version )."; Bitplane, Zurich, Switzerland). For 
qualitative image analysis (all CLSM figures shown in the manuscript), 
CLSM images recorded under optimum CLSM settings were presented 
as selected by the CLSM system (pinhole and gain setting). For 
quantification, representative %"x images (z-stacks) were recorded 
under reference gain and pinhole settings of the CLSM (not under 
sample-specific optimum settings to account for setting-specific CLSM 
sensitivity) at ( independent fields of view for each sample (biological 
replicate). The rectangular tool in Fiji was used to measure the total 
fluorescence intensity for F-actin, collagen type I, and ZO-& for each view. 
Subsequently, the total fluorescence intensity was normalized to the 
number of cells in each view as determined from the number of nuclei 
(DAPI staining), which accounts for artefacts due to di,erences in cell 
packing.
In Vitro Functional Analysis: Trans-epithelial electrical resistance (TEER) 
measurements of epithelial cells grown on the optimized membrane 
were measured periodically using the Millicell-ERS system (Millicell 
ERS-!, Millipore, USA). The cell-specific resistance can be obtained by 
subtracting the total resistance across the cell culture membrane with 
cells from the resistance reading across the acellular membrane. TEER 
is calculated by multiplying the cell-specific resistance (Ohm, %) and 
the e,ective surface area of the membrane (cm!). The experiments were 
repeated three times and a mean value was determined. For ALI culture, 
!""#µL of cell culture media was added to the apical part and resistance 
measured.
To measure the permeability in the apical-to-basolateral direction, 
first, the culture medium was removed from the basolateral 
compartment and the cells were washed with PBS. Then, &# mL of 
culture media (phenol red-free) and ".(#mL FITC-Dextran (%#kDa, Sigma-
Aldrich) were added to the basolateral and the apical compartment of 
the epithelial barrier, respectively. Cells were then incubated at +- °C to 
equilibrate. Samples from the basolateral were taken at ", +", $", )", 
and &!" min (culture media replaced with an equal volume) in a black 
)$-well plate and were analyzed by the plate reader (Safire !, Tecan) with 
excitation and emission wavelengths of %)" and (!(# nm, respectively. 
The apparent permeability coe'cient (Papp, cm#s!&) is calculated using 
the Equation# $, where dQ/dt is the steady-state flux or the transport 
rate, A is the surface area of the membrane (cm!) and C" is the initial 
concentration of FITC-Dextran added to the apical compartment 
(mg#mL!&).[$%] Before and after the experiment, TEER was measured to 









IL-! Release: The pro-inflammatory IL-* protein released by the 
interleukin-* promoter (pIL*)-reporter A(%) cell line was quantified using 
the luciferase reporter assay ONE-GloTM (Promega, Cat.No. E$&!", 
Mannheim, Germany) according to the manufacturer’s instruction. After 
stimulating cells for !% h by adding TNF-alpha (&(#ng#mL!&) to the cell 
culture medium[*,%*] and subsequent stretching (!% h), a mixture of cell 
lysate and reagent (&:&) measured by the luminometer ()$-well format, 
GLOMAX, Promega, Germany). IL-* challenge did not impair cell 
viability (WST-&) or barrier integrity (TEER) (data not shown).
Cell Uptake of Nanoparticle: A(%) cells were grown on the BETA 
membrane (growth area: %.) cm!) until cells reached confluence. Culture 
media (Phenol red-free DMEM (Gibco) supplemented with &"% FCS 
(Gibco) and &% v/v Pen/Strep (&"" U mL!&, Gibco)) was aspirated from 
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the apical part and allowed cells to culture under ALI conditions for # day. 
Afterward, two scenarios were followed I) unstretched and II) stretched 
conditions (Figure$ %A). For static conditions, the membranes were 
placed in the VITROCELL CLOUD & (Vitrocell, Waldkirch, Germany) for 
nebulization of #"" and #"""$nm amine-modified polystyrene (PS-NH!) 
particles (Sigma-Aldrich, St. Louis, USA), diluted by a factor of #" in 
".'% NaCl. The light intensity-weighted hydrodynamic size distribution 
(z-diameter) of the PS particles in suspension was measured by 
dynamic light scattering (DLS) using a Malvern Zetasizer Nano ZS Plus 
(Model Nr. ZEN'&"", Malvern Instruments, UK) both prior and after 
nebulization (nebulized droplets were collected in a ("$mL Falcon tube). 
This revealed a !!"% increase of the (z-average) diameters from #"".)$to 
##*.*$nm and from #"!& to ##+'$nm due to nebulization (see Figure$S%, 
Supporting Information). For the cell-stretch model, particles were 
nebulized directly onto the cells via the integrated nebulizer in the apical 
chamber (Figure$%A). The cell-deposited particle dose of !.#$µg cm"! was 
determined from the previously determined aerosol deposition e,ciency 
of (!% of the CIVIC system.[&#] For this dose, the fractional area coverage 
was determined to be '"% and '% for NPs and MPs, respectively 
(density of PS-NH!: #."($g cm"'). After the nebulization of particles, a 
cyclic physiologic mechanical stretch (!#% #SA strain) was applied to 
the cells. The output rate of the nebulizer and the sedimentation time 
for both scenarios were ".($mL min"# and '$min, respectively. After ! h, 
the cells (under static and stretched conditions) were fixed and prepared 
for the CLSM analysis.
Statistical Analysis: All data except those designed by Minitab were 
analyzed using GraphPad Prism * (GraphPad Software, La Jolla, CA, 
USA). Outliers were identified using the Grubbs’ method. Student’s 
t-test (unpaired, two-tailed) and one-way ANOVA followed by post hoc 
Tukey’s multiple comparison test were used to compare the means of 
two groups and the means of multiple groups, respectively. Results with 
a p$<$ "."( or smaller were considered as a significant level. DoE were 
designed and the variables were optimized using Minitab #* software 
(Minitab Inc., State College, PA, US). ANOVA was applied to evaluate 
whether the model is statistically significant at a +(% confidence level.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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Figure S1. FIB-SEM micrograph of the membrane at phase I (non-porous), showing some 
superficial hollows on the apical side (marked by *). The green and red dotted lines indicate 
the cross-section of the membrane (basal to apical) and the “gelatin islands” in the structure, 
respectively. Scale bar is 2 µm. 
 
Figure S2. EDX-SEM analysis of the fabricated membrane in phases I and II. (A) in phase I, 
the disc-shapes in the membrane structure are full of nitrogen, which is representative of 
gelatins that have been distributed on the PCL bulk. (B) Removal of gelatin from the 
membrane in phase II after incubation in culture media for 6 days, showing no nitrogen in the 
structure.  
 
Figure S3. SEM images of A549 cells grown on the nine different membrane types with 
varying PCL/gelatin mixing ratio, evidencing the morphology and adhesion of the cells 
(seeding cell density: 1x105 cells cm-2, LLC culture for 6d). For cell culture, the membranes 
were placed between two polycarbonate holders and kept under static, submerged culture 
conditions (LLC) for 6 days. Scale bar is 20 µm. 
 
 
Figure S4. (A) SEM micrograph of bronchial epithelial 16HBE14o− cells were fully grown 
on the membrane (cell density: 2x105 cells cm-2). (B) Semi-decellularized membrane by 0.1% 
SDS, which shows ECM materials and protein strands deposited on the membrane. Scale bar 








































Figure S5. Role of the initial stiffness of the membrane on the formation/arrangement of F-
actin. The stiffness of the membranes in phase I alters the arrangement and formation of F-
actin in A549 cells while no significant changes were detected in the cell numbers (seeding 
cell density: 1x105 cells cm-2, LLC culture for 6d). Images were further quantified using the 
surface rendering of IMARIS (version 9.0; Bitplane, Zurich, Switzerland). The representative 
images (z- stacks) were quantified at 5 independent fields of view (regions-of-interest:134.95 
µm x 134.95 µm) for each sample. The cell nucleus (blue, DAPI), cytoskeleton (green, F-
actin). The scale bare is 10 µm. Data are reported as the mean ± SD; *P < 0.05 by one-way 
ANOVA with Tukey test. 
 
Figure S6. The effect of cyclic mechanical stretch on ZO-1 tight junction formation, and 
barrier integrity. Fluorescent CLSM images of ZO-1 tight junction formation of A549 cells 
under static (ALI culture), physiologic (21% ∆SA), and non-physiologic (35% ∆SA) cyclic 
mechanical stretch (ALI) conditions. A549 cells grown on the (optimum) BETA membrane 
under static (6d LLC and 6d LLC plus 24 h ALI) and dynamic/ALI (21% and 35% ∆SA for 
24 h) culture conditions. Nuclei (DAPI, blue) and ZO-1 (red). The scale bar is 20 µm. 
 
Figure S7. Hydrodynamic, light-intensity weighted size (Z-diameter) distribution of nominal 
100 nm and 1000 nm particles before (red line) and after (green line) nebulization measured 
by dynamic light scattering (DLS, Zetasizer). This reveals an approximate 20% increase in 
average particle size due to nebulization. 
 
Movie 1. Z-stack FIB-SEM tomography of an already populated membrane with A549 cells 
(24.5 nm interval). The images were aligned using NIH Fiji and then reconstructed by 








































Movie 2. Surface rendering (by IMARIS) of 3D reconstruction CLSM images of 100 nm NPs 
after 2 h under static (ALI) conditions. DAPI (blue), PS-NH2 (red), and F-actin (green). 
 
Movie 3. Surface rendering (by IMARIS) of 3D reconstruction CLSM images of 1000 nm 
microparticles after 2 h under static (ALI) conditions. DAPI (blue), PS-NH2 (red), and F-actin 
(green). 
 
Movie 4. Surface rendering (by IMARIS) of 3D reconstruction CLSM images of 100 nm NPs 
under physiologic cyclic mechanical stretch conditions (ALI culture, 21% ∆SA, 2 h). DAPI 
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Evolution has endowed the lung with exceptional design providing a large surface area
for gas exchange area (ca. 100 m2) in a relatively small tissue volume (ca. 6 L). This
is possible due to a complex tissue architecture that has resulted in one of the most
challenging organs to be recreated in the lab. The need for realistic and robust in vitro
lung models becomes even more evident as causal therapies, especially for chronic
respiratory diseases, are lacking. Here, we describe the Cyclic In VItro Cell-stretch
(CIVIC) “breathing” lung bioreactor for pulmonary epithelial cells at the air-liquid interface
(ALI) experiencing cyclic stretch while monitoring stretch-related parameters (amplitude,
frequency, and membrane elastic modulus) under real-time conditions. The previously
described biomimetic copolymeric BETA membrane (5µm thick, bioactive, porous, and
elastic) was attempted to be improved for even more biomimetic permeability, elasticity
(elastic modulus and stretchability), and bioactivity by changing its chemical composition.
This biphasic membrane supports both the initial formation of a tight monolayer of
pulmonary epithelial cells (A549 and 16HBE14o!) under submerged conditions and
the subsequent cell-stretch experiments at the ALI without preconditioning of the
membrane. The newly manufactured versions of the BETA membrane did not improve
the characteristics of the previously determined optimum BETA membrane (9.35%
PCL and 6.34% gelatin [w/v solvent]). Hence, the optimum BETA membrane was
used to investigate quantitatively the role of physiologic cyclic mechanical stretch (10%
linear stretch; 0.33 Hz: light exercise conditions) on size-dependent cellular uptake
and transepithelial transport of nanoparticles (100 nm) and microparticles (1,000 nm) for
alveolar epithelial cells (A549) under ALI conditions. Our results show that physiologic
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stretch enhances cellular uptake of 100 nm nanoparticles across the epithelial cell barrier,
but the barrier becomes permeable for both nano- and micron-sized particles (100 and
1,000 nm). This suggests that currently used static in vitro assays may underestimate
cellular uptake and transbarrier transport of nanoparticles in the lung.
Keywords: lung cell model, cyclic stretch, ALI culture, bioinspired membrane, particle study
INTRODUCTION
The lung is the largest organ of the human body built
to accommodate the extraordinary size of required gas
(oxygen-carbon dioxide) exchange surface area (ca. 100 m2)
corresponding to about half the size of a tennis court (Weibel,
1970, 2009) within a relatively small volume (ca. 6 l; <10%
of body volume). Direct exposure to airborne particles, such
as cigarette smoke particles, urban dust and particles from
indoor sources (e.g., cooking and laser printer) jeopardizes
the fragile architecture of this organ, causing pulmonary lung
diseases, such as asthma and chronic obstructive pulmonary
disease (Pope et al., 2009; Hänninen et al., 2010; Schaumann
et al., 2014). Out of the wide size range of inhalable
particles (up to 10µm diameter), nanoparticles (NPs) with
a diameter between 100 and 300 nm have been shown to
undergo epithelial-endothelial translocation, i.e., they can cross
the alveolar tissue barrier into the blood circulation and
from there to other organs (Kreyling et al., 2013). Moreover,
ultrafine NPs (<100 nm in diameter) have received increasing
attention due to their enhanced surface area per mass of
particles, which has been associated with both acute and
chronic lung disease (Peters et al., 1997; Schmid and Stoeger,
2016).
Improvement of the predictive power of pre-clinical in vitro
models as an alternative to animal experiments according to
the 3R principles (replacement, refinement, and reduction)
relies on enhancing their biomimetic features. Over the past
decades in vitro cell culture models of the lung epithelial cells
have evolved significantly from technologically simple, non-
physiologic, submerged cell culture systems to an advanced
level of in vitro cell culture models at the air-liquid interface
(ALI) (Doryab et al., 2016). In these advanced lung models,
epithelial lung cells are seeded on the apical (air) side of a
porous/perforated membrane, which is in contact with the cell
culture medium located on the basal side. This setup mimics in
vivo conditions, initiating polarization of cells, and secretion of
protective lining fluids (surfactant), which do not occur under
submerged conditions where cells are completely covered with
cell culture medium (Doryab et al., 2019). Hence, ALI cell
cultures provide more physiologic conditions and potentially
clinically more relevant results when testing drug/toxin e!ects
on the lung as compared to submerged cultures (Paur et al.,
2011).
Moreover, in vitro lung models have been developed to exert
cyclic mechanical stretch to cells mimicking the breathing-
induced cyclic stretch conditions in the alveolar lung tissue in
order to include this important stimulus for cell physiology and
morphology in the cell culture models (Doryab et al., 2019).
Hence, addition of this type of stimulus may prove useful
for preclinical drug testing and assessment of toxin- and/or
particle-induced toxicity. Most of the studies reported in the
literature used commercially available cell-stretch technologies
(e.g., Flexcell strain unit; Flexcell International Corp., USA)
that are only suitable for submerged culture conditions
(Edwards et al., 1999; Vlahakis et al., 1999; Hammerschmidt
et al., 2004; Guenat and Berthiaume, 2018; Doryab et al.,
2019).
Nevertheless, a variety of in vitro models has been developed
to combine cyclic cell-stretch and ALI culture conditions for
more biomimeticmodels of the alveolar air-blood barrier. Ideally,
these advanced models enable (I) cyclic mechanical activation of
the (multi-)cell cultures at the ALI, (II) basal perfusion of the
culture medium, mimicking blood circulation, and (III) dose-
controlled, aerosolized substance delivery. While the former two
items have been implemented in various models, the latter is
often missing (Doryab et al., 2019; Artzy-Schnirman et al., 2020).
In 2010, the seminal work performed by Ingber et al. at the
WYSS Institute of Harvard University introduced a microfluidic
lung bioreactor often referred to as “lung-on-a-chip” (Huh et al.,
2010). The concept of these systems is comparable to standard
(multi-)cell culture models of the lung cultured at the ALI on
an elastic, perforated membrane, which can be mechanically
activated (stretched) combined with basal medium perfusion
on a miniature-scale (shift from milli- to microfluidic system).
Nowadays, these microfluidic systems have been evolved from
a simple bi-channel structure (Huh et al., 2010; Stucki et al.,
2015) to a complex airway network (acini-on-chips) (Artzy-
Schnirman et al., 2019). However, wide-spread use of these
systems is still hampered by the high degree of complexity
associated with operating these systems (Ehrmann et al., 2020).
These types of biomimetic alveolar barrier models not only have
the potential to predict clinical outcome during early preclinical
drug or toxin testing and accurate but also for mimicking
drug/particle transport from the lung into the blood. In fact,
the latter is part of the clinical testing (phase I of clinical
trial) required for regulatory licensing of safety and e"cacy of
novel drugs.
All of these models and recent developments su!er from
a lack of a suitable biomimetic membrane, acting as a cell-
substrate. An appropriate membrane should emulate the main
characteristics of the supporting extracellular matrix (ECM)
of the cells, such as thickness, sti!ness, permeability, and
bioactivity. Commercially available polycarbonate (PC) and
polyethylene terephthalate (PET) membranes are widely used
in (static) ALI culture systems that do not mimic the sti!ness
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(or rather “softness”) of the ECM in the lung. Silicone-based
materials, such as poly(dimethylsiloxane) (PDMS, Sylgard
184) are generally cast for cell-stretch applications due to
their suitable mechanoelastic properties (Doryab et al., 2019).
Nonetheless, adsorption of proteins/growth factors to and
leaching of uncured oligomers from PDMS membranes has
been recognized as potential cause of adverse e!ects on cell
physiology (Regehr et al., 2009). Recently, synthetic/natural
electrospun sca!olds with a thickness range of !20–200µm
have been fabricated with suitable properties for lung cells using
co-polymers consisting of poly(!-caprolactone) (PCL)/star-
shaped polyethylene glycols (sPEG) functionalized with
biomolecules (Nishiguchi et al., 2017), poly-L-lactic acid
(PLLA)/decellularized pig lung ECM (PLECM) (Young et al.,
2017), and PCL/gelatin (Higuita-Castro et al., 2017). The
stretchability of these sca!olds/membranes has not been
determined as they were employed only under static cell
culture conditions.
We have recently introduced a novel porous and elastic
membrane for in vitro cell-stretch models of the lung cultured
under ALI conditions (Doryab et al., 2020). This innovative
hybrid biphasic membrane, henceforth referred to as Biphasic
ElasticThin forAir-liquid culture conditions (BETA)membrane,
was developed to optimize membrane characteristics for the
two phases of cell-stretch experiments under ALI conditions,
namely the initial cell seeding, attachment and growth phase
under submerged cell culture conditions (phase I) followed
by an ALI acclimatization and cell-stretch phase at the ALI
(phase II). As these phases require distinctly di!erent membrane
properties, the BETA membrane has been designed to be
biphasic. As the pores are initially filled with a wettable,
water-soluble and hence sacrificial material (gelatin), the BETA
membrane provides initially a non-porous and wettable enough
(WCA " 70#) substrate for initial cell adhesion and growth
into a confluent epithelial monolayer on the apical side of
the membrane (closed pores avoid inadvertent transmembrane
migration of cells) (phase I). Subsequently, dissolution of the
sacrificial material results in su"cient porosity, permeability
and stretchability for up to 25% reversible linear strain
(without plastic deformation), granting suitable ALI cell culture
conditions under cyclic mechanical stretch (phase II). In contrast
to typically used stretchable poly(dimethylsiloxane) (PDMS)
membranes, the BETA membrane is bioactive enough to support
the proliferation and formation of a confluent layer of alveolar
(A549) and bronchial (16HBE14o$) epithelial cells without
pre-coating with ECM proteins (e.g., Matrigel) (Doryab et al.,
2020).
Right now, the main limitations of the BETA membrane
are the relatively larger thickness (ca. 5µm) compared to
the alveolar-capillary tissue barrier (ca. 1µm) and higher
sti!ness [uniaxial Young’s modulus: 1.8 ± 0.7 MPa (1D
stretch); 0.78 ± 0.24 MPa (3D stretch)], which is similar to
or better than other typically used porous membranes for
lung cell-stretch cultures (e.g., PDMS), but still about 100-
fold lager than the elastic modulus (3–6 kPa) reported for
alveolar walls/tissue (Doryab et al., 2020). Moreover, the ideal
membrane is as bioactive as possible to provide optimum
growth conditions for (primary) cell cultures and perfectly
permeable to minimize membrane e!ects on transbarrier
transport measurements.
In the present study, we attempted to improve the previously
described limitations of the “optimum” BETA membrane with
respect to thickness, permeability, elasticity (elastic modulus
and stretchability), and bioactivity by changing its chemical
composition. This is supported by newly applied analytical
parameters (e.g., 3D porosity and mapping of surface topology
of the membrane). Moreover, we provide a detailed technical
description of the recently introduced Cyclic In VItro Cell-
stretch (CIVIC) bioreactor for cell-stretch experiments under
ALI conditions (Doryab et al., 2020) with particular attention
to refinements over its earlier version (MALI, Moving Air-
Liquid Interface bioreactor) (Cei et al., 2020). Subsequently, the
e!ect of cyclic stretch on the particokinetics of aerosol-delivered
nano- (100 nm) and microparticles (1,000 nm) in an alveolar
tissue barrier model (A549) cultured under ALI conditions was
investigated quantitatively with respect to size-dependent cellular
uptake and transepithelial transport of particles.
RESULTS
Advanced in vitro Cell-Stretch System
(CIVIC)
The Cyclic In VItro Cell-stretch (CIVIC) system, which was
employed for cell-stretch experiments with the BETAmembrane,
is a modified version of our previously described MALI system
(Cei et al., 2020) mainly with respect to material stability,
(BETA) membrane fixation, pressure sealing, and quality control
including real-time monitoring of the amplitude and frequency
of the cyclically stretched cell-covered membrane. The CIVIC
system allows for culturing of lung epithelial cells under
ALI, cyclic mechanical stretch, and medium (blood) perfusion
conditions in combination with dose-controlled delivery of
aerosolized substances to the cells. This in vitro scenario
resembles closely aerosol deposition onto the air-blood barrier of
the lung as encountered during inhalation therapy or breathing
of ambient aerosol. The details of the technical aspects of the
CIVIC system are presented in Figures 1A,B and the Methods
and Materials section. A movie of the cyclically stretched
membrane in the “breathing” CIVIC system can be found in the
Supplementary Video 1.
Characterization and Optimization
Bioinspired Stretchable Membrane (BETA)
Asmentioned above, we recently described an optimized biphasic
copolymeric membrane for cell growth inspired by the ECM in
the alveolar region of the lung (Doryab et al., 2020). The initially
non-porous membrane consists of two polymeric components
namely poly(!-caprolactone) (PCL) and gelatin, tailored to
facilitate initial cell adhesion and growth under submerged
condition (phase I) (Figures 1C, 2A). Upon contact with cell
culture medium, the gelatin at the surface of the membrane turns
into a hydrogel, which is conducive to cell growth (lowers water
contact angle; provides favorable conditions for cell adhesion
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FIGURE 1 | The CIVIC system used in this study. (A) Schematic depiction of the CIVIC system under (top) static (unstretched) and (bottom) dynamic (stretched and
perfusion) conditions with the pressure-based strain/elasticity monitoring system. A thin, permeable, and stretchable membrane (BETA) placed in the (PDMS-free)
main chamber of the bioreactor separates the apical (air) and basal (medium) compartments. Lung cells are grown on the membrane at ALI and perfused with culture
medium by circulating the medium in the basal compartment with a perfusion pump to mimic blood flow. Cyclic mechanical stretch is applied to the cells on the
membrane by applying cyclic (positive) pressure (P1) to the apical compartment. The cell/membrane stretch profile can be monitored via a pressure sensor in the air
volume of the medium reservoir (P2), which is connected to the main chamber. The apical compartment of the bioreactor can be connected to a nebulizer to deliver
aerosolized particles/drugs to the cells. (B) Snapshot of the main chamber of the CIVIC bioreactor system. (C) Photograph of the BETA membrane in the PC holder of
the CIVIC system, which is transparent, thus favorable for direct cell imaging applications.
and proliferation). Gelatin also serves as “sacrificial” material,
i.e., it is gradually dissolved by the medium turning the initially
non-porous, sti! membrane into a porous/permeable and more
elastic membrane as required for nurturing ALI cell cultures
via basolateral medium and during cell-stretch experiments
(phase II) (Figure 2B). We previously determined the optimum
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concentrations of PCL and gelatin (9.35% PCL and 6.34% gelatin
[w/v solvent]) for membrane fabrication by spin coating with
respect to matching the properties of the BETA membrane to the
basement membrane of the alveolar tissue using a widely used)
optimization approach [design of experiment (DoE)].
Due to remaining limitations of the “optimum” BETA
membrane with respect to thickness and sti!ness (ca. 100-
fold reduction needed to match alveolar basement membrane)
(Polio et al., 2018; Doryab et al., 2019; Bou Jawde et al.,
2020), we attempted to improve the performance characteristics
of the membrane by expanding the previously tested range
of PCL/gelatin mixing ratios. For this, new membranes were
manufactured with PCL concentration larger than the previously
explored upper limit of 10% [w/v solvent], namely 15% PCL
mixed with 6, 8, and 10% [w/v] (Figure 2A). The characteristics
of these three newly generated BETAmembranes were compared
with previously characterized membranes consisting of 10%
PCL mixed with 6, 8, and 10% [w/v] and the optimum BETA
membrane (9.35% PCL and 6.34% gelatin [w/v]).
Surface analysis of the optimumBETAmembrane (9.35% PCL
and 6.34% gelatin [w/v solvent]) using Atomic Force Microscopy
(AFM) showed an average roughness height of 1.31µm
(Figure 2C). The cross-sectional structure of the membrane was
studied using Focused Ion Beam-Scanning Electron Microscopy
(FIB-SEM). The data show that gelatin forms spherical “islands”
in the PCL membrane (Figure 2D, left panel). These gelatin
islands also extend deep into the PCL membrane, leaving a
favorable interconnected 3D network of pores after dissolution of
the gelatin in phase II, as confirmed by Energy Dispersive X-ray
Spectroscopy (EDS)-FIB-SEM (Figure 2D, right panel).
Analysis of the water contact angle (WCA)—one of the key
properties of cell attachment and growth of the three new
membranes reveals a range of 70–76! indicating that all of these
membranes are wettable (Figure 2E). The uniaxial tensile test
of the membranes prior to cell seeding (in phase I) revealed
that Young’s modulus (elastic modulus) varies between 5.33
± 1.90 and 21.41 ± 4.65 MPa (Figure 2F). Moreover, all of
the membranes can endure at least 8% linear reversible strain,
which is required for physiologic cell stretch conditions in the
lung (Doryab et al., 2019), except for PCL 10% gelatin 6%
[w/v], which can withstand only 4% linear strain. Another
important parameter for culturing of cells under ALI conditions
is the porosity of the membrane at the end of phase II (ALI
culture), which varies between 1.8 ± 2.5 and 49.7 ± 1.4%, where
the highest and lowest porosity corresponds to the membrane
consisting of PCL 10% gelatin 10% and PCL 15% gelatin 8%
[w/v], respectively (Figure 2G). It is noteworthy, that there is
excellent agreement between empirically determined porosity
and theoretically derived (upper limit of) porosity (volume
fraction of gelatin), if the composition-derived theoretical
porosity exceeds 40% (here: PCL 10% gelatin 8% and PCL 10%
gelatin 10%).
In addition, repeatedly performed WST1 assays showed that
the metabolic activity (cell viability) of A549 cells increases with
incubation time on the membranes (Figure 2H). This indicates
that the relatively few initial seeded cells are proliferating and
gradually covering the entire membrane as indicated by WST1
values near 100%, representing the WST1 signal obtained for
standard Transwell PET inserts. After a 4–6 days growth period
(depending on membrane composition), all of the membranes
are covered with a confluent monolayer layer of epithelial cells
(Figure 3A). As an additional measure of cytocompatibility,
the release of intracellular lactate dehydrogenase (LDH) from
the cytosol due to uncontrolled cell death was measured. The
small release of LDH (<0.5% of totally available LDH) indicates
that these membranes display low cytotoxicity (Figure 2I),
which implies that the membranes do not release or leach
significant amounts of toxic materials when incubated with the
cell culture medium.
In summary, the three new membranes consisting of 15%
[w/v] (with 6–10% [w/v] of gelatin) did not improve the
key characteristics of a membrane for cell-stretch experiments
at the ALI. While their wettability as quantified by WCA
was not statistically di!erent from that of the optimum
BETA membrane (Figure 2D), the membrane with the lowest
Young’s modulus and hence highest elasticity (prior to removal
of gelation) displayed an extremely low porosity of 2% as
compared to the 15.32% of the optimum BETA membrane
(Figure 2F). Such a low porosity value is a knock-out criterion
for the membrane since it prevents e"cient trans-membrane
transport of nutrients (or drugs or nanoparticles) and hence
nourishment of cells cultured at the ALI. Hence, the previously
determined optimum BETA membrane (9.35% PCL and 6.34%
gelatin [w/v solvent]) is superior to all of the 15% PCL
membranes and therefore remains the composition of the
optimum BETA membrane, which is used for cell experiments
described below.
Bioactivity of the BETA Membrane
We also evaluated the bioactivity of the (optimum) BETA
membrane using two lung epithelial cell lines namely human lung
alveolar epithelial cells (A549) and human bronchial epithelial
cells (16HBE14o"). CLSM (confocal laser scanning microscopy)
analysis showed that A549 cells grew on the membrane into
a confluent cell monolayer resulted in the formation of E-
cadherin—a transmembrane adhesion protein—which plays a
pivotal role in cell-cell contact and polarization of cells at the
ALI. Moreover, F-actin rich regions representing a network
of polymeric microfilaments of the cytoskeleton were formed,
which is essential for important cellular functions, such as
cell motility, cell division, vesicle and organelle movement,
cell signaling as well as the establishment and maintenance
of cell-cell junctions and cell morphology (Figure 3A; images
reflect day 6). From the DAPI-stained images (Figure 3A)
the number of cells (nuclei) per surface area was determined
(4.3 # 105 cells cm"2). Since this value is 2.9-fold larger
than the seeding density of the cells (1.5 # 105 cells cm"2),
this indicates that substantial cell proliferation has occurred
during the 6 days of cell growth under submerged culture
conditions. For reference, we also compared the bioactivity of
the BETA membrane with that of a commercially available
standard Transwell R$ insert (PET) membrane. It is evident
that while initial cell growth/metabolic activity (WST1 signal)
on the BETA membrane was slower/lower, this di!erence
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FIGURE 2 | Characterization of the biphasic (BETA) membrane used in this study. (A) Schematic depiction of the biphasic membrane concept. (Top) During phase I,
gelatin forms a hydrogel due to contact with water (cell culture medium), which serves as adhesion point for epithelial cells of the lung and facilitates subsequent cell
proliferation until a confluent epithelial cell layer is formed. After 4 days (phase II), the gelatin has been dissolved in water leaving behind a network of interconnected
pores in the PCL membrane, which provides space for further cell spreading and at the same time enhances both membrane permeability and elastic modulus.
(Bottom) Different membranes with various combinations of mixing ratio of PCL and gelatin—in the PCL/gelatin solution used for membrane
manufacturing—expected to obtain a wide range of physicomechanical properties. (B) Top view of the ultrastructure of the “optimum” membrane (9.35% PCL and
6.34% gelatin [w/v of TFE], i.e., P/G = 9.35/6.34), which is also used for the analysis presented in (C,D). The scale bar is 100µm. (C) Surface topography of an 80 !
80 µm2 section of the membrane analyzed by Atomic Force Microscopy (AFM; left) and its corresponding z-amplitude profile (right) showing an average roughness
height of 1.31µm. (D) Cross-sectional analysis of the membrane using Focused Ion Beam-Scanning Electron Microscopy (FIB-SEM, left panel) and Energy Dispersive
X-ray Spectroscopy FIB-SEM (EDS-FIB-SEM, right panel), indicating that gelatin is distributed throughout the PCL membrane during the late stage of phase I. The
thickness of the membrane thickness ca. 5µm. The scale bar is 2µm. The newly manufactured membranes (P15G6, P15G8, and P15G10) are analyzed (and
compared to previously reported results (Doryab et al., 2020) with respect to (E) Water Contact Angle (WCA), (F) Young’s modulus (uniaxial, phase I, under dry
conditions), (G) porosity obtained empirically by the liquid displacement method—and theoretical (maximum) porosity (gelatin volume fraction), (H) cell viability
analyzed by WST1 assay on days 2, 4, and 6 of culture relative to PET Transwell® cell culture insert (H), and (I) cytotoxicity (LDH assay at day 6) of the three newly
investigated membranes with different mixing ratios of PCL and gelatin. The LDH release for each membrane was normalized by the maximum possible LDH level
(LDH contained in all cells). Typically, LDH < 10% is considered non-cytotoxic. There is no significant difference between the LDH release of Transwell® inserts and the
different mixing ratios of BETA membranes. Optimum values for WCA, Young’s modulus, empirical porosity, and theoretical (maximum) porosity were 69 ± 5 ["], 9.0 ±
1.9 [MPa], 15.32 [%] and 37.6 [%], respectively. Data are reported as the mean ± SD, n = 3.
had disappeared on day 4–6 (Figure 2H). The ultrastructural
analysis exhibited a flattened cell morphology when cells
grew on the BETA membrane (Figure 3B). Furthermore,
cells showed superior interaction and integration with the
BETA membrane as compared to the Transwell R# insert
(Figure 3B).
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FIGURE 3 | Bioactivity of the BETA membrane (optimum: 9.35% PCL and 6.34% gelatin [w/v of TFE]). (A) Z-stack Confocal Laser Scanning Microscopy (CLSM) of
human alveolar epithelial cells (A549) on the membrane (under static submerged culture conditions for 6 days) demonstrating the formation of a confluent uniform cell
layer. The cell nuclei (DAPI, blue), expression of the cell-cell adhesion protein E-cadherin (red), and formation of F-actin filaments (green). The scale bar is 10µm. (B)
SEM image of A549 cells after proliferation on a (left) biphasic membrane and (right) a commercial Transwell® insert (6 days of submerged culture). The scale bar is
10µm. (C) Effect of leaching from BETA and PDMS membrane on cell viability (WST1 assay; A549 cells). BETA and PDMS membranes were incubated for 2 days in
cell culture medium and this medium was used to grow A549 cells for 1 and 4 days in a standard 12-well tissue culture well plate. The reduced cell viability for
PDMS-conditioned medium after 4 days indicates that some substances (e.g., uncured oligomers) leaching from the PDMS have a cytotoxic effect. This effect is not
seen for the BETA membrane. The viability data were normalized that of a standard 12- well cell culture plate with fresh medium. Data are reported as mean ± SD. n
= 8; ****P < 0.00001 by one-way ANOVA with Dunnett test. (D) Z-stack and orthogonal CLSM view of (XY) with side views of YZ (right) and XZ (bottom) optical
projection of the human bronchial epithelial cells (16HBE14o!) on the membrane visualizing a confluent cell monolayer and the formation of tight junctions (culture
conditions: 6 days submerged and 24 h ALI culture); cell nucleus (DAPI, blue), F-actin filaments (green); ZO-1 tight junction (red). The scale bars are 100µm (for the
20" projection view) and 20µm (for the 63" projection view).
PDMS (Sylgard 184) membranes are commonly used in
cell-stretch devices due to their mechano-elastic properties.
However, it has been reported that uncured oligomers of
PDMS are released into the culture medium during cell
culture, which might be toxic for the cells (Regehr et al.,
2009; Carter et al., 2020). Hence, we assessed the leaching
of unwanted components of the PDMS membrane compared
to the (optimum) BETA membrane (Figure 3C). Medium
incubated for 48 h with PDMS and BETA membranes was
used to culture A549 cells under submerged conditions. After
1 day, no significant di!erence was detected in cell viability
for the two materials. However, after 4 days of incubation,
a 36% reduction in cell viability was detected for the cells
incubated with PDMS-leached medium, while only 6% of
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viability reduction was observed for the BETA membrane-
leached medium as compared to cells cultured with pristine cell
culture medium.
We also examined the bioactivity of the BETA membrane
using the human bronchial epithelial cell line 16HBE14o!.
Cells were grown on the (optimum) BETA membrane for 6
days under submerged and 1 day under ALI conditions. A
confluent epithelial barrier with the formation of the F-actin was
observed (Figure 3D). SEM analysis also confirmed the CLSM
findings (Supplementary Figure 2). Excellent barrier integrity
was also confirmed by a TEER value of 451 ± 55! cm2, which
is consistent with data reported for 16HBE14o! cells in the
literature (Ehrhardt et al., 2002) and higher than the TEER value
for A549 epithelial confluent cell monolayer on the BETA (136±
23 ! cm2).
Nano- and Microparticle Kinetics Study
As an application of the in vitro cell-stretch lung model (CIVIC),
we investigated the cellular uptake by and transepithelial
transport of nano- and microparticles of A549 cells under
physiologic cyclic mechanical stretch (10% linear, 0.33Hz)
applied for 2 h. The stability of the stretch parameters as well as
the sti!ness [Young’s modulus: 0.78 ± 0.24 MPa (mean ± SD,
n = 5)] of the membrane was monitored continuously during
the entire experiment with the di!erential pressure monitoring
system of the CIVIC system. The metabolic activity of the cells
did not show any evidence of reduced viability due to aerosol
exposure and 2 h of cyclic stretch (Supplementary Figure 3).
This study shows that 2 h of cyclic stretch a!ects cellular
uptake and intracellular distribution, but not trans-cellular
transport in a size-dependent way. The former is qualitatively
evident from CLSM images revealing that cellular uptake of 100
and 1,000 nm particles under unstretched (static) ALI conditions
was very limited and cell-associated particles were mostly located
close to the air-facing, apical cell surface (Figure 4B). In contrast,
100 nm NPs were internalized more e"ciently under stretch
conditions and co-localized with the F-actin cytoskeleton deeper
within the cell (Figure 4B). On the other hand, stretch did not
enhance cellular uptake of 1,000 nm microparticles and particles
were still localized close to the apical cell surface, but positioned
preferably between adjacent cells rather than randomly as
without stretch (Figure 4B). Quantitative fluorescence analysis of
the CLSM images revealed a 2.4-fold increase of cellular uptake
of 100 nm NPs under stretch, while there was no statistically
significant e!ect of stretch on cellular uptake for 1,000 nm
microparticles (Figure 4C).
In addition, spectrophotometric analysis of the basal medium
revealed the transepithelial transport (translocation) of particles
after 2 h under static and stretch-activated conditions of A549
cells on the BETA membrane or on 3µm pore (static)
PET membranes of 6-well Transwell R" inserts (Figure 4D).
For Transwell R" inserts, the particles were delivered with a
VITROCELL R"Cloud 6 system to A549 cells (Lenz et al., 2014)
and then cultured under (static) ALI conditions.
After 2 h of incubation time under static conditions, the
transport fractions across A549 cells on both Transwell R" inserts
and BETA membranes for 100 and 1,000 nm particles were
below the detection limit, except for the 1.8 ± 0.4% transport
of 1,000 nm particles observed for Transwell R" inserts (two-way
ANOVA followed by post-hoc Tukey’s multiple comparison test)
(Figure 4D and Table 1).
For cell-stretch, the transepithelial transport of 100 and
1,000 nm particles across the A549 cell-covered BETAmembrane
was increased to 30.0 ± 1.7 and 21.0 ± 11.3%, respectively, but
no statistically significant dependence on size was observed (no
stretch can be applied to Transwell R" inserts). Hence, cell-stretch
significantly increased the translocation of 100 and 1,000 nm
particles across the alveolar epithelial barrier independent of
particle diameter (see Table 1 and Figure 4D).
DISCUSSION
In the quest for overcoming limitations of traditional in
vitro models of the lung, the field of bioengineering has
witnessed significant e!orts toward developing advanced in vitro
models striving to mimic more closely the human pulmonary
environment (de Souza Carvalho et al., 2014). This has led
the way from mono-cellular submerged cell lines to primary
co-culture cell models at the ALI (air-blood barrier), from
static cell culture media and cell layers to medium perfusion
(pulmonary blood flow) and cyclic stretch (breathing-induced
mechanical tissue strain), and from millifluidic (#cm2 cell area,
mL of media) into microfluidic systems often referred to as
lung/acinar-on-a-chip technologies (Huh et al., 2012, 2013; de
Souza Carvalho et al., 2014; Benam et al., 2015; Tenenbaum-
Katan et al., 2018; Ainslie et al., 2019; Artzy-Schnirman et al.,
2019). While lung-on-a-chip technologies are starting to become
commercially available (e.g., Alveolix, Switzerland and Emulate,
USA), also millifluidic lung bioreactors are expected to continue
to play a role due to their ease-of-handling, a larger amount of
cell samples suitable for many standard assay kits, and lower
maintenance e!orts.
At the core of any cell-stretch lung bioreactor/chip is a
porous and elastic membrane on which the cell culture model is
cultured. For lung/acinar-on-a-chip systems mainly 3.5–10µm
thick PDMS membranes are used for cell seeding and growth
of an alveolar or bronchial tissue barrier (Huh et al., 2010;
Stucki et al., 2015). PDMS membranes are widely used for their
high mechano-elasticity, with Young’s modulus of $1–3 MPa
(Wang et al., 2014). While perforated PDMS membranes are
suitable for small-sized lung-on-chip applications (#mm2), they
are too fragile for larger millifluidic (#cm2) devices. Moreover,
PDMS membranes have low wettability (WCA % 115&)
(Supplementary Figure 1) and therefore require pre-treatment
and/or coating with ECM proteins to facilitate su"cient
cell adhesion and proliferation (Wang et al., 2010). Another
disadvantage is that uncured oligomers of PDMS can leach into
the cell culture medium resulting in changes and cell physiology
(Regehr et al., 2009; Carter et al., 2020). Our investigation
of a PDMS film has confirmed reports from the literature
that cells may experience reduced cell viability due to the
leaching of toxins into the cultured in a medium (Regehr et al.,
2009). Alternatively, commercial electrospun biocompatible
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FIGURE 4 | Cellular uptake and membrane-association of aerosolized nano- and microparticles for alveolar epithelial (A549) cells and translocation across the
epithelial barrier (2 h incubation). (A) Schematic of the CIVIC bioreactor system for particle study. A549 cells were seeded on the BETA membrane (cell density: 2 !
105 cells cm"2, 4 days LLC, and 1-day ALI culture). Amine-modified polystyrene (PS-NH2) nano- and microparticles (100 and 1,000 nm diameter, respectively) are
then nebulized onto the cells with the nebulizer of the bioreactor. After 2 h, the cells were fixed and prepared for CLSM analysis. (B) 3D reconstruction z-stack of
CLSM images presented as orthogonal (XY) and side views (YZ, right) of monolayered, confluent cells on the membrane after nebulization of 100 and 1,000 nm
fluorescently labeled, amine-modified polystyrene (PS-NH2) particles under non-stretched and physiologically stretched (10% linear, 0.33Hz for 2 h) under ALI
conditions. Cell nucleus (DAPI, blue), particles (red) and F-actin filaments of the cytoskeleton (green). Arrows, arrowheads, and asterisk indicate internalized particles,
cell-membrane associated (extracellular) particles (on the apical cell surface) and particles located between cells, respectively. (Scale bar: 20µm). (C) Quantitative
cellular uptake of particles measured by fluorescence intensity of z-stacks, showing that physiologic cyclic mechanical stretch enhances uptake of 100 nm NPs as
compared to static conditions, while there is no effect on 1,000 nm microparticles [Representative images (z-stacks) were recorded at 5 independent fields of view for
each sample (n = 4); region of interest: 134.95 ! 134.95µm]. Y-axis is presented fluorescence intensity data in a log scale. Data are reported as the mean ± SD;
(Continued)
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FIGURE 4 | *P < 0.01 by two-way ANOVA and data were corrected by Sidac for multiple comparison tests. (D) Translocation of 100 and 1,000 nm particles across
the cell layer grown on unstretched PET Transwell® inserts and on the BETA membrane (under unstretched and stretched conditions) (n = 3). ** Show the comparison
between stretched with the corresponding experiment under unstretched conditions. Data are reported as the mean ± SD; **P < 0.001 by two-way ANOVA and data
were corrected by Tukey for multiple comparison tests.
TABLE 1 | Transport of 100 and 1,000 nm particles across A549 cell-layer grown
on BETA or PET Transwell® insert membrane (3µm pores) at ALI within 2 h of
particle exposure (mean ± SD; n = 3).
Translocation [%]
Run
100 nm 1,000 nm
Transwell®/Unstretched <LOD* 1.8 ± 0.4
BETA/Unstretched <LOD <LOD
BETA/Stretched 30.0 ± 1.7 21.0 ± 11.3
* <LOD, below limit of detection.
poly(carbonate)urethane (PCU) membranes (Bionate R! II 80A,
The Electrospinning Company, UK) have been tested for cell
growth in a millifluidic lung bioreactor. They proved inadequate
due to their hydrophobic nature (in spite of pre-coating with
ECM proteins) and associated poor cell proliferation, their
relatively large thickness (ca. 75µm), and their inability to
prevent the formation of multilayered epithelial tissue deep
within the membrane rather than at its apical side (Cei et al.,
2020).
The BETA membrane, which overcomes some of these
limitations (Figure 5), has a thickness of"5µm, which is thinner
than conventional PET or PC/PET membranes used in static
Transwell R! inserts (#10µm) and similar to the lower range of
advanced PDMS membranes (#3.5–10µm) (Huh et al., 2010;
Stucki et al., 2015). The two polymer components, i.e., gelatin
and PCL were chosen for their wettability and mechanical
properties, respectively. The presence of gelatin initial non-
porous membrane (BETA in phase I) is conducive to cell
adhesion/growth without requiring further surface modification
and prevents apically seeded epithelial cells from unwanted
migration through the membrane to the basal side, fostering the
formation of a monolayer of epithelial cells on the apical side.
The gradual dissolution of gelatin by cell culture medium induces
su!cient porosity for culturing of cells at the ALI and even results
in the secretion of innate ECM secreted by the cells. In contrast
to PDMS, no adverse e"ect on cell viability due to leaching has
been observed (Figure 3C).
As mentioned above, one of the main advantages of the
PDMS membranes is their high mechano-elasticity with Young’s
modulus of #1–3 MPa (Wang et al., 2014), which is still ca.
100-fold larger than that of alveolar tissue with 3–6 kPa (Polio
et al., 2018; Bou Jawde et al., 2020). Since the previously derived
optimized BETA membrane (PCL/gelatin = 9.35%/6.34% [w/v
solvent] or P/G = 9.35/6.34) (Doryab et al., 2020) has an initial
Young’s modulus of 9.0 ± 1.9 MPa (prior dissolution of gelatin),
the present study tested the hypothesis that an increased PCL
concentration of 15% (rather than 6–10% as tested previously)
will result in a more elastic membrane. It became evident, that
while a ca. 2-fold lower (uniaxial) Young’s modulus (5.3 ± 1.2
MPa for P15G6) could be obtained (Figure 2F), the porosity
would be prohibitively low (2% for P15G6) for su!cient trans-
membrane nutrient transport during ALI culture conditions.
Hence, the previously determined optimum BETA membrane
(P/G= 9.35/6.34) was used for the cell-stretch cell experiments.
It is important to note that albeit the (optimum) BETA
membrane has an initial (uniaxial) Young’s modulus of 9.0 ±
1.9 MPa prior to the dissolution of gelatin (prior to phase
I), the (uniaxial) Young’s modulus reduces to 1.84 ± 0.66
MPa after dissolving sacrificial gelatin (day 6 under submerged
conditions; end of phase II) (Doryab et al., 2020). When
measured under more realistic, triaxial stretch conditions in the
CIVIC (pressure monitoring method), the elastic modulus of
the BETA membrane decreased from 1.33 ± 0.14 MPa (day 1;
partial gelatin dissolution) to 0.78 ± 0.24 MPa (day 6) (Doryab
et al., 2020), which is ca. 2-fold lower than the corresponding
uniaxial value (1.84 ± 0.66 MPa). Considering that the latter
was measured under dry conditions these two values can be
considered equal within expected experimental uncertainties,
which indicates that the BETA membrane is quite isotropic.
In the present study, we recognized the limited value of 2D
porosity (pore-area fraction at the surface of the membrane),
did not correlate well with the gelatin volume fraction of
the membrane, for membrane optimization with respect to
3D porosity (through pores) as only an interconnected 3D
pore structure allows for su!cient contact between apically
located cells and basal medium during ALI cell culturing.
The measurement method for 3D porosity described here
was in excellent agreement with the theoretically predicted
porosity from gelatin volume fraction, if the latter was
larger than 41% (Figure 2G). This indicates that for gelatin
volume factions larger than 41% all of the available gelatin
can eventually be reached and hence dissolved by culture
medium, i.e., the gelatin-induced 3D pore structure is perfectly
interconnected, which is optimum for ALI culture conditions.
For gelatin factions below ca. 35%, the 3D porosity falls
below 10% implying that increasing “islands” of gelatin are
formed, which are completely engulfed by non-soluble PCL
(Figure 2B of Doryab et al., 2020). Thus, future e"orts for
improved membrane composition should focus on gelatin
volume fractions near or above 40% to provide su!cient
3D porosity.
In summary, the optimum BETA membrane is relatively
thin ("5µm) with a suitable permeability (9.9 $ 10%6 cm
s%1 for FITC-dextran 4 kDa and 15.3% 3D porosity), which
can provide su!cient contact between ALI cultured cells on
the apical and medium on the basal side of the membrane
(Weibel, 1970; Doryab et al., 2019). The BETA membrane
is also stretchable up to 25% linear strain (during phase
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FIGURE 5 | Qualitative comparison between key properties of conventional porous membranes (PET and PDMS) used for static and dynamic (cell-stretch) in vitro
lung models at the air-liquid interface and the BETA membrane presented here. The scores are based on biomimetic relevance as compared to the alveolar basement
membrane. The permeability was measured as apparent permeability (Papp) for FITC-dextran (4 kDa). Stretchability and through pores refer to the elastic modulus
and pores connecting the apical and basal sides of the membrane, respectively.
II), which includes the range of physiologic strain (up to
12% linear) and non-physiologic over-stretch conditions as
discussed below. While the BETAmembrane is more biomimetic
than most other membranes currently available due to the
low WCA (68!) and 3D interconnectivity of the pores,
the BETA membrane still has a ca. 100-fold higher elastic
modulus and thickness of the alveolar tissue and basement
membrane, respectively (Polio et al., 2018; Doryab et al.,
2019; Bou Jawde et al., 2020). The former is expected to
alter cell physiology as compared to lung conditions and the
latter may result in bias transbarrier transport studies. Future
research on membrane technology mimicking the alveolar
basement membrane should focus not only on matching the
physicochemical properties of the basement membrane but
also on its microstructural (network of ECM fibers) and
molecular structure.
Thus, further research is needed to close this physiologic
gap. Several alternative synthetic sca!olds have presented
promising results for lung, such as biofunctionalized or
synthetic-peptide-based synthetic sca!old (Nishiguchi et al.,
2017). Despite the natural-based sca!old (e.g., collagen type
I), synthetic sca!olds can be tailored to have selective tunable
properties, mimicking the microenvironment of cells to facilitate
cell adherence, proliferation, and di!erentiation. However,
artificial sca!olds, i.e., natural, synthetic, and natural/synthetic
introduced until now are unable to concurrently mimic all
the physical, mechanical, and biological properties of the
natural ECM or basement membrane of the pulmonary cells.
The biomimetic biphasic sca!old reported here has excellent
structural, mechanical, and biophysical characteristics and can be
a suitable alternative for growing epithelial cells not only in the
monoculture but also in co-culture and triple co-culture models
(Lehmann et al., 2011; Heydarian et al., 2019).
Ultimately, su"ciently biomimetic in vitro models of the
alveolar tissue should not only focus on the basement membrane
but also include more advanced primary alveolar cell models,
such as the commercially available primary-derived hAELVi cells
(Kuehn et al., 2016) or EpiAlveolar cell model (MatTek, Inc.)
(Barosova et al., 2020). The combination of both aspects should
lead to even more biomimetic and hence clinically predictive
models of the alveolar barrier.
The millifluidic CIVIC bioreactor utilizes positive pressure
to mechanically stretch a cell-covered elastic membrane activate
stretchable and thus allows for ALI cell culture conditions
with medium perfusion, cyclic stretch, and monitoring of the
pressures in the apical and basal compartment of the bioreactor is
leveraged for real-timemonitoring of amplitude and frequency of
cyclic stretch and of tri-axial Young’s modulus of the cell-covered
membrane. This allows for precise selection of stretch conditions
and quality control of key experimental conditions during the
course of the cell-stretch experiment. Moreover, an aerosol-cell
delivery unit using a clinically relevant nebulizer enhances its
applicability to drug testing suitable for inhalation therapy.
It is instructive to relate the characteristic stretch and
perfusion parameters of the CIVIC equipped with the BETA
membrane to clinical conditions. The BETA membrane can
sustain linear stretch amplitudes of up to 25% (Doryab et al.,
2020). Population-based averages for breathing frequency and
tidal volume during heavy exercise are 26 breaths per minute
(33 bpm for women) and 1.92 L (1.36 L), respectively (ICRP,
1994). For typical lung inflation of 3.3 L (2.7 L) at functional
residual capacity (FRC, at end of exhalation), this tidal volume
corresponds to a 58% (50%) increase in lung volume yielding
a 17% (15%) linear and 36% (31%) area change (assuming the
alveolar sacs are spherical). Analogous, the stretch conditions
were chosen here for the particokinetics study (10% linear at
0.33Hz = 20 bpm) correspond to a tidal volume of 1.09 L
(female 0.89 L), which is similar to “light exercise” conditions
(male: 1.25 L, 20 bpm; female: 0.99 L, 21 bpm) (ICRP, 1994).
Consequently, linear strain larger than 17% (or 35%!SA), which
may occur for instance during positive pressure ventilation, is
considered over-distension or non-physiologic strain, possibly
provoking apoptosis and necrosis, increase permeability and
release of inflammatory mediators (such as Interleukin-8) in
alveolar epithelial cells (Edwards et al., 1999; Vlahakis et al., 1999;
Hammerschmidt et al., 2004).
The maximum positive di!erential pressure applied to the
apical side of the cells during a cyclic stretch in the CIVIC
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(2.5 kPa) is higher than exerted onto the lung tissue during
normal exhalation (0.1–0.5 kPa), but similar to conditions during
mechanical ventilation at the intensive care unit of a hospital
(normal: 1.5–2.0 kPa, 2.5 kPa acceptable peak value; 3.0 kPa
should not be exceeded for an extended period of time) (Hall,
2016). Finally, the medium perfusion rate of 400 µL min!1 has
to be put into context with the area of gas exchange (membrane
area: 5 cm2) for comparison with the lung. The ratio of area
and perfusion rate of the CIVIC is with 1.25 m2/(L min!1)!1
considerably lower than that of the lung [20 m2/(L min!1)!1
= 100 m!2/(5 L min!1)], but the corresponding flow rate of
6.4 L min!1 in the CIVIC system technically not be di!cult to
establish since it would require tubing with much larger diameter
enhancing the laboratory footprint unduly.
It is well known that the size of particles plays a key role
in cellular uptake and internalization of the particles (Takenaka
et al., 2012; Zhu et al., 2013). We found that both 100
and 1,000 nm amine-coated particles could not be internalized
by alveolar epithelial cells (A549) under static/unstretched
conditions (2 h after aerosolized particle delivery). Moreover,
1,000 nm microparticles were also not taken up by cells under
stretched conditions, which can be explained by endocytic
uptake (most relevant uptake mechanism for epithelial cells)
being limited to ca. 500 nm particles (Winnik and Maysinger,
2013; Zhu et al., 2013; Annika Mareike Gramatke, 2014). In
contrast, the relatively e!cient cellular uptake of 100 nm NPs
is consistent with previous observations that positively charged
(amine-coated) NPs tend to interact with the negatively charged
cell membrane, which enhances their uptake as compared to
neutral or even negatively charged particles of the same size
(Rothen-Rutishauser et al., 2006). The observed colocalization of
NPs with the F-actin cytoskeleton in A549 cells is conducive for
further intracellular tra!cking and endocytosis of the NPs within
cells (Foroozandeh and Aziz, 2018). For in vitro pharmacokinetic
testing, ALI culture conditions have several advantages over
submerged cell culture settings. In addition to more physiologic
and tighter barrier function, burst-like pharmacokinetic profiles
as typically seen in patients can only be observed for ALI
conditions (Meindl et al., 2015; Schmid et al., 2017) since this
resembles rapid depletion of the pulmonary drug reservoir due to
drug transport into the blood.Moreover, the cell-delivered dose is
often poorly known under submerged conditions due to variable
particle-cell transport rates in cell culture medium (Teeguarden
et al., 2007; Schmid and Cassee, 2017). In contrast, under ALI
conditions, the aerosol dose is delivered immediately directly
onto the epithelial barrier mimicking the conditions of inhaled
particles in the lung. To date, in vitro particokinetic studies
are mainly performed under submerged culture conditions,
and to the best of our knowledge, no quantitative transbarrier
particokinetic (translocation) studies under cell-stretch ALI
conditions have been reported, yet.
For sub-100 nm NPs the translocated fraction of particles is
inversely proportional to particle size in both static in vitro cell
and in vivo animal models of the lung (Kreyling et al., 2014;
Bachler et al., 2015). For A549 cells at ALI and rodent models
after NP instillation, the first plateau of particle translocation is
achieved within 2 h for 80 nm gold NPs, but it is considerably
larger for (static) A549 cells (ca. 2% of the delivered dose) as
compared to particle instillation in rats (ca. 0.2%) (Kreyling et al.,
2014; Bachler et al., 2015). For A549 cells, receiving doses larger
than 0.1 µg cm!2 for gold NPs has resulted in a decrease in the
transport rate (Bachler et al., 2015).
The 2 h translocation fraction of 100 nm amine-modified
polystyrene particles observed in this study was below the
detection limit [ca. 1.0% (Transwell) and ca. 3% BETA], which
is in general agreement well with the results from Bachler and
colleagues (Bachler et al., 2015), if we consider that the larger
than 0.1 µg cm!2 (here 2.1 µg cm!2) cell-delivered dose may
have lowered the transport fraction. On the other hand, the
1.8% of translocation fraction for 1,000 nm particles (Transwell
inserts) appears relatively large considering that virtually no
translocation of microparticles has been reported in in vivo
biokinetics studies. The absence of 1,000 nm translocation for the
BETA membrane (below detection limit of ca. 3%) is consistent
with these in vivo results. While it may be expected that cyclic
stretch a"ects the transepithelial mobility of particles by, e.g.,
additional convective particle transport, changes in paracellular
barrier integrity, and e"ects on cellular uptake and transport
mechanisms, the relatively large increase to 30 and 20% for 100
and 1,000 nm particles is unexpectedly high. Since these values
even agree within experimental uncertainty it is unlikely that
this is the result of an active cellular transport process especially
since endo-/exocytosis as the most e"ective cellular uptake and
transport mechanism for epithelial cells is limited to sizes below
500 nm. Moreover, substantially enhanced cellular uptake was
only observed for 100 nm particles (Figure 4B). Therefore, we
assume that this large increase in translocation fraction is due
to a combination of passive mechanisms, such as rupture of the
relatively weak tight junctions of A549 cells yielding intracellular
gaps, which allows for enhanced convective transport of particles
irrespective of particle size due to leakage of the medium in and
out of the apical space where the particles are residing.
CONCLUSION
The “optimum” copolymeric BETAmembrane (P/G= 9.35/6.34)
applied here is biomimetic in the sense that it is thin ("5µm),
surface wettable, permeable with proper pore size for cell growth
and interconnected 3D pore structure, elastic and bioactive,
and somewhat comparable to the ECM in the alveolar region.
However, it still is ca. 100-fold too thick and sti" as compared to
the basement membrane of the alveolar region. These limitations
could not be alleviated by enhancing the poly(!-)caprolactone
(PCL) concentration 15% (w/v). Using the “optimum” we
showed that the CIVIC can be utilized for cellular uptake
and transepithelial transport studies under physiologic stretch
and ALI conditions including aerosolized substance delivery.
While the results for static conditions are in general agreement
with literature data, unexpectedly high translocation of both
100 and 1,000 nm particles under physiologic stretch (light
exercise) was observed for an A549 alveolar lung barrier. This
suggests that more appropriate cell (co-)culture models with
more pronounced tight junctions and advanced primary cell
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culture models should be employed for cell-stretch experiments.
Studies in the field of respiratory diseases are expected to benefit
greatly from the development of more biomimetic and reliable
in vitro models of the lung as currently available. We believe
our system presents a valuable step toward improvement of the
predictive value of advanced lung cell models.
MATERIALS AND METHODS
Cell Culture
Human alveolar type-II like epithelial cells (A549) were cultured
and maintained in Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F-12 (DMEM/F12, 1:1 v/v, Gibco) supplemented with
10% FCS (Gibco), 1% (v/v) Pen/Strep (100U mL!1, Gibco),
1% L-glutamine (2mM, Gibco), and 2-phospho-L-ascorbic acid
(0.1mM, Sigma). Human bronchial epithelial cells (16HBE14o!)
were cultured in MEM/F12 medium (Gibco) supplemented with
10% FCS (Gibco), 1% (v/v) Pen/Strep (100U mL!1, Gibco) and
1% L-glutamine (2mM, Gibco).
For longitudinal monitoring of cell viability (WST1), A549
cells were grown on the BETA membranes by seeding cells
with a cell density of 1.5 " 105 cells cm!2 on a UV sterilized
BETA membrane (e!ective growth area: 1.3 cm2, depending on
application). A PTFE holder was used for keeping the BETA
membranes) and on Corning R# Costar R# Transwell R# cell culture
inserts (PET, 12-well, 1.1 cm2; 3µm pore) (control). Cells were
then cultured for 6 days under submerged conditions (basal
and apical medium volumes were 1.5 and 0.5mL, respectively)
followed by 24 h under ALI conditions. Similarly, 16HBE14o!
cells were also grown on the BETA membrane (cell seeding
density: 2 " 105 cells cm!2; e!ective growth area: 1.3 cm2) for
6 days under submerged and 24 h under ALI conditions.
Immediately prior to cell-stretch experiments the membrane
was placed in the CIVIC and the media volume in the basal and
reservoir chamber of the CIVIC were 4 and 12mL (including
2mL in the connecting tubing), respectively.
In vitro Cell-Stretch System (CIVIC)
We used the CIVIC system to apply cyclic stretch to cells grown
on the BETAmembrane under ALI culture conditions (Figure 1).
The main chamber of the CIVIC bioreactor is separated by
the BETA membrane into an apical (humidified air) and a
basal (perfused cell culture medium) compartment mimicking
the air-blood barrier of the lung including its breathing-related
cyclic stretch induced by oscillation of the apical pressure
(Figures 1A,B and Supplementary Video 1). The cell culture
medium in the basal compartment is circulated using a peristaltic
pump to mimic blood flow (400 µL min!1). Cells grown on the
membrane are subjected to a uniform cyclic triaxial strain by
applying a cyclic (here: sinusoidal) positive pressure to the apical
chamber by cyclic opening of a valve connected to pressurized
cleaned house air and a valve connected to ambient air. The entire
system is placed in an incubator (37$C) to maintain optimum cell
culture conditions. The dry house air is entering the chamber
for pressurization via a humidifier and the initially dry air in
the apical compartment can be humidified by nebulization of
small volume (2 µL) of saline using the nebulizer described
below (Figures 1A,B). Both amplitude and frequency of stretch
can be set by an Arduino integrated development environment
(or IDE) software (Arduino IDE 1.0.5 for Windows). For BETA
membranes, the CIVIC bioreactor is able to apply physiologic
linear strain: (0–17%) and non-physiologic (over-stretch; 17–
25%) stretch conditions, as described below.
The CIVIC system is a modified version of the previously
described MALI bioreactor system (Cei et al., 2020). The
overall setup and geometry of the MALI system have not
been changed. However, the following technical improvements
were implemented. All of the components in contact with
culture medium are nowmanufactured with PDMS-free material
(namely polycarbonate, PC) to prevent potential artifacts due
to leaching of toxicants from the PDMS into the cell culture
medium. Moreover, an upgraded design of the PC holder
more e!ectively prevents membrane slipping and leakage
of culture medium during pressure oscillations required for
inducing cyclic cell stretch as described below. The pressure
sealing of the main chamber was improved and not only
the pressure in the basal compartment (headspace of the
medium reservoir, P2), but also the pressure in the apical
compartment was measured continuously (P1) (Figure 1A)
using two piezoresistive, monolithic silicon pressure transducers
(MPX5050, Freescale Semiconductor, Munich, Germany).
A clinically used vibrating mesh nebulizer (Aeroneb Pro/Lab,
Aerogen Inc., Galway, Ireland) is positioned at the top of the
apical chamber for delivery of aerosolized substances to the cells
on the BETAmembrane. This type of nebulizer has liquid output
rates and mass median droplet diameters ranging from 0.2 to
0.8mL min!1 and 2.5 to 6µm, respectively, depending on the
specific type of nebulizer (Ding et al., 2020). Nebulization of
10 µL of liquid and subsequent spatially uniform deposition
onto the cells cultured on the BETA membrane (5 cm2) with a
deposition e"ciency of 52% occurs within 2min due to cloud
settling (Cei et al., 2020). These aerosol delivery parameters
are, independent of nebulizer performance in terms of droplet
diameter or liquid output rate (Lenz et al., 2014) since cloud
settling depends on the fractional aerosol volume in the air
only and hence on the nebulized aerosol volume (10 µL)
and the volume of the apical compartment of the chamber.
Vibrating mesh nebulizers contain a porous membrane for
aerosol production, which may be a!ected by cyclic positive
pressure. Since aerosolized substance delivery is short (2min)
relative to typical cell-stretch experiments (>2 h), aerosolized
substance application is typically decoupled from cyclic cell
stretch, i.e., cell-stretch is not applied during aerosolization.
This patented aerosol-cell exposure unit has recently been
made commercially available as VITROCELL R#Cloud MAX
(VITROCELL Systems, Waldkirch, Germany), albeit only for
standard transwell inserts, which cannot be subjected to cyclic
stretch. When positive pressure is applied apically to the
membrane (P1), the initially relaxed, flat, horizontally oriented
membrane is stretched triaxially downwards expanding the
volume of the apical compartment by a dome-shaped volume
!V (Figures 1A, 4A). Due to the incompressible nature of water
(culture medium), this change in apical volume reduces the
air-filled headspace of the medium reservoir by !V and the
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corresponding increase in pressure (P2) can be directly related
to the linear/area amplitude of membrane stretch (Figure 1A).
This special feature of the CIVIC bioreactor enables real-time
monitoring of the experimental stretch parameters (amplitude,
frequency) and Young’s modulus of the cell-covered membrane
with thickness t during triaxial stretch under wet conditions
(contact with culture medium) by continuously monitoring the
apical and basal pressures (P1 and P2, respectively). While the
stretch frequency can be directly derived from the time course
of P1 or P2, the linear (1D) and area (2D) amplitude as well as
Young’s modulus (elastic modulus; E, kPa) of the membrane can
be determined from the maximal values of P1 and P2 according



















































Initially, the membrane is non-stretched and the pressure in both
the apical and basal compartment is at ambient pressure P0 (on
average 98.0 kPa in Munich, Germany) (see Figure 1A). Under
these conditions, the radius (area) of the membrane a is 1.26 cm
(5 cm2) and the headspace volume in the medium reservoir V0 is
30mL (40mL vessel filled with 10mL medium). The deflection
of the membrane perpendicular to the membrane (!h) can
be obtained from the corresponding change in apical/basal air
volume !V, which is determined from Equations (1), (2) and
the measured pressures P1 and P2. Young’s modulus (elastic
modulus; E, kPa) of the membrane can then be obtained from
Equation (3), where t is the thickness of the membrane (ca. 5µm;
calculated by cross-sectional SEM analysis). For dome-shaped
geometry (spherical cap), one can find the relative linear and area















The amplitude of cell stretch can be calculated from Equation
(4), where !h is the membrane deflection (0 # !h # 0.11 cm)
(Equations 1–3) and !S is membrane change in surface area
during the stretch. P1 and P2 are 100.5 and 99.5 kPa for
physiologic stretch (10% linear strain or 21% !S), respectively.
For optimum BETA membrane, the CIVIC bioreactor is
able to apply a linear mechanical strain of up to 17% (or 3,
which covers both physiologic and non-physiologic (overstretch)
conditions. For those conditions, the optimum BETA membrane
is resilient to 48 h cyclic stretch with no deformation, rupture,
and creep.
Membrane Fabrication
We recently introduced a novel ultra-thin co-polymeric
membrane (BETA) transitioning from an initially sti!,
hydrophilic, non-porous membrane to an elastic, porous
substrate, providing optimum cell culture conditions during the
two phases of typical in vitro alveolar cell-stretch experiments
at the ALI (Doryab et al., 2020). Briefly, we employed a
two-component (hybrid) polymeric material consisting of
poly(!-caprolactone) (PCL: Sigma-Aldrich, Mn 80,000) and
gelatin (Type A from porcine skin, Sigma) chosen for their
mechano-elastic and bioactivity properties, respectively.
Di!erent mass ratios of PCL and gelatin were dissolved in
TFE [(2,2,2-trifluoroethanol) with >99.8% purity, Carl Roth
GmbH, Karlsruhe, Germany] and stirred until the blend became
homogenous. The PCL/gelatin mixture was then added to a
custom-made spin-coater (2,000 rpm) to produce a thin film
which was left to dry under vacuum (Figure 2A). The initially
non-porous membrane (phase I: initial cell adhesion and
growth) becomes gradually permeable (phase II: ALI culture)
upon contact with the cell culture medium. The underlying
concept of a biphasic membrane for cell-stretch experiments
under ALI conditions mimicking the conditions in the alveolar
tissue has been described in the introduction. The optimum
concentrations of PCL and gelatin was determined previously
as 9.35% PCL and 6.34% gelatin [w/v solvent]; solvent: $99%
TFE (2,2,2-trifluoroethanol) (Doryab et al., 2020). Here, three
new membranes with 15% PCL and 6, 8, and 10% of gelatin
were manufactured. The membranes were placed in a holder for
placement in the CIVIC system during cell-stretch experiments
as described below (Figure 1C). Membranes were sterilized
before cell culture experiments with ethanol and ultraviolet (UV)
light exposure. The membrane is optically transparent and hence
suitable for modern cell microscopy technologies.
Membrane Characterization
The membranes were characterized in terms of thickness,
ultrastructure, pore size, elemental and chemical composition,
surface wettability, elastic modulus, 3D porosity, and cell
proliferation (viability and cytotoxicity).
Physical, Elemental, and Chemical Characterization
Thickness, ultrastructure, and pore size of the membranes
were analyzed by Scanning Electron Microscopy (SEM). The
samples were fixed in 6% (v/v) glutaraldehyde (Sigma-Aldrich)
and then dehydrated in gradient ethanol solutions followed
by HDMS (hexamethyldisilazane, Sigma-Aldrich) for 15min
and subsequently mounted onto aluminum stubs, sputter-
coated with platinum using Leica EM ACE600 vacuum coater,
and imaged by SEM (Zeiss Crossbeam 340, Carl Zeiss AG,
Oberkochen, Germany) with acceleration voltage of 2 kV. We
also used Energy Dispersive X-ray Spectroscopy (EDS, X-maxN,
Oxford instruments) with an acceleration voltage of 8 kV
to study qualitative elemental and the local distributions of
certain elements (Carbon and Nitrogen) in the sample. Focused
Ion Beam (FIB)/SEM (Zeiss Crossbeam 340, Carl Zeiss AG,
Oberkochen, Germany) and FIB/SEM/EDS were employed to
investigate the cross-sectional structures of the membranes at
high resolution (30 kV; 700 pA and 1.5 nA). Surface roughness
was assessed by an Atomic Force Microscope (AFM, Nanosurf
Flex-Axiom) at room temperature. A scanning area of 80µmwas
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chosen. Scan rates of 0.5–0.15Hz were used duringmapping with
512 points per scan.
Surface Wettability (Water Contact Angle)
The surface wettability or Water Contact Angle (WCA) of
the membranes was determined with the sessile drop method
using an automated contact angle system OCA20 with an image
processing system as described previously (Doryab et al., 2020).
Elastic Modulus (Young’s Modulus)
Uniaxial (1D) tensile test (BOSE 5500 system, ElectroForce, Eden
Prairie, MN, USA) with a load capacity of 22N at a rate of 0.01
mm/s until rupture was used to calculate Young’s modulus of the
membrane (in phase I). Young’s modulus of the membrane in
wet (phase II) condition was measured using our novel pressure-
based technique integrated into our CIVIC system described in
more detail in Figure 1A.
Porosity
We used the liquid displacement method to measure the 3D
porosity of the interconnected three-dimensional (3D) pore
network of the membranes. Briefly, membranes were submerged
in ethanol (EtOH, !99% purity) for 24 h. Gravimetric analysis
prior to and after soaking the membrane with EtOH revealed the
volume of EtOH (VEToH) inside the pores (V = m/!; mEtOH =
di!erence of mass prior to and after soaking; !EtOH = 0.789 g
cm"3) and the volume of the dry membrane (Vm) [mm =mass of
membrane prior to soaking; !m is the volume-weighted density of
PCL (1.145 g cm"3) and gelatin (1.3 g cm"3)]. The empirical 3D





To account for EtOH adsorption on and/ormicroporosity of PCL
itself, the apparent porosity of the pure PCL membrane (9.3 ±
1.7%; according to Equation 5) was subtracted from themeasured
porosity of the PCL/gelatin membranes.
Moreover, one can estimate the upper limit of porosity from
the chemical composition of the membrane. Assuming gelatin
has been completely dissolved in the culture medium (PCL is
insoluble), one finds a theoretical upper limit for porosity from
the volume fraction of gelatin based on Equation (6), where Vg
and VPCL are the volume fraction of gelatin and PCL in the
composite of PCL/gelatin, respectively, and !g and !PCL are the










Cell Proliferation, Morphology, and Cell Viability
Cell proliferation was assessed from the known number of
cells seeded on the membrane (day 0) and the cells counted
based on DAPI-stained (cell nucleus) CLSM images at the end
of the submerged cell culture conditions (day 6). Moreover,
cell proliferation was monitored indirectly with higher time-
resolution by measuring cell viability in terms of a non-
destructive metabolic activity assay (WST1, Roche, Mannheim,
Germany), provided the metabolic activity of the cells is similar
during the 6 days of cell growth. This test was performed on
cell covered BETAmembranes (1.3 cm3) and Corning R# Costar R#
Transwell R# cell culture inserts (PET, 12-well, 3µm pore), which
was used as a commercial membrane to compare cell viability,
cell number and morphology with that of the BETA membrane.
Each membrane was incubated with 1mL diluted WST1 reagent
(1:15) at 37$C. After 15min, 150 µL supernatant was transferred
to a 96-well plate (4 times for each membrane) and absorbance
was measured in a plate reader (MagellanTM Tecan) at 450 nm.
All the results were normalized to the mean value of blank.
Lactate Dehydrogenase (LDH) Release
The cytotoxicity e!ect of the manufactured membranes was
assessed by the detection of the release of lactate dehydrogenase
(LDH; Roche Applied Science, Mannheim, Germany) from
the cells, which indicates perforation of the cell membrane.
According to the manufacturer’s protocol, the determination of
LDH activity was determined in the basal (and apical) medium
by absorbancemeasurement at a wavelength of 492 nm. The LDH
release is presented as the ratio of LDH dose (LDH concentration
times medium volume) in the cell culture medium and the high
control (cells treated with 2% [w/v] Triton X-100). Transwell
inserts were used as a positive control since BETAmembranes are
more limited in supply than standard Transwell inserts. The LDH
release for each membrane was normalized by the maximum
possible LDH level (LDH contained in all cells).
PDMS-Leached in Cell Culture Medium
We fabricated PDMS films for studying the leaching of PDMS
oligomers into the culture medium. Briefly, the elastomers
and crosslinker (1:10, Sylgard 184, Dow Corning) were mixed
and degassed under vacuum. After casting, the film was cured
in an oven at 60$C overnight. The PDMS film (thickness:
5µm) was then cut using a standard biopsy punch (size:
5.0mm; Kai medical, Solingen, Germany). The membranes were
washed with PBS (three times) and disinfected using EtOH 80%
and UV before immersing in the Dulbecco’s Modified Eagle
Medium: Nutrient Mixture F-12 (DMEM/F12, 1:1 v/v, Gibco)
supplemented with 10% FCS (Gibco), 1% (v/v) Pen/Strep (100U
mL"1, Gibco), 1% L-glutamine (2mM, Gibco). The PDMS
punches and BETA membranes of the same size were soaked in
2mL of culture medium for 2 days (the ratio of the surface area
and the bulk volume of the membrane to the culture medium
were 0.1 cm2 mL"1 and 4.9% 10"5 cm3 mL"1).
The PDMS- and BETA-incubated media containing leached
compounds were used to investigate their e!ect on cell viability
with the WST1 assay. For this, A549 cells (1.5 % 105 cells cm"2)
were cultured under submerged conditions in 12-well multiwell
plates using PDMS- and BETA membrane-leached media for up
to 4 days and repeatedly analyzed for viability (WST1). As a
control, A549 cells were seeded on the bottom of the well plate.






































Doryab et al. Bioinspired in vitro Lung Model
Immunofluorescence
Cells were fixed in 4% paraformaldehyde (Sigma-Aldrich),
washed with PBS and, permeabilized by 0.3% Triton X-100
(Sigma-Aldrich) in PBS at room temperature. To prevent any
unspecific antibody binding, a blocking bu!er (5% BSA and
0.1% TritonX-100) was added for 10min. The cells were then
incubated overnight at 4!C with Anti-E-Cadherin (mouse,
1:1,000; Invitrogen) and anti–ZO-1 monoclonal (mouse, 1:100;
Invitrogen), in a blocking bu!er (5% BSA and 0.1% TritonX-
100). Cells were then incubated with secondary antibody Alexa
Fluor R" 488 goat anti-mouse IgG (1:500; Invitrogen) and Alexa
Fluor R" 555 goat anti-mouse IgG (1:500; Invitrogen). The F-
actin cytoskeleton and cell nuclei were stained with Phalloidin
594 (1:40) and DAPI (1:100), respectively. The cells were then
embedded in Glycergel (DAKO Schweiz AG, Baar, Switzerland).
All cell images were acquired using a confocal laser scanning
microscope (CLSM; LSM710, Carl Zeiss; Oberkochen, Germany)
coupled to the Zen2009 software. For intensity quantification of
particles, the images were recorded at five independent fields of
view (region of interest: 134.95 # 134.95µm) for each sample.
The rectangular tool (Fiji) was used to measure the mean
fluorescence intensity of background-subtracted images.
TEER Measurement
Trans-epithelial electrical resistance (TEER) measurements of
epithelial cells grown on the membrane were measured using the
Millicell-ERS system (Millicell ERS-2, Millipore, USA). TEER is
calculated by multiplying the cell-specific resistance (Ohm, !)
and the e!ective surface area of the membrane (cm2). The TEER
value of the blank BETA membrane was determined as 78 ±
10 (! cm2), which was then subtracted from the cell-covered
membrane TEER values.
Particokinetic Studies
For particle studies, we chose fluorescent amine-modified
polystyrene (PS-NH2) spheres, fluorescent orange (Sigma-
Aldrich, St. Louis, USA), with a mean diameter of 100
and 1,000 nm for particle study (Figure 4A) since amine-
functionalized surfaces (positively charged particles) are
associated with higher cellular uptake and internalization as
compared to neutral or negatively charged ones (Rothen-
Rutishauser et al., 2006; Zhu et al., 2013). A549 cells were
grown on the optimized BETA membrane until confluence
(submerged conditions for 6 days) and left for acclimatization
at the ALI for 1 day. Particles were then nebulized directly
onto the cells [deposited mass dose: 2.1 µg cm$2; surface
area dose: 1.2 cm2 cm$2 (100 nm particles); 0.12 cm2 cm$2
(1,000 nm)] and incubate with the cells for 2 h under stretched or
unstretched conditions.
For the unstretched experiments, the membranes were
first put in special holders and placed in a 6-well plate
which was then positioned in the aerosol-cell exposure
chamber of a VITROCELL R"Cloud 6 system (VITROCELL
Systems, Waldkirch, Germany; aerosol exposed area: 146 cm2,
deposition factor: 0.97), followed by nebulization of 250 µL
of particle suspensions (1.25mg mL$1 in 0.3% NaCl) with
subsequent aerosol sedimentation onto the cells with 3min
as described by Lenz and colleagues (Lenz et al., 2014).
Corning R" Costar R" Transwell R" cell culture inserts (6-well,
PET membrane with 3µm pores) were also used to compare
transepithelial translocation of particles with cells cultured on the
BETA membrane under unstretched and stretched conditions.
For stretch experiments, particles are delivered to the cells
using the nebulizer integrated in the CIVIC as described
above (Figures 1A,B, 4A) with a known delivery e"ciency of
52% (Doryab et al., 2020). Subsequently, a physiologic cyclic
mechanical stretch (10% linear at 0.33Hz) corresponding to
respiratory conditions during light exercise was applied to the
cells for 2 h.
The fractional particle transport across the epithelial barrier
was determined by quantitative fluorescence spectroscopy of the
culture media in the basal compartment of both unstretched
and stretched treatment using a plate reader (Safire2TM, Tecan;
excitation: 520 nm, emission: 540 nm). For normalization to the
cell-delivered dose a standard curve of the particle suspension
in cell culture medium basal medium volume prepared and
measured for fluorescence intensity. For the measurement of
quantitative cellular uptake of particles with CLSM, the samples
were washed with PBS to remove free or weakly adsorbed
particles from the apical side of the cell layer. Subsequently, the
cells on the membranes were fixed in 4% paraformaldehyde for
CLSM analysis. The CLSM images (z-stacks) were then recorded
at five randomly selected fields of view for each sample (n =
4; region of interest: 134.95 # 134.95µm) and quantified for
cumulative fluorescence intensity of z-stacks.
Statistical Analysis
All data were analyzed using GraphPad Prism 8.4 (GraphPad
Software, La Jolla, CA, USA). The details of each statistical
analysis were presented in the caption of the figures.
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Supplementary Figure 1 | The Water Contact Angle (WCA) of the PDMS and
BETA membranes using an automated contact angle system OCA20 with an
image processing system (mean ± SD).
Supplementary Figure 2 | SEM micrograph of bronchial epithelial 16HBE14o!
cells grown on the membrane (cultured 6 days submerged and 24h ALI culture).
(Left) Confluent cell layer scale bar of overview and the magnified insert is 25 and
2µm, respectively. (Right) Pseudocolored cells (using the GNU Image
Manipulation Program (GIMP 2.10.8) (http://www.gimp.org/), showing cracks
between cells, which were induced due to dehydration of the samples for SEM.
The scale bar is 10µm.
Supplementary Figure 3 | No significant effect of 2 h physiologic stretch and
particle exposure (diameter: 100 and 1,000 nm) on cell viability (WST1 assay;
A549 cells) was observed. The viability data were normalized by the
corresponding value of the Transwell inserts (no stretch) (Data are reported as
mean ± SD. n = 3; Two-way ANOVA with Sidak test).
Supplementary Video 1 | BETA membrane motion in the CIVIC bioreactor
system when a cyclic mechanical stretch (linear strain: 10%; breathing/stretch
frequency: 0.33Hz) is applied to the membrane.
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Figure S1. The Water Contact Angle (WCA) of the PDMS and BETA membranes using 




Figure S2. SEM micrograph of bronchial epithelial 16HBE14o− cells grown on the 
membrane (cultured 6 days submerged and 24 h ALI culture). Left: Confluent cell layer 
scale bar of overview and the magnified insert is 25 µm and 2 µm, respectively. Right: 
Pseudocolored cells (using the GNU Image Manipulation Program (GIMP 2.10.8) 
(http://www.gimp.org/), showing cracks between cells, which were induced due to 







































Figure S3. No significant effect of 2 h physiologic stretch and particle exposure (diameter: 
100 nm and 1000 nm) on cell viability (WST1 assay; A549 cells) was observed. The 
viability data were normalized by the corresponding value of the Transwell inserts (no 




Supplementary Movie 1. BETA membrane motion in the CIVIC bioreactor system when 
a cyclic mechanical stretch (linear strain: 10%; breathing/stretch frequency: 0.33 Hz) is 
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We describe the engineering design, computational modeling, and empirical per-
formance of a moving air–liquid interface (MALI) bioreactor for the study of aerosol
deposition on cells cultured on an elastic, porous membrane which mimics both
air–liquid interface exposure conditions and mechanoelastic motion of lung tissue
during breathing. The device consists of two chambers separated by a cell layer
cultured on a porous, flexible membrane. The lower (basolateral) chamber is per-
fused with cell culture medium simulating blood circulation. The upper (apical)
chamber representing the air compartment of the lung is interfaced to an aerosol
generator and a pressure actuation system. By cycling the pressure in the apical
chamber between 0 and 7 kPa, the membrane can mimic the periodic mechanical
strain of the alveolar wall. Focusing on the engineering aspects of the system, we
show that membrane strain can be monitored by measuring changes in pressure
resulting from the movement of media in the basolateral chamber. Moreover, liquid
aerosol deposition at a high dose delivery rate (>1 µl cm!2 min!1) is highly efficient
(ca. 51.5%) and can be accurately modeled using finite element methods. Finally, we
show that lung epithelial cells can be mechanically stimulated under air–liquid in-
terface and stretch!conditions without loss of viability. The MALI bioreactor could
be used to study the effects of aerosol on alveolar cells cultured at the air–liquid
interface in a biodynamic environment or for toxicological or therapeutic
applications.
K E YWORD S
aerosol exposure, air–liquid interface, bioreactor, flexing membrane
1 | INTRODUCTION
During the past decade, the development of bioreactors and micro-
fluidic systems (organ!on!chip) for organotypic in vitro models has
been a dynamic field of research with the vision of reducing or even
replacing in vivo animal studies in drug development and risk
assessment. One of the keys to success is the establishment of bio-
mimetic culture and exposure conditions, which is expected to
enhance the capacity of in vitro models to predict outcomes for
human health.
The lung is one of the most challenging organs for in vitro
modeling since it is not only perfused by blood, but also in direct
Daniele Cei and Ali Doryab share first authorship; Arti Ahluwalia and Otmar Schmid share senior authorship.



































contact with ambient air. Inhalation of gaseous toxins, viruses, and
dispersed particles (aerosols) may cause inflammation and stress,
contributing to the development or exacerbation of diseases such as
asthma or chronic obstructive pulmonary disease (Hänninen et al.,
2010; Peters et al., 1997). The smallest, ultrafine, or nano!sized
particles (less than 100–300 nm in diameter) are especially under
intense scrutiny due to their enhanced surface area (per unit mass),
which has been associated with the prevalence of acute and chronic
lung disease (Peters et al., 1997; Schmid & Stoeger, 2017), and their
enhanced probability of translocation from the lung to blood circu-
lation and from there to almost all secondary organs such as liver,
brain, and even placenta (Kreyling et al., 2013). On the other hand,
inhalation of medical aerosol has a long!standing history in the
treatment of lung diseases (Stein & Thiel, 2017).
Upon deposition of the aerosol onto the lung epithelium, the
soluble fraction of the aerosol is quickly diluted by bodily fluids, while
the nonsoluble particles remain on the epithelium. The subsequent
interaction of (nonsoluble) particles with the pulmonary epithelium is
a complex process, mediated by the breathing!induced rhythmical
contraction of the diaphragm, which generates a periodic change in
alveolar volume accompanied by stretching and relaxation of the
alveolar walls. How this movement contributes to biokinetics and
cellular uptake of particles within and beyond the alveolar tissue, or
to downstream inflammatory processes is not clearly understood,
partly because of the lack of appropriate models which can
recapitulate the dynamic alveolar microenvironment (Min et al.,
2013; Roan & Waters, 2011).
In vivo studies on the effects of inhaled aerosols are traditionally
performed on animal models (Nahar et al., 2013; Sakagami, 2006).
While animal models capture the general effects on a peripheral
tissue, the whole lung, and the entire organism, biomimetic in vitro
testing with human cells accounts for human!specific responses
to stimuli and in!depth analysis of cell/tissue!specific response
pathways.
However, the predictive power of in vitro test systems for
clinical conditions in humans is expected to depend on their biomi-
metic qualities, that is, their ability to adequately model the most
biologically relevant features of the in vivo conditions (Darquenne
et al., 2016). To this end, several alternative methods for mimicking
the lung epithelial barrier have been developed. Perhaps the best
known is the air–liquid interface (ALI) barrier model, based on a
static culture of lung!derived cells grown on a permeable membrane
with the apical side of the cells in contact with air and the basolateral
side is wetted by the medium. ALI pulmonary epithelial cells polarize,
that is, the air!side is structured differently than the medium side
resembling the in vivo conditions in various aspects including cilia!
formation, the formation of tight cell–cell contacts as well as secretin
of lung lining fluid (Paur et al., 2011). Nevertheless, growing pul-
monary cells on a static membrane at the ALI does not mimic the
periodic mechanical strain experienced by alveolar cells under in vivo
conditions due to breathing, which may affect the cellular response
to toxins or therapeutics (Cavanaugh et al., 2006; Min et al., 2013;
Savla et al., 1997; Schmekel et al., 1992).
ALI cultures also allow for direct deposition of aerosols onto
epithelial cells mimicking the humid pulmonary environment in vivo.
The currently available technologies for aerosol!cell deposition can
be classified according to their employed deposition mechanisms
(Paur et al., 2011), namely diffusion and/or sedimentation (Bitterle
et al., 2006), impaction (Schreier et al., 1998), electrostatic pre-
cipitation (Savi et al., 2008), thermophoretic deposition (Broßell et al.,
2013), gravitational settling (Hein et al., 2010), and cloud motion
(Lenz et al., 2014). Although many of these devices (except for
thermophoretic deposition), are commercially available, to the best of
our knowledge no aerosol delivery system has yet been reported for
studies on cell systems encountering cyclic stretch (Doryab et al.,
2019), which has been shown to substantially alter cell physiology in
terms of secretion of alveolar surfactant, metabolic activity, and cy-
totoxicity for human alveolar epithelial cells (Huh et al., 2010). To
address the issue of cyclic stretch, more advanced in vitro cell models
have been developed and have been systematically reviewed by
Doryab et al. (2019). Most devices apply pneumatic or motor!driven
cyclic stretch in liquid–liquid conditions (Campillo et al., 2016). The
FlexCell Culture System® (Flexcell International Corp.) is one such
commercial device with a mechanically active substrate: Epithelial
cells are cultured on a silicone membrane and stretched by applying
negative differential pressure on the other side of the membrane.
However, due to the mechanism of actuation, the membrane cannot
be porous and thus cannot provide ALI conditions. A number of ALI
systems have been developed such as the well!based system with
moving walls reported by Choe et al. (2006) and Tomei et al. (2008),
but they do not allow for fluid flow or aerosol deposition. One of the
most cited cell!stretch models is the micro!scaled lung!on!a!chip
developed by the WYSS Institute combines ALI conditions, and a
stretchable silicone membrane and medium flow (Huh et al., 2010).
The two!channel system also employs negative pressure actuation,
but in a different configuration than the FlexCell device: the rec-
tangular membrane is attached to a flexible frame on the two shorter
sides. Upon mechanical activation of the frame by the application of a
vacuum, the membrane stretches. Stucki et al. (2015) reported a lung
on a chip system with a two!chamber configuration separated by a
flexible membrane; the basal chamber also has a flexible bottom
which is actuated by the application of pressure. Both of these chip
devices allow for perforation of the membrane and hence for ALI cell
culture conditions but neither are amenable to effective and re-
producible aerosol!cell delivery which are necessary for quantitative
aerosol dose!cell response studies. Moreover, the handling of the
peripheral microfluidic technology for maintenance of adequate cell
culture conditions can be a challenge which is acknowledged by re-
searchers developing lung!on!a!chip devices (Artzy!Schnirman et al.,
2019; Doryab et al., 2016; Ehrmann et al., 2020). Here we report the
engineering of a moving air–liquid interface (MALI), bioreactor as an
enabling tool for studies on pulmonary cells and tissues in physio-
logical and pathological conditions. The bioreactor consists of an
apical and basolateral compartment separated by a pressure!
actuated flexible membrane. Designed on the scale of a standard
six!well Transwell, the bioreactor's basolateral compartment contains






































cell culture medium, which flows through the bioreactor mimicking
blood circulation while the apical side is interfaced with a nebulizer
for efficient, dose!controlled aerosol delivery to cells. MALI's per-
formance was investigated in terms of cyclic membrane stretch and
aerosol delivery characteristics. An evaluation of the cytocompat-
ibility of the system components was performed assessing the effect
of physiologic cyclic stretch on A549 lung epithelial cells.
2 | DESIGN OF THE MALI SYSTEM
2.1 | The overall design and working principle
At the heart of the MALI system is the modular MALI bioreactor,
similar to that described in Mazzei et al. (2010) and Giusti et al.
(2013). The bioreactor with its two chambers and their respective
hydraulic and pneumatic circuits is depicted in Figure 1a. Between
the two chambers is a flexible porous membrane for cell culture
which mimics the alveolar air–tissue interface. A peristaltic pump
drives medium through the basolateral chamber modeling the blood
side and providing a continuous nutrient supply to the cell layer as
well as the removal of metabolites and signaling molecules which
may also be delivered to other bioreactors with cells or tissues from
other organs (e.g., liver). The apical chamber simulates the air!facing
side of the alveolar barrier and includes a pair of electropneumatic
regulators and a clinically relevant aerosol generator. The latter
provides dose!controlled aerosolized substance delivery to the cells
simulating drug delivery during inhalation therapy or exposure to
airborne particles.
The membrane is actuated by cyclic switching of two pressure
regulators, which allow oscillation of air pressure in the apical chamber
between ambient and a few kPa above ambient pressure. This in turn
leads to a periodic downward deflection and relaxation of the mem-
brane simulating the inhalation and exhalation phase during respira-
tion. Figure 1b shows the complete MALI system which is described in
detail herein. The system was designed to recapitulate the cyclic
stretch of the alveoli during breathing, covering both physiological and
pathological levels of strain (physiological: 4%–12% linear strain†,
pathological up to 20% linear strain) at a typical breathing frequency
of 0.2 Hz (Huh et al., 2010; Patel, 2011; Ren et al., 2009; Roan &
Waters, 2011; Vlahakis et al., 1999; Waters et al., 2012).
2.2 | Finite element method modeling of the MALI
bioreactor
The MALI bioreactor's design and performance were simulated using
finite element methods (FEMs). A first model of the basolateral
chamber was used to optimize its dimensions by evaluating the dis-
placement field of the membrane at different bioreactor heights and
different pressures applied apically to the elastic membrane (de-
scribed in Section 3). A second FEM model was used to estimate the
deposition of aerosol on the membrane in the apical chamber both in
terms of total dose and spatial distribution.
2.3 | FEM model of the basolateral chamber
including membrane activation
The basolateral chamber model was generated using the fluid!
structure interaction (FSI) module of the Comsol Multiphysics 4.3a
software (COMSOL AB). The domain consists of a cylindrical cham-
ber with variable height and an inlet and outlet for cell culture media
(Figure S1), while the membrane is modeled as a deformable disk
(with the same elastic modulus as the membrane used for cell culture,
see Section 3) placed on top of the basolateral chamber of the
bioreactor and subject to a variable positive pressure from the top
simulating air pressure in the apical chamber. A sequence of quasi!
static conditions is used to simulate the stretching motion of the
membrane. In particular, the steady!state condition for constant
apical pressure is modeled for a range of pressures covering that
applied during dynamic activation of the membrane. Viscous drag and
fluid pressure on the membrane resulting from the flow of medium is
also accounted for. The fluid dynamics were solved in the laminar
flow regime for an inflow of 0.4 ml min!1 as suggested by Mazzei
et al. (2010). No!slip conditions were assumed at all interfaces in-
cluding the virtual wall representing the membrane, which was also
coupled with the FSI module to account for its displacement.
The model was solved for different bioreactor heights
(H = 10–20mm, 1!mm increments) and various apical differential
pressures across the membrane (1–10 kPa, 1!kPa increments). The
optimum height is the best compromise between a small chamber
volume (i.e., low height, yet sufficient to allow obstruction!free mem-
brane stretching) and low applied pressure to achieve a given mem-
brane deformation. In fact, the larger the chamber, the lower the flow
resistance when the medium is squeezed out of the chamber by
membrane motion. To simulate pathological strains (20%), the max-
imum vertical displacement of the center of the membrane in the
z!direction required during the operation was estimated as "7mm. A
total chamber height of 14mm was considered the best compromise to
allow unencumbered displacement of the membrane with low!pressure
values (maximum 7 kPa in the model) while maintaining a chamber with
a volume reasonably close to that of a typical cell culture well. An
example of membrane displacement is shown in Figure 2a, while videos
of the model can be downloaded from the Supporting Information.
2.4 | FEM modeling of the apical chamber including
aerosol deposition
To guarantee dose!controlled aerosol delivery, we based the
dimensions of the apical chamber on that of the ALICE Cloud device
reported in Lenz et al. (2009). The patented technology takes
†The term “linear strain”, when applied to alveolar distension, refers to a change in
alveolar radius as described in the Supporting Information, Section H.






































F IGURE 1 Setup and components of the moving air–liquid interface (MALI) system: (a) Schematic of the MALI system (without electronics)
consisting of the bioreactor (here referred to as MALI bioreactor) with a basolateral (a) and an apical (b) chamber separated by a flexing
porous membrane. The fluidic circuit for the cell culture medium comprises a chamber (a), a media reservoir (c), and a pump (d). Compressed air
(e) for pressure actuation of the stretchable membrane is driven through the upper circuit. A pressure sensor (f) is used to evaluate
membrane deflection in real!time. The top of the bioreactor is fitted with an aerosol inlet tube for the positioning of a nebulizer above the
membrane. (b) Photo of the entire MALI system [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 2 Finite element method models: (a) Model of the stretchable Bionate® membrane showing three!dimension membrane
displacement surface plot for a basolateral chamber of height 14mm with an applied apical pressure of 7 kPa. Example of CFD analysis of cloud
settling: (b) Lateral view of the apical compartment of the bioreactor and the nebulizer tube representing the relevant domain for aerosol
delivery to the membrane, which is located at the bottom of the domain. (c) Volume fraction of water in aerosol cloud at 0.4 s after activation of
the nebulizer; (d) Thickness in mm and spatial distribution of deposited aerosol (liquid film) on the membrane 5min after the start of the
nebulization [Color figure can be viewed at wileyonlinelibrary.com]






































advantage of the generation of a cloud which is more efficient for
aerosol deposition onto cells in ALI conditions with respect to single
droplet dynamics. The main technical refinement of the aerosol unit
of the MALI bioreactor relates to the use of a cylindrical aerosol
exposure chamber with a cross!sectional area just large enough to
expose the ca. 5!cm2 membrane in the bioreactor as compared to the
relatively large cubical exposure chamber of the ALICE Cloud system
(ca. 125 cm2), which was designed for simultaneous exposure of up to
six 6!well Transwell inserts (Lenz et al., 2014). The FEM model of the
apical chamber was developed to evaluate aerosol!cloud deposition
on the membrane. As the geometry is axially symmetric (Figure 2b) it
was solved with a two!dimension (2D) model.
Typically, the nebulizer is filled with 10 µl of an aqueous solution. It
emits a dense cloud of aerosol with a speed of about 2.5m/s directly into
the aerosol inlet tube which leads into the apical chamber
(Figure 2b). Using the computational fluid dynamics software Fluent 14.0
(Ansys Inc.), cloud motion in the air!filled chamber was modeled with the
Eulerian Multiphase module (here two phases: air and cloud), where the
dense cloud (i.e., droplet suspension) is treated as a secondary fluid
interacting with the primary fluid (air). Each fluid phase was solved with
the Eulerian discretization method and their interaction was taken into
account assuming no slip at the boundaries of the domain. Input para-
meters for the model are reported in the Supporting Information.
As the Eulerian–Eulerian method is not able to evaluate particle
deposition onto surfaces due to the two!phase approach taken, an
Eulerian Wall Film module was added to the model. Here, the interac-
tion between the fluid phase and wall surface is considered to evaluate
film formation due to particle settling. Continuity and momentum
equations were modified to evaluate deposition effects due to liquid!
wall collision under the influence of inertial impaction and gravitational
settling. A user!defined function (UDF) was compiled to simulate the
accumulation of liquid on the bottom of the apical chamber where the
membrane is located. The UDF generates a negative source term (sink)
extracting the part of the fluid that collides with the membrane and
considers it as “collected” from the liquid phase.
As seen from Figure 2c and the Supporting Information Videos,
the modeled cloud velocity profile at the beginning of the aerosol
exposure (0.4 s after activation of the nebulizer) propagates through
the center of the tube and deposits at the base and sides of the apical
chamber. Figure 2d depicts the spatial uniformity of the aerosol
deposited on the membrane at the end of the exposure. The result
indicates uniform aerosol deposition over the entire cell!covered
area except for a narrow region at the rim. An analysis of the de-
position efficiency reveals that 85% (asymptotic value) of the liquid
settles on the membrane within 5 min.
3 | MATERIALS AND EXPERIMENTAL
METHODS
The design, construction, and testing of the main components of the
MALI system are described here, with further technical details re-
ported in the Supporting Information.
3.1 | Membrane fabrication and characterization
Electrospun Bionate® II 80A (The Electrospinning Company) was
used as a flexing membrane and porous support for epithelial cells.
Bionate is a biocompatible poly(carbonate)urethane copolymer used
in chronically implanted devices (i.e., pacemaker leads, ventricular
assist devices, catheters, hip/knee joints, etc.; Bélanger et al., 2000;
Khan et al., 2005; Zdrahala & Zdrahala, 1999). According to the
manufacturer's specifications, the membranes are 75.4 ± 6.6!!m
thick (Lehmann et al., 2011), with a fibre diameter of
3.06 ± 0.36 !m. These parameters are consistent with our measure-
ments from confocal microscopy.
The mechanical properties of the Bionate membranes were
evaluated for assessing their suitability as a stretchable support for
alveolar cell culture systems. First, the elastic modulus was evaluated
using a twin column testing machine (Z005; Zwick!Roell) equipped
with a high precision load cell (loading 10N, resolution 20mN) under
dry conditions, with a uniaxial strain rate of 0.1% s!1. Rectangular
samples were stretched up to 30% of their initial length in order to
determine the extent of the elastic region. The Bionate membrane
was also soaked for 0, 1, 2, 4, and 7 days in culture media (Dulbecco's
modified Eagle's medium [DMEM], see Section 3 and Supporting
Information E) at 37°C and the mechanical tests were repeated for
evaluation of fatigue effects while submerged in DMEM at 37°C. In
addition, cyclic deformation was applied for 3 h at a strain corre-
sponding to normal breathing conditions (5% strain, 0.2 Hz, 37°C in
DMEM). The elastic modulus was evaluated at different time points
(1, 2, 4, and 24 h) through the least!squares linear fitting of the
uniaxial stress–strain curve.
3.2 | Fabrication of MALI bioreactor
Both chambers of the MALI bioreactor are fabricated from poly-
dimethylsiloxane (PDMS; Sylgard 184 Kit; Mascherpa), using milli!
molding as described in Vozzi et al. (2011). The Bionate membrane is
clamped between two 3D!printed polylactide acid (PLA) rings
designed with a press!and!click male–female coupling as shown in
Figure S3c. Once assembled in the ring, the membrane can be easily
handled without touching or damaging. The PLA ring with the
membrane is lodged in a PDMS hoop and inserted between the apical
and basolateral chambers (see Figure S3b).
3.3 | Fluidic system and membrane displacement
The basolateral chamber is perfused with media through a peristaltic
pump and a fluid reservoir. When positive pressure is applied in the
apical chamber, the actuation of the membrane results in the dis-
placement of some of the basolateral medium into the media
reservoir (Figure 1a). As the reservoir is airtight, any change in
medium volume will result in a change of air pressure in the vessel,
which is directly related to the displaced medium volume according






































to the general gas law or by performing a simple pressure–volume
calibration. Assuming that no liquid passes through the membrane
(which is the case here) and that the membrane actuation results in a
hemispherical deformation of the membrane, the displaced medium
volume can be related to the linear strain exerted on the deformed
membrane through classical equations of thin shell mechanics (see
Supporting Information). Hence, by monitoring the differential air
pressure in the medium reservoir during the application of cyclic
overpressure in the apical chamber, the membrane strain can be
monitored in real!time. Further details on the components of the
fluidic and control system are reported in the Supporting
Information.
3.4 | Aerosol delivery system and aerosol dosimetry
The apical compartment consists of three parts (Figures 1 and 2a):
the cylindrical apical chamber, a vibrating mesh nebulizer (Aeroneb
Pro/Lab; Aerogen Inc.) positioned axially above the stretchable
membrane and a cylindrical aerosol tube connecting both elements
(Barapatre et al., 2015; Lenz et al., 2014). Membrane actuation is
interrupted during the operation of the nebulizer and subsequent
aerosol settling, which typically takes less than a couple of minutes
(for 10 µl of nebulized liquid).
Measurements of aerosol dose and distribution on the mem-
brane were performed with quantitative spectrophotometry and a
fluorescence imaging system, respectively (Barapatre et al., 2015;
Lenz et al., 2014). For dosimetry analysis, the nebulizer was loaded
with 10 µl of a 15 µg/ml fluorescein sodium salt solution in
phosphate!buffered saline (Sigma!Aldrich Chemie GmbH) and at-
tached to MALI bioreactor, replacing the membrane with a glass slide
to facilitate retrieval of the deposited fluorescein. After the experi-
ment, the glass slide was carefully rinsed with 500 µl water and the
fluorescein concentration in the retrieved solution was measured
using a microplate fluorescence reader (Safire II; Tecan Inc.; excita-
tion/emission = 483/525 nm). The aerosol delivery efficiency was
determined by normalizing the measured dose to the amount of
liquid nebulized. Using this technique, the retrieval efficiency was
determined to be 100% (within experimental uncertainties; data not
shown).
For assessment of spatial uniformity of aerosol deposition on the
cells, 10 µl of an aqueous suspension (0.05% wt/vol) of fluorescent
polystyrene nanoparticles (SkyBlue; Kisker Biotech GmbH & CoKG;
particle diameter: 450 nm, excitation/emission = 680/720 nm) was
nebulized in MALI. Again, nanoparticles were deposited on a glass
slide located at the position of the membrane and the resulting
fluorescence pattern on the glass slides was measured with a fluor-
escence imaging system (IVIS Lumina II; PerkinElmer).
Both sets of experiments (deposition efficiency and spatial uni-
formity of deposition) were performed at five different nebulizer
duty cycles (100, 50, 25, 12.5%, and 6%), corresponding to a range
between 500 (100%) and 30ms (6%) of nebulizer on!time per 500ms
time period. We note that SkyBlue nanoparticles cannot be used for
the determination of aerosol delivery efficiency since their retrieval
efficiency from the glass slide is less than 100%. On the other hand,
fluorescein cannot be used for measuring spatial uniformity of
aerosol delivery onto the membrane (glass slide) due to the rapid
drying of the aerosol droplets after deposition which results in
quenching of the fluorescence signal. Hence, two different fluor-
escent tracers had to be employed for the determination of both
efficiency (dose) and spatial uniformity of aerosols delivered to the
cells.
3.5 | Cell culture
An alveolar epithelial type II!like cell line derived from a human
adenocarcinoma (A549) was used to assess the impact of handling
and set up of the MALI bioreactor on cells, in terms of cyto-
compatibility, viability, and confluency of the cell layer. These cells
are widely employed as a model of the alveolar epithelial barrier
(Lehmann et al., 2011; Lenz et al., 2013, 2009; Oostingh et al., 2008;
Ren et al., 2009; Schmid, Jud et al., 2017). We used a standard
DMEM based medium, with the source and components reported in
the Supporting Information.
Bronchial epithelial 16HBE14o! cells (cell seeding density:
2 ! 105 cells cm!2) were also used to study cell adherence to the
electrospun Bionate membrane. Cells were cultured in minimum
essential medium (Gibco) supplemented with 10% fetal calf serum
(Gibco), 1% (vol/vol) Pen/Strep (100 Uml!1; Gibco) for 6 days under
submerged culture conditions and 2 days under ALI culture.
3.6 | Preparation Bionate membranes and cell
culture
The Bionate membranes were hydrophobic (water contact angle >
90°) and not cell adhesive in their pristine state. Thus, as detailed in
the Supporting Information, they were treated with ethanol and
Matrigel, which contains components present in the alveolar basal
lamina. The Matrigel!coated membranes were mounted in the hoops
and placed in 50!mm diameter Petri dishes; 1 ! 106 cells were seeded
on the apical (top) side of the membrane (0.2 ! 106 cells/cm"). A
number of different conditions were examined to assess the impact
of the various preparation and handling steps.
I. “Membrane control” (negative control)—cells were grown on the
Bionate membrane (mounted in the PLA ring) under optimum
growth conditions, that is, cells in submerged culture conditions
applying 2ml of cell culture medium on the apical side and 8ml in
the Petri dish (basolateral side) and in an incubator (5% CO2,
37°C, 100% humidity) for the entire experimental time (7 days).
II. “Bioreactor control”—same as membrane control, but after Day 6 the
mounted membranes were transferred into the bioreactor prefilled
with the medium in the lower (basolateral) chamber and left for a
further day in the incubator with no medium on the apical side.






































III. “MALI non!stretched” and “MALI stretched”—same as “Bior-
eactor control,” but, after 21 h of ALI, cells were exposed to a
flow (0.4 ml min!1) and flow and stretch (5% strain, 0.2 Hz with a
perfusion rate of 0.4 ml min!1) conditions, respectively for 3 h.
The assessment was based on cell viability (protein content),
cytotoxicity, and confluency of the epithelial cell layer.
3.7 | Cell assays and imaging
Cytotoxicity was assessed by the detection of the enzyme lactate
dehydrogenase (LDH) in the supernatant of the cell culture (LDH;
Roche Applied Science). The leakage of LDH from the cytoplasm into
the supernatant is characteristic of membrane damage.
The total protein content of cells is an indirect measure of the
number of cells populating the membrane and hence of their growth
and viability. It was determined from the protein concentration of the
cells using the Bio!Rad Protein assay (Cat. No 500!0006; Bio!Rad)
according to the manufacturer's protocol.
Confocal microscopy analysis allows for visualization of the cell
layer on the membrane, providing information on the degree of con-
fluency of the cell layer, their morphology, and their viability status. To
this end, a series of z!stack images were acquired and processed using a
Carl Zeiss LSM710 system and associated software. Scanning electron
microscopy (Zeiss Crossbeam 340; Carl Zeiss AG; operating voltage of
2 kV) was used to evaluate cell attachment of bronchial epithelial
16HBE14o! cells on the Bionate membrane. Additional technical details
on cell assays are given in the Supporting Information.
3.8 | Data analysis
Unless stated otherwise, all data are reported as mean ± SD for at
least three independent measurements (n " 3). The one!way analysis
of variance test was used to evaluate the statistical significance of
effects. The significance level was set at p < .05 for each test.
4 | RESULTS
4.1 | Membrane elasticity and real!time monitoring
of cyclic strain
The (uniaxial) stress–strain behavior of the Bionate membrane is
depicted in Figure 3a. An approximately linear elastic behavior was
observed up to about 15% uniaxial strain, with an elastic modulus of
2.14 ± 0.18MPa as derived from a linear least!square fit of the
stress–strain curve. The elastic modulus obtained for the Bionate
membrane was not affected by incubation in DMEM at 37°C, even
after 7 days of complete submersion. Moreover, cyclic stretching for
uniaxial strains between 1% and 15% for up to 3 h under wet con-
ditions did not alter its elastic modulus, suggesting its suitability for
operation in dynamic conditions in a cell culture environment.
By measuring the change in pressure and hence volume in the
mixing chamber during the application of cyclic overpressure in the
apical chamber, we were able to estimate the linear strain of the
membrane. As seen from Figure 3b, in the range 0–6 kPa over-
pressure, the response is approximately linear. Moreover, the MALI
bioreactor was found to be leak!tight for medium flow rates up to
1ml min!1 and apical differential air pressures up to 20 kPa.
It is noteworthy, that membrane activation at a physiologic linear
strain of 5% requires application of about 2–3 kPa on the apical side
(Figure 3b), slightly larger than differential pressure occurring during
physiological breathing (for rest and heavy exercise conditions about
0.3 and 0.9 kPa, respectively; Ravikrishnan, 2006). However, since
cells consist mainly of water and water is incompressible, they can
easily cope with these small increases in pressure conditions as evi-
denced by our cell culture data presented in Section 4.3.
4.2 | Aerosol delivery
As seen from Figure 4a, we found that the delivery efficiency is
51.5 ± 1.0% of the 10 µl of a liquid filled into the nebulizer in-
dependent of the duty cycle. The aerosol was nebulized within a few
F IGURE 3 (a) Typical uniaxial stress–strain curve of the Bionate membrane. Red arrows indicate the direction of the test and the green
dashed line is the least!squares linear fit for 0%–15% strain, giving a slope of 2.14 ± 0.18MPa. (b) Calibration of the membrane's linear strain by
the application of cyclic overpressure in the apical chamber, using the equations reported in the Supporting Information [Color figure can be
viewed at wileyonlinelibrary.com]






































seconds and subsequent cloud settling onto the cells took 1–2min.
We estimated the dose delivery rate to be higher than 1 µl cm!2
min!1. After nebulization 12.6 ± 0.4% of the invested liquid remained
in the nebulizer reservoir, again without any statistically significant
dependence on the duty cycle. The rest of ca. 35% must have been
deposited on the lateral and top walls of the bioreactor.
Moreover, the aerosol is deposited uniformly as seen from
Figure 4b, which depicts the measured fluorescence intensity on the
apical surface after the nebulization of fluorescent aerosol. The pixel!
by!pixel fluorescence (dose) variability resolved on a cellular scale
(pixel: 5 ! 5 µm) across the centreline of the membrane is 19% (9.4%/
49.2%). This indicates that aerosol deposition on the cells is some-
what less uniform than predicted by the computational model
(ca. 10%; see Figure 2c), which may be due to the larger grid size in
the FEM model (200 ! 200 µm). Within 0.12 cm of the wall, there is a
steep decrease in dose due to edge effects, as predicted by the
model.
4.3 | Cell viability, cytotoxicity, and stretch
experiments
Figure 5 indicates that the handling of the cells in the MALI system
does not have any detrimental effect on cell viability and cytotoxicity
levels (necrosis). For all investigated cases, the protein content of the
cells is constant at about 450 µg and the cytotoxicity of 4%–6% is
F IGURE 4 Aerosol delivery to the cells in the moving air–liquid interface system for different nebulizer duty cycles (fractional on!time of the
nebulizer) is effective, reproducible, and spatially uniform. (a) Aerosol deposition (delivery) efficiency of a fluorescein salt solution was
51.5 ± 1.0% (mean ± SD; for five duty cycle settings) and reproducibility of better than 11% (of mean delivery). Moreover, 12.6 ± 0.4% of the
administered liquid (red symbols) cannot be nebulized and remains in the nebulizer independent of the duty cycle. (b) Fluorescence
intensity image of SkyBlue nanoparticles nebulized on a glass slide shows uniform delivery over the entire cell!covered area on a cellular
resolution level (49.5 ± 9.4%; pixel: 5 ! 5 µm) except near the rim (0.121 cm), where the intensity drops sharply to zero due to the
presence of the bioreactor wall [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 5 There are no statistically significant adverse effects on cells during handling and operation of the moving air–liquid interface
(MALI) system: (a) Cell growth/viability (protein content). (b) Bytotoxicity (lactate dehydrogenase release) relative to membrane
control (<10% is typically considered noncytotoxic). n = 2–4; mean ± SEM






































well below 10%, which is typically considered as nontoxic regime.
Moreover, none of the investigated conditions differs significantly
from the “Membrane control.”
Confluency of the cell layer was investigated with confocal
microscopy after staining for cell nuclei and actin filaments of the
cytoskeleton. Figure 6 shows that cells reach confluency by the end
of Day 7. While there is reasonably good cell coverage over most of
the membrane (Figure 7a), cells were not confluent near the rim
(Figure 7b). In fact, the morphology of A549 cells changes from a
rounded shape in confluent regions to an elongated morphology of a
migrating cell in these regions. An elongated shape indicates less
healthy cells, which may be due to insufficient Matrigel coating on
the fibers at the edges. We did not observe significant differences in
cell morphology between the negative control and any of the MALI
conditions in Figure 5, including dynamic stretch conditions. Bron-
chial epithelial 16HBE14o! cells also adhered to the surface of the
membrane, again some regions of the membrane were not covered
by the cells likely due to nonuniform coating of Matrigel (Figure S9).
5 | DISCUSSION
Despite significant efforts, lung!on!a!chip devices which include
perfusion and cyclic cell!stretch such as that reported in the ground!
breaking work of Hu et al. (2010) are not widely used, partially due to
technical challenges associated with microfluidic systems such as
clogging of fluidic channels and aerosol delivery via micro!scale air
channels (Ehrmann et al., 2020). Therefore, a milli!scale lung bior-
eactor “MALI,” where cells are cultured under ALI conditions with
perfusion of media, cyclic cell!stretch, and dose!controlled aero-
solized drug delivery was developed as an alternative, to facilitate a
more wide!spread use of advanced biomimetic lung models. In this
study, the key engineered elements of the MALI system were tested
and evaluated. Firstly, a key element of the MALI system is dose!
controlled delivery, based on a vibrating mesh nebulizer, which is
widely used in clinical settings (Aeroneb Pro). Typically, the fraction
of invested substance deposited on the cell layer can vary sig-
nificantly between 0.1% to ca. 20% depending on the experimental
setup and chosen deposition mechanism (Desantes et al., 2006; Paur
et al., 2011). For testing of experimental drugs deposition efficiencies
of less than 10% are often prohibitive due to high substance cost. The
setup presented here is a dose!optimized version of the previously
described ALICE Cloud technology (commercially available as
VITROCELL®Cloud; VITROCELL Systems), which leverages cloud
dynamics for uniform deposition of aerosols onto cells (Lenz et al.,
2014; Röhm et al., 2017). The change in design reported here in-
creases the deposition efficiency from 2.8% per six!well Transwell
insert in the ALICE Cloud to 51.5% of the invested drug onto the cells
in a spatially uniform and highly reproducible way, which is a sig-
nificant improvement over the traditional Cloud technology. The
MALI aerosol unit described here has recently become commercially
available as VITROCELL Cloud MAX technology (VITROCELL Sys-
tems), for use with standard Transwell inserts in static cell culture
systems. Aerosol deposition in the MALI occurs within ca. 1 min and
is performed under static conditions, that is, it is decoupled from the
cyclic stretch. This mimics aerosol therapy under clinical conditions
where patients inhale therapeutic aerosols with a single breath fol-
lowed by a ca. 1 min breath!hold period for enhanced aerosol de-
position. For applications requiring long!term aerosol delivery, the
nebulizer could be activated periodically during the cyclic stretch
experiment, but this mode of operation was not investigated here.
Modeling the complex dynamic motion of the highly!dense cloud
of aerosol in the apical chamber of the MALI bioreactor is not a
simple task, since the cloud density is high enough to induce multi-
phase coupling. Nonetheless, the Eulerian Multiphase FEM model
predicted the experimentally determined cell!delivered aerosol dose
reasonably well. Empirical data show that the aerosol is relatively
uniformly deposited on the cells with a dose variability of about 20%
about the mean dose (for cellular resolution; Figure 4b) and a narrow
annular region near the walls for the bioreactor with steeply
F IGURE 6 Confocal microscopy images showing confluent cell regions of A549 cells on Bionate® membrane (typical for all conditions). The
right panel represents the cell nuclei (4",6!diamidino!2!phenylindole staining, blue); the middle panel shows the actin cytoskeleton (phalloidin
staining, red); the right panel presents the merged images from the left and middle panel (Scale bar = 100 µm) [Color figure can be viewed at
wileyonlinelibrary.com]






































decreasing dose. Both of these aspects are captured by the FEM
model (Figure 2c). Moreover, the FEM model predicted an aerosol
deposition efficiency of 85%, which was corrected to 74.3% to ac-
count for the fact that only 12.6% of the invested liquid remained in
the nebulizer. Considering the degree of uncertainty in the initial
conditions, namely spatial distribution, speed, and angular direction
of the cloud droplets emitted from the vibrating mesh which were
assumed to be uniform, constant (2.5 m s!1) and perpendicular to the
plane of the vibrating mesh, respectively (all values are approxima-
tions), the FEM model is in reasonably good agreement with the
empirically determined cell!delivered dose of 51.5%. Thus, the model
can be used to guide further optimization of the aerosol delivery
efficiency.
The MALI bioreactor was purposely designed to be modular,
housing both purposely designed and commercial membranes.
Indeed, one of the most crucial elements of any stretching in vitro
model of the lung is the membrane for cell seeding and growth,
which should be elastic, stretchable, resilient to long!term cyclic
strain under aqueous conditions, and porous/permeable to allow for
ALI culture conditions. Mechanical tests showed that the electro-
spun Bionate is a suitable material with respect to its mechan-
oelastic properties revealing no degradation or hysteresis in the
uniaxial stress–strain curve for up to 24 h cyclic stretch (up to 15%
uniaxial strain, 0.2 Hz). It also has a porous structure and a high
surface area to volume ratio, mimicking the natural extracellular
matrix in native tissues. As an important feature of quality control
during experiments, the MALI system allows for real!time mon-
itoring of the stretch level and frequency by monitoring the pres-
sure change in the medium reservoir and relating it to a
corresponding linear strain.
F IGURE 7 Confocal microscopy images showing confluent and nonconfluent regions of A549 cells and their penetration into the Bionate®
membrane after 3 h of stretching. (a) Large confluent cell region (cell nuclei are depicted in blue) embedded in the fibrous structure of the
Bionate® membrane (white lines indicate fibers of the membrane). From the xz! and yz!cross sections through the membrane (top and right
section of the image, respectively), it is evident that the position of the cell layer within the membrane varies. It is often found near the apical side
(thick white line of xz!/yz!images represent the glass coverslip on the apical side), but it can also reside within the membrane as also shown
in Figure S8. (Scale bar = 100 µm). (b) Nonconfluent cell regions (cell nuclei in blue; cytoskeleton in red) are most prevalent near the rim of the
membrane (wall of the bioreactor). (Scale bar = 100 µm). (c) Higher!resolution orthogonal view of confocal microscopy images (XY) with side
views of YZ (right) and XZ (bottom) (Scale bar = 50 µm). (d) Confocal z!stack of A549 cells on Bionate membrane (covering a total depth of 16 µm),
showing confluent cell regions of A549 cells. Both Panel c and d demonstrate that the alveolar epithelial cell layer is at least partially
multi!layered rather than the mono!layered structure found in the lung. (Scale bar = 50 µm). The cell nucleus (4",6!diamidino!2!phenylindole, blue),
F!actin cytoskeleton (phalloidin, red) [Color figure can be viewed at wileyonlinelibrary.com]






































The membrane also has to be conducive to cell growth which
implies wettability, biocompatibility, and good cell adhesion. Here,
the alveolar lung epithelium cell line A549 and bronchial epithelial
cell line 16HBE14o were used for basic biologic validation experi-
ments of the MALI bioreactor system. Advanced cell culture models
such as cocultures or (immortalized) primary lung epithelial cells
(hAELVi; Kuehn, 2016), are planned for future investigations.
Cell growth and cytotoxicity assays showed that alveolar lung
epithelial cells (A549) form a viable cell layer within 7 days and 3 h of
physiologic cyclic stretch (5% linear strain, 0.2 Hz) did not impair cell
viability or morphology. These results are consistent with previous
stretch studies with A549 cells and other lung epithelial cells
(DiPaolo et al., 2010; McAdams et al., 2006; Tschumperlin &
Margulies, 1998; Vlahakis et al., 1999). However, the hydrophobic
membrane has to be pretreated with ethanol and water to render it
wettable and then coated with Matrigel to allow for sufficient growth
of A549 alveolar epithelial cells. It is also noteworthy that the cells
penetrate into the porous structure, which is much thicker than the
basal lamina (typically less than 1 !m). Thus, the cells assemble along
with the multiple layers within the structure instead of forming a
single epithelial monolayer on top of the membrane. The thickness of
the membrane may also interfere with transbarrier transport pro-
cesses. Besides improving the uniformity of the coating, other bio-
compatible materials such as natural/artificial hybrid composites with
similar elastic properties but more conducive to cell growth and more
effective at ensuring the formation of a contiguous cell monolayer or
3D full!thickness epithelial tissue could be developed (Doryab et al.,
2019). In this direction, we have recently fabricated a biohybrid
membrane with mechanical properties suitable for use in stretching
experiments in MALI under both physiologic and pathological con-
ditions (Doryab et al., 2020).
6 | CONCLUSION
The MALI bioreactor system represents a novel dynamic in vitro
stretch model of the alveolar air–blood interface with aerosol delivery.
It combines physiologic ALI culture conditions with medium perfusion
and cyclic cell!stretch mimicking blood circulation and breathing ac-
tivity of the lung, respectively. The MALI system provides uniform
aerosol distribution on the cells and extremely high dose efficiency
(51.5%) making it suitable for testing of even costly substances such as
experimental drug candidates. Finally, in consistency with previous cell
stretch studies, lung epithelial cell morphology, growth, and cytotoxi-
city were not affected by physiological strains.
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A. Videos of the FEM models  
Videos can be downloaded from this link: 
https://drive.google.com/drive/folders/1wYa3CEJ0wxSAEZ8wve5JfYpGgBgLXK2-?usp=sharing 
B. Basal chamber domain in FEM model  
The basolateral chamber (see Figure S1) was scaled to allow the membrane to expand freely during 
breathing. 
Figure S1 shows the dimensions of the basal chamber as implemented in the FEM model. The model was 





Fig. S1: Basolateral chamber domain as described by the FEM model. The inlet and outlet diameters are 1 and 2  mm 
respectively. The height H was varied between 10 and 20 mm in the parametric model. 
 
C. Input parameters for the FEM model representing the apical chamber 
The following constants were used for the two-phase model:  
AIR phase: air density = 1.225 kg/m3 and viscosity = 1.7894 10-5 Pa·s, pressure = 101.3 kPa, temperature = 








































For the CLOUD phase (secondary fluid): considering a total aqueous volume of 10 µL in an apical chamber 
of 18.8 mL over a period of 2 s, a mean water volume fraction of 2×10-4 was assumed (water: viscosity =10-
3 Pa·s and density= 1000 kg/m3).   
For a water volume fraction of 2×10-4 the cloud density is 16% higher than that of air, thus we can consider 
a two phase air-droplet system in which cloud motion is present (Hinds, 1999).  
The nebulizer was modelled as an inlet surface for water on the top of the aerosol inlet tube. The initial 
speed of both water droplets and air at the inlet was set to 2.5 m/s (as determined by a setup having the 
cloud pass through two consecutive light gates placed at a known distance from each other). Considering 
that nebulizer is typically on for 2 s, the liquid volume output rate was set at 5 µL/s with an active period 
of 2 s by implementing a User Defined Function (UDF) in the FEM model. 
D. MALI design and prototype 
MALI bioreactor components were fabricated using the "milli-molding" method: a polydimethylsiloxane 
solution was casted into molds made of stainless steel (Figure S2). SolidWorks 2017 software (Dassault 
System, Vlizy-Villacoublay, France) was used to design both the bioreactor and the molds. 
Polydimethylsiloxane (PDMS, Sylgard 184 1.1 kg Kit, Mascherpa, Milan, Italy) was prepared according to 
the manufacturer’s instructions (1:10 PDMS monomer-catalyser mix). The bubbles formed during the 





Fig. S2: 3D sketch of MALI molds and bioreactor designed using SolidWorks. 
 
The bioreactor is divided into four parts: the two chambers (basolateral and apical chamber, Figure S3A) 
and a membrane holder (Figure S3 B and C). Any type of membrane or even a gravimetric sensor can be 











































Fig. S3: MALI prototype parts: A) basolateral chamber (on the right) and apical chamber (on the left) with tubing,  B) PDMS 
hoops, C) PLA retaining ring (Dint= 25 mm, Dext = 29 mm). 
 
The holder is composed of two 3D printed rings that hold the membrane (Figure S3C), embedded in two 
PDMS hoops coupled by a male-female joint (Figure S3B). An Ultimaker 3D printer (3D Printing, 
Geldermalsen, Netherlands) was used to realize the polylactide acid (PLA) holding rings. In addition to 
ensuring no slippage of the membrane, the PLA rings enable easy handling of the membrane without 
touching or damaging it – particularly important during cell culture (see Section 3B&E, main text).  The PLA 
ring assembly with the membrane is lodged in a PDMS hoop and held in between the apical and basolateral 
chambers. As all three parts (basolateral chamber, membrane hoop and apical chamber) are made of 
PDMS, the self-adhesive properties of PDMS allow O-ring-free sealing by applying a small squeezing 
pressure. In the final configuration, the membrane has a total area of 4.9 cm2, while the useful area for cell 
seeding is 4.2 cm2. 
The chambers and the holder are held together by a 3D fabricated ABS (acrylonitrile butadiene styrene) 
clamping system (yellow parts, Figure S4). It is composed of a base, where the bioreactor is housed, and a 





Fig. S4: MALI bioreactor enclosed and sealed in the clamping system. 
 
The waterproofness of the bioreactor is guarantee by the clamping system and the use of PDMS, which 
is self-adhesive and deformable. The whole device (bioreactor and clamping system) can be sterilized by 
ethanol solution, gas plasma, or ultraviolet light. All wetted parts of the MALI system were sterilized with 
80% ethanol (EtOH) and ultraviolet light before the cell culture experiments.  
 As shown in Figure 1A (main text), the basolateral chamber is perfused with media through a closed loop 
circuit consisting of a peristaltic pump (Ismatec IPC 4, IDEX Health & Science, Germany - component d in 
Figure 1A,  main text) and a medium reservoir (a 40 mL polystyrene bottle, Falcon- component c in Figure 
1A, main text) all connected by 1 mm id silicone tubing. The flow rate is typically set to 0.4 mL/min (Mazzei 
et al., 2010) and the whole basolateral circuit contains 10 mL of medium.  For mechanical activation of the 
membrane, two electro-pneumatic regulators (ITV0010-2BL-Q, SMC, Italy - component e in Figure , main 
text) controlled by a microcontroller (Arduino Uno board with additional PCB board, Arduino, Turin, Italy) 
were connected to a compressed air supply (house air between 0.001 and 0.1 MPa) and to ambient air 
allowing for cyclic pressure variations. The residual air volume is compressible, which allows for direct 








































pressure sensor (component f in Figure 1A, main text - MPX5050, Freescale Semiconductor, Munich, 
Germany). 
E. Control System 
A control box was designed for containing all the components that regulate the membrane distension and 
the fluid flow, i.e. for the hardware for the control of both hydraulic and pneumatic circuits. Currently, the 
system can monitor and control 2 bioreactors (2 membranes) at the same time, but it can be expanded to 
allow for multiplexed membrane exposure. The main limitation to adding more bioreactors is the 
requirement for additional pumps or multiple pump heads. 
A dedicated microprocessor manages the cyclic inflow and outflow of compressed air in the apical 
chamber, while a user-friendly interface allows the control of stretching entity. The control system can be 
divided into four different parts (Figure S5):  
• a controlled pressure air circuit: for controlled air injection to stretch the membrane, with a controller 
board and a dedicated microcontroller; 
• a peristaltic pump: for fluid flow in the basolateral chamber; 
• a liquid reservoir: used as a liquid reserve and oxygen exchange point, for evaluating membrane 
displacement through the measurement of air pressure; 
• a user interface: a user-friendly analogue interface to control test parameters and performance. 
Each part was designed and validated before connecting to the whole system. 
 
 
Fig. S5: Schematic of the control box layout. 
F. Membrane preparation and cell culture 
The membranes used in this work were hydrophobic and not cell adhesive in their pristine state. Thus, 
prior to coating with an adhesive layer and seeding with cells, the Bionate® membranes mounted in the 
rings were rendered hydrophilic by dipping in 40% EtOH and then sterilized in 80% EtOH for 15 min followed 
by 15 min exposure to UV light on both sides, as instructed by the manufacturer. To promote cell adhesion 
and spreading, the membranes were then coated were coated with 1.72 mg/mL MatriGel (Corning, cat. # 
356234, Kaiserslautern, Germany) which contains components present in the alveolar basal lamina. 
Specifically, MatriGel was thawed in the refrigerator (4°C) overnight and diluted to a protein concentration 








































fibers of the Bionate® membrane. Each membrane was placed in a well of a 6-well plate filled with 1 mL 
MatriGel and incubated for 1 h at room temperature followed by 30 min at 37°C. Subsequently, the excess 
MatriGel was aspirated and the membranes in their rings were mounted between the two PDMS hoops for 
integration in the bioreactor. The cell culture medium for the A549 cells consisted of DMEM/F12/L-Glut/15 
mM HEPES buffered medium (Invitrogen, Germany) containing 100 Unit/mL penicillin, 100 µg/mL 
streptomycin, 0.5 mg/mL gentamycin sulfate (G418, Invitrogen, Germany), 25 µg/mL of Amphotericin B 
(Antimycotic) and 10 % fetal calf serum (FCS).  
 
G. Cell assays and imaging: technical details 
The LDH  assay was performed using the Cytotoxicity Detection Kit from Roche (Roche Diagnostics, Cat. No. 
11644793001, Mannheim, Germany) according to the manufacturer’s protocol. The LDH concentration in 
500 µL of the cell culture supernatant was determined by absorbance measurements at a wavelength of 
492 nm. As 100% control of the available LDH, cells cultured on a Bionate® membrane under submerged 
conditions in the petri dish in the incubator were treated with 2 % (w/v) Triton X-100 (100% level). The 
relative LDH release of a given sample (LDH concentration normalized to the 100% control level) is defined 
as cytotoxicity value. Less than 10% LDH release was regarded as non-toxic. The effect of different media 
volumes was accounted for by converting the LDH concentration of each sample into the LDH dose (= LDH 
concentration times the volume of media). 
For imaging, cells on the Bionate® membrane were fixed for 15 min at room temperature in 3% 
paraformaldehyde (in PBS) and stored in 0.1M glycine (in PBS). Cell membranes were permeabilized for 15 
min at room temperature using 0.2% Triton X-100 (in PBS). Cytoskeletal actin was visualized by incubation 
with Phalloidin (BodipyFL, Invitrogen) diluted 1:40 in 1% BSA (in PBS) for 1 h at room temperature. Nuclear 
staining was achieved with ProLong® Gold Antifade Reagent containing DAPI (Invitrogen).  
Confocal imaging was performed at various locations of the Bionate® membrane (Z-stacks, 512 x 512 pixels, 
8 bit) using a LSM710 system (Carl Zeiss) and a Plan-Apochromat 63x/1.40 Oil Ph3 objective lens (Carl Zeiss). 
The confocal data sets were analyzed and processed either with Imaris 7.4.0 (Bitplane) or with AxioVision 
4.8 (Zeiss) software. 
For Figure 6, cells were fixed in 4% paraformaldehyde (Sigma-Aldrich), washed with PBS and, permeabilized 
by 0.3% Triton X-100 (Sigma-Aldrich) in PBS at room temperature. To prevent any unspecific antibody 
binding, a blocking buffer (5% BSA and 0.1% TritonX-100) was added for 10 min. The F-actin cytoskeleton 
and cell nuclei were stained with Phalloidin 594 (1:40) and DAPI (1:100), respectively. The cells were then 
embedded in Glycergel (DAKO Schweiz AG, Baar, Switzerland). All cell images were acquired using a 
confocal laser scanning microscope (LSM710, Carl Zeiss; Oberkochen, Germany) coupled to the Zen2009 
software. For the scanning electron microscopy (Figure S9), the samples were fixed in 6% (v/v) 
glutaraldehyde (Sigma-Aldrich) and then dehydrated in gradient ethanol solutions followed by HDMS 
(hexamethyldisilazane, Sigma-Aldrich). 
H. Thin shell theory for relating membrane linear strain to overpressure in the medium reservoir 
When referring to alveolar distension, the term “linear strain” refers to a change in alveolar radius. To 
determine the linear strain in the MALI bioreactor, we represent the deformed membrane as a spherical 










































Fig. S6: The membrane is approximated as a spherical cap with variable height h. 
Assuming an isotropic elastic membrane with negligible thickness subject to uniform pressure load, 
the linear strain (i.e. the change in membrane radius as it undergoes deformation) is related to the 
axial displacement h as in E1 (Mazzei et al., 2010; Polyanin and Alexander V. Manzhirov, 2006; Rausch 
et al., 2011; Roan and Waters, 2011; Timoshenko and Woinowsky-Krieger, 1959; Wade, 1954) :  





Assuming that the deformations are small (h<<r), the expression simplifies to (Wade, 1954): 
ℎ = #$2 &''  E2 
Thus, the maximal membrane displacement in the axial direction can be correlated with the linear strain 
of its surface. Moreover, the volume of water displaced by the membrane (ΔV)- and the resulting 
overpressure in the reservoir- as it stretches and relaxes during the application of cyclic pressure in the 
apical chamber is also correlated with the axial displacement according to (Polyanin and Alexander V. 
Manzhirov, 2006): 
∆- = .ℎ )/0+ +
10
2 * E3 
The change in air volume in the reservoir is directly proportional to the change in overpressure and the 
proportionality constant can easily be determined from the ratio of ambient air pressure (absolute) and 
the air volume in the medium reservoir without membrane stretch, i.e. h=0). Thus, h can be derived from 
the overpressure signal. Subsequently, E2 can be used to derive the corresponding linear strain (δr/r). 
Figure S7 shows an example of the overpressure measured in the reservoir during an exposure experiment. 
 
 









































I. Cell penetration into the scaffold 
Figure S8 shows how cells penetrate around 35 μm into the scaffold forming 6 to 7 multiple layers. 
The inter-stack distance is 4 μm. 
 
Figure S8. Confocal microscopy of A549 cells on the Bionate® membrane after 3h of stretching. Confocal stack of 
DAPI stained cells (Blue) with the Bionate membrane (apical surface=a; basal surface=i) ), showing ca. 35 µm of 
cell infiltration into the scaffold. Inter stack-distance is 4 μm. The scale bar is 100 µm. 
J. Adherence and proliferation of bronchial epithelial 16HBE14o− cells to the scaffold 
 
Figure S9. Scanning electron microscopy (SEM) micrograph shows bronchial epithelial 16HBE14o− cells forming 
a confluent layer on the electrospun Bionate membrane (cell density: 2x105 cells cm-2, 6 days under 
submerged conditions and 2 days under ALI culture), except for a few regions, possibly due to localized, non-
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Evolution of Bioengineered Lung Models: Recent Advances 
and Challenges in Tissue Mimicry for Studying the Role of 
Mechanical Forces in Cell Biology
Ali Doryab, Sinem Tas, Mehmet Berat Taskin, Lin Yang, Anne Hilgendorff, Jürgen Groll, 
Darcy E. Wagner, and Otmar Schmid*
Mechanical stretch under both physiological (breathing) and pathophysi-
ological (ventilator-induced) conditions is known to significantly impact all 
cellular compartments in the lung, thereby playing a pivotal role in lung 
growth, regeneration and disease development. In order to evaluate the 
impact of mechanical forces on the cellular level, in vitro models using lung 
cells on stretchable membranes have been developed. Only recently have 
some of these cell-stretching devices become suitable for air–liquid interface 
cell cultures, which is required to adequately model physiological conditions 
for the alveolar epithelium. To reach this goal, a multi-functional membrane 
for cell growth balancing biophysical and mechanical properties is critical to 
mimic (patho)physiological conditions. In this review, i) the relevance of cyclic 
mechanical forces in lung biology is elucidated, ii) the physiological range for 
the key parameters of tissue stretch in the lung is described, and iii) the cur-
rently available in vitro cell-stretching devices are discussed. After assessing 
various polymers, it is concluded that natural-synthetic copolymers are prom-
ising candidates for suitable stretchable membranes used in cell-stretching 
models. This work provides guidance on future developments in biomimetic 
in vitro models of the lung with the potential to function as a template for 
other organ models (e.g., skin, vessels).
DOI: 10.1002/adfm.201903114
1. Introduction
Respiratory diseases such as chronic 
obstructive pulmonary disease (COPD) 
and asthma are among the leading 
causes of death worldwide and will be 
the third leading cause of death by 2020. 
In the US alone it is estimated that the 
direct and indirect healthcare expenditure 
of COPD will be $50 billion.[1] In spite 
of the expected increase in prevalence of 
chronic lung disease, there are currently 
no cures–only symptomatic therapies and 
lung transplantation for end-stage disease 
patients.[2,3]
The lung gains its most critical and 
sophisticated functionality through the 
defined arrangement of an extracellular 
matrix (ECM), which is maintained and 
populated by a variety of !60 different cell 
types. All of the different cellular compart-
ments in the lung face a continuous but 
dynamic environment due to mechanical 
forces occurring with each breath. The 
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main pulmonary function of gas exchange at the epithelial-
endothelial interface goes hand in hand with the surveillance 
of complex environment-host interactions. Although these 
critical functions are enabled by the presence and interaction 
of various cell types, direct exposure to gases, and airborne 
particles, including cigarette smoking, combustion/industrial/
occupational emissions or inadvertently released (nano-)parti-
cles from consumer products is known to put the lungs at risk 
for environmentally induced diseases outlined above.[4]
In light of the urgent need for further research into the 
mechanisms of lung disease and novel therapeutic concepts, 
experimental approaches have largely utilized animal models 
or isolated primary cells.[5,6] Despite sophisticated effort in this 
research field, translation of promising drug candidates from 
animal, mostly rodent, models into the clinical setting often 
fails. In order to meet this need, an increasing number of 
biomimetic in vitro and ex vivo lung tissue models have been 
developed to i) study specific cellular effects and ii) translate 
observations into the clinic.
Efforts toward more biomimetic in vitro cell models include 
multicell co-culture models consisting of up to five different 
cell types and the shift from cell lines to potentially more physi-
ologic primary cell cultures, which includes the most recent 
lung-on-a-chip technology.[7] In recent years, these efforts also 
started to recognize the role of mechanical stimuli, that not 
only play a role in lung development and regeneration, but 
when pathologic, have also been shown to have a role in disease 
onset, mitigation, and chronicity.[8,9] Mechanical stretch has 
been shown to modify cell proliferation, differentiation, secre-
tion, and migration through regulation of specific signaling 
pathways leading to changes in gene expression and protein 
synthesis.[10,11] Figure 1 depicts an overview over the most rel-
evant mechanisms induced or impacted by a cellular stretch.
Despite acknowledging of the importance of mechanical 
forces to mimic (patho)physiologic conditions (and thus reliably 
study relevant treatment and injury mechanisms), only a very 
limited number of in vitro models allow mechanical stretching 
of pulmonary epithelial cells. Moreover, nearly all of these 
models were designed for nonphysiologic submerged conditions 
with cell culture medium completely covering the cells, rather 
than physiologic air–liquid interface (ALI) culture conditions 
(Figure 2a), where epithelial cells are exposed to air resulting in 
cell polarization and secretion of a protective liquid layer such 
as mucus and/or alveolar lining fluid.[10,12–16] This was mainly 
owed to establishing feasibility, i.e., the  technological  simplicity 
of submerged cell culture systems. Only a few of these cell-
stretching devices are commercially available (e.g., Bioflex 
 culture plate, Flexcell International Corp., USA) and thus there 
has been a challenge of bringing these setups to biologists with 
expertise in pulmonary biology (Figure 2e).
On the other hand, the advantages of cell and tissue-based 
bioreactor systems includes the creation of biomimetic culture 
conditions that significantly improve the physiological relevance 
of cell and tissue cultures by controlling microenvironment 
parameters and facilitating mass transfer of nutrients.[17–20] 
Nonetheless, one of the main limitations of the  currently avail-
able stretchable systems is the lack of suitable membranes, 
which are both suitable for ALI cell culture conditions and 
closely mimicking the physiologic conditions in the lung.
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In order to address these questions, the present review 
focuses on in vitro devices for cyclic stretch as well as ALI cul-
ture conditions of pulmonary epithelial cells, which have been 
developed in the past decade (Figure 2b). The technical aspects 
of these systems are presented and the physiologic implications 
of stretch on cellular function and biological response as well 
as membrane design, candidate materials, and manufacturing 
processes are reviewed. Furthermore, the potential of alterna-
tive membrane materials for improved biomimetic characteris-
tics are discussed.
2. Stretch-Related Lung Biology
Lung has a complex architecture partitioned into 23 genera-
tions of airways enabling oxygen transport and carbon dioxide 
transport in and out of the blood, respectively, via the large air–
liquid interface presented by the surface area of the alveolar 
tissue (gas exchange region of the lung).[21] Figure 3a depicts 
the whole murine lung from trachea, bronchus, bronchioles 
(I and II) down to the typical three-dimensional (3D) honey-
comb architecture of the alveoli (III–V). The surface of the 
lung is covered with epithelial cells, which represent the inter-
face between air and liquid (tissue) typically referred to as ALI. 
Strictly speaking, the entire epithelium is not directly exposed 
to air, since epithelial cells secrete a protective liquid layer 
consisting of mucus and/or alveolar lining fluid in the bron-
chial and alveolar region, respectively. These conditions can 
be mimicked in vitro by air-lifting epithelial cells and exposing 
them to air (ALI culture). The alveolar region is an elastic and 
mechanically dynamic part of the lung experiencing nearly 
constant cyclic stretch motion with significant impact on many 
aspects of lung metabolism, function, and growth.[22,23] The 
mechanical forces are mainly a result from inspiratory infla-
tion and expiatory deflation of the lung and to a lesser degree 
due to pulsatile blood flow.
2.1. Physiologic Stretch and Biological Membrane Conditions
During normal tidal breathing at rest (!500 mL tidal volume), a 
healthy lung normally inflates at a frequency of !0.20 Hz (12–15 
inhalation-exhalation cycles per minute for rest conditions) 
causing the alveoli to increase in size and surface area (Table 1). 
Under these respiratory conditions, the basement membrane, 
which represents the structural core of the air–blood barrier, is 
stretched to a linear strain of 4%.[24–26] During heavy exercise 
the respiratory frequency and tidal volume can increase up to 
about 0.55 Hz (26–33 breaths per minute) and 1900 mL, respec-
tively,[27] resulting in an increase in linear strain of !12% in the 
alveoli[28] reaching even 20% in pathological scenarios such as 
acute respiratory distress syndrome (ARDS).[29]
Adv. Funct. Mater. 2019, 1903114
Figure 1. Role of (cyclic) mechanical forces in lung epithelium. Proliferation, differentiation, adhesion, migration, and apoptosis of lung epithelial 
cells are regulated by cyclic stretch. These effects can be initiated by several distinct cellular pathways such as the MAPK/ERK pathway, which results 
in the differentiation of fetal epithelial cells,[45] the cAMP-PKA-dependent signaling pathway mediating differentiation of fetal ATIIs,[46] and activation 
of YAP/TAZ and the signaling cascade of Cdc42/F-actin/MAPK mediating alveolar regeneration.[47,48,200] Cyclic strain induced by ventilation regulates 
pulmonary epithelial morphology by a pathway involving Src, focal adhesion kinase (FAK), and then MAPK/ERK signaling.[49] High deformation opens 
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A thin basement membrane (thickness !50 nm) lies under-
neath both the epithelial and endothelial cell layers and 
consists of small fibrils of collagen and elastin and rare fibro-
blasts (Figure 3a–c). In the alveolar-capillary barrier these two 
basal laminae are fused so that no interstitial tissue can form 
between them.[30] These basement membranes are a perme-
able barrier with diminutive tiny pores. Although there is no 
general opinion about the size of these pores, some reports 
on animal lungs[31,32] suggest two types of pores one being 
<2.5 nm in diameter and a small fraction of larger pores 
(<400 nm).[33] The mean thickness of the alveolar-capillary 
barrier (region of fused epithelial-endothelial basement mem-
brane) is 1.1 µm.[30,34] The average thickness of the air–blood 
barrier (alveolar-capillary barrier at the site of gas exchange) 
is smaller (0.62 µm),[30,35] since the gas exchanges occurs 
preferentially at the sites of closest proximity between air and 
blood. The stiffness of healthy whole human alveolar tissue 
(measured as Young’s elastic modulus) is estimated to range 
1–2 kPa.[36,37] Under pathological conditions such as idio-
pathic pulmonary fibrosis (IPF), the stiffness of the basement 
membrane can increase to !16.5 kPa[37] due to enhanced secre-
tion and deposition of ECM proteins by both epithelial cells 
and fibroblasts.
2.2. Role of Mechanical Stretch in Lung Biology
Mechanoreceptors on the cell surface can detect mechanical 
stretch and subsequently convert this stimulation into bio-
chemical signals activating downstream signaling pathways.[38] 
The consequences of mechanical forces on lung biology has 
been determined from numerous in vivo and in vitro experi-
ments and is summarized in Figure 1. Table 2 presents an over-
view of the results from in vitro studies covering a wide range 
of stretch conditions and cell types.
Cyclic mechanical stretch has been shown to alter prolif-
eration, differentiation, and migration of pulmonary epithelial 
cells.[10,11,39–44] These effects can be mediated by activation 
Adv. Funct. Mater. 2019, 1903114
Figure 2. Schematic depictions and photos of in vitro epithelial cell culture systems and stretching devices. a) In vitro cell culture model under sub-
merged conditions. b) In vitro static cell culture model under ALI conditions using Transwell insert. c) A stretching system using a solenoid unit: Fetal 
rat lung cell on a Gelfoam sponge fixed to the dish at one end, and another end is stretched using an electromagnetic field.[74] d) A cell-stretching 
device to apply a uniform, equibiaxial strain to the cells: The membrane deformed by moving the indentor to provide an equibiaxial strain.[75] e) Com-
mercial Flexcell strain unit (Flexcell International Corporation): This device applies uniaxial radial strain by regulating vacuum pressure underneath 
a flexible silicone membrane. f) The MALI bioreactor system: The system is composed of a basal and an apical chamber separated by a stretchable, 
porous membrane and two fluidic systems for cell culture medium. Epithelial cells cultured on a membrane under ALI conditions. A pressure regu-
lator in the apical chamber to actuate the flexible membrane in a controlled manner.[91] g) (left) A microfluidic system for co-culture of epithelial and 
endothelial cells under ALI and mechanical stretch: This microsystem applies a uniaxial strain on a stretchable, porous PDMS membrane by regu-
lating the pressure in the side chambers (right) Image of a side and tope view of an actual microfluidic. Reproduced with permission.[94] Copyright 
2010, American Association for the Advancement of Science h) (top) A lung-on-a-chip array: The membrane is stretched in a triaxial direction using 
pneumatic microchannels located at the bottom of the basolateral chamber.[60] (down) Photograph of a modified lung-on-chip with 6 independent 
chamber, reproduced under the terms and conditions of the Creative Commons Attribution 4.0 International License.[99] Copyright 2018, The Authors, 
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of several distinct cellular pathways such as the mitogen- 
activated protein kinase/extracellular-regulated protein kinase 
(MAPK/ERK) pathway via binding of the epidermal growth 
factor (EGF) to the epidermal growth factor receptor (EGFR), 
which results in the differentiation of fetal epithelial cells.[45] 
Fetal alveolar epithelial type II cells (ATIIs) can be induced via 
activation of the transcription factor-dependent protein kinase 
(cyclic adenosine 3!,5!-monophosphate (cAMP)-protein kinase 
A (PKA)-dependent) signaling pathway during cyclic equibiaxial 
 elongation.[46] It has also been shown that YAP (Yes-associated 
 protein) is a key mediator in regulating cyclic mechanical 
stretch and together with the signaling cascade (the Cdc42/F-
actin/MAPK), they can promote alveolar regeneration.[47] YAP 
and TAZ (transcriptional co-activator with PDZ-binding motif), 
the Hippo signal-regulated transcriptional co-activators, can 
also be stimulated by the mechanical signals that are sensed 
Adv. Funct. Mater. 2019, 1903114
Figure 3. Lung morphology and cellular structure as guidance for bioinspired lung models. a) A 3D reconstruction of the entire murine lung 
tissue obtained with light sheet fluorescence microscopy (LSFM) depicting trachea, bronchi, small (terminal) bronchioles (I), distal bronchial tree 
(II) and 3D honeycomb structure of the alveolar region as observed with confocal microscopy on precision cut lung slices (III) as well as surface 
rendering, (IV) and 2D images thereof (V). Panels I-III reproduced with permission.[202] Copyright 2019, American Chemical Society. Green: tissue 
structure, blue: nuclei. b) Schematic of cellular composition of the human airway tree from upper bronchus to alveolus. c) (left) SEM image of the 
human alveolar wall showing the very thin tissue barrier separating capillary blood and air (right) TEM image of alveolar-capillary region depicting the 
alveolar epithelium (EP), capillary endothelium (EN), basement membranes (BM) as part of the air–blood barrier, fibroblast (FB), and erythrocyte (EC) 
(Electron microscopy images Reproduced with permission[35] Copyright 1978, Elsevier. Reproduced with permission.[203] Copyright 2011, Wiley-VCH). 
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by cells and trigger cell survival signaling.[48] In addition, cyclic 
stretch can alter cell morphology of alveolar epithelial cells 
(ATs) and activate Src protein tyrosine kinase[49] including actin 
cytoskeleton remodeling and cell alignment (and orientation) in 
fetal ATIIs and can be regulated via RhoA and Rac1 signaling 
proteins, members of the Rho small GTPase family of hydro-
lyzing enzymes, when cells experience mechanical stretch.[50]
Studying the effects of mechanical distension on the expres-
sion of specific markers for the alveolar epithelial type I (ATI) 
and type II (ATII) cell phenotypes showed that mechanical 
distension (21%, surface area) influences alveolar epithelial 
phenotypic expression in vitro at the transcriptional level and it 
appears that both transcriptional and posttranscriptional mech-
anisms are involved.[51]
Mechanical stretch can influence the expression of ECM 
components,[52] proliferation rate[10] and may also impact the 
expression of surfactant protein C and B (SP-C and SP-B),[53–56] 
synthesis of surfactant-related phospholipids,[57] calcium mobi-
lization,[55,58] and induce tropoelastin[59] in ATIIs. Furthermore, 
applying cyclic mechanical strain (21%, surface area) on pri-
mary human pulmonary ATs increases epithelial barrier perme-
ability for small hydrophilic molecules and enhances metabolic 
activity.[60] The role of amplitude, frequency, or uniformity of 
stretch on these aspects has not been systematically investi-
gated, yet.
Excessive mechanical stretch can also induce apoptosis, 
phosphatidylcholine secretion, necrosis in ATIIs[61,62] and 
more severe release of cytokines, especially inflammatory 
mediators such as interleukin-8 (IL-8). Vlahakis et al. have 
reported that excessive cyclic cell stretch (30%, surface area) 
for up to 48 h upregulated the production and release of IL-8 
by immortalized human alveolar epithelium (A549 cells).[63]
Moreover, it has been shown that mechanical strain can 
affect wound healing and wound closure of both airway 
and alveolar epithelium. Closure was inhibited by excessive 
mechanical strain such as distention, elongation, and com-
pression.[39–41] In addition to cyclic strain, the combined effects 
of fluid and interface flows (surface tension) and high trans-
mural pressures during mechanical ventilation can play a role 
in the development of ventilator-induced lung injury (VILI) 
especially in patients who are suffering from ARDS. These 
aspects can exacerbate lung injury through overdistension of 
alveolar sacs (volutrauma), cyclic alveolar collapse, and expan-
sion (atelectrauma), as well as activation of the inflammatory 
cascades.[64]
In summary, it is evident that cyclic mechanical forces are 
governing factors in numerous critical regulatory functions of 
the lung particularly during lung development.[65,66]
3. Stretch Devices for In Vitro Cell Models  
of the Lung
The currently available stretch devices for in vitro cell models 
of the lung can be stratified by their applicability in cell culture 
conditions, i.e., submerged or ALI and by their degree of minia-
turization (macro-/microfluidic; Table 3). The fundamental con-
cepts of the traditional submerged and the more physiologic ALI 
cell culture conditions are schematically depicted in Figure 2a,b. 
While in submerged conditions cells are typically attached to 
plastic wells and culture medium covering the cells, under ALI 
conditions, epithelial cells are grown on a perforated membrane 
(typically polyethylene terephthalate, PET) with air on the apical 
side and cell culture medium on the basal side. ALI cell cultures 
are a more physiologic model of the lung epithelium as they
t NJNJDUIFJOUFSGBDJBMGVODUJPOPGUIFFQJUIFMJBMCBSSJFSPGUIF
lung separating air from interstitial or blood fluid.
t BMMPXGPSQPMBSJ[BUJPOPGUIFFQJUIFMJBMDFMMTXIJDISFTVMUTJOB
more tightly regulated cell barrier and apical secretion of natural 
protective liquid layers such as mucus or alveolar lining fluid.[67]
t BMMPXGPSNPSFDPNQMFYBOEIFODFNPSFQIZTJPMPHJDNVMUJDFMM
co-cultures consisting of, e.g., epithelial cells with macrophages 
on the apical side and dendritic or endothelial cells on the basal 
side of the porous membrane serving as cell support.[68–70]
t BMMPXGPSEFMJWFSZPGBJSCPSOFHBTFTPSBFSPTPMT	ESVHTPSUPY-
ins) directly to the epithelial cells, which is both conducive for 
direct measurement of the cell delivered dose via, e.g., quartz 
crystal microbalances[69] and more predictive for clinical out-
come than pipetting of these substances into the cell culture 
medium as done under submerged culture conditions.[7,67]
In the following section, we present an overview of the cur-
rently available stretch devices for in vitro models of the lung 
epithelium under submerged and ALI cell culture conditions 
and the more recently introduced microfluidic devices typically 
referred to as lung-on-a-chip models.
3.1. Devices for Submerged Cell/Tissue Culture Models
The vast majority of cell-stretching devices described in the 
literature refer to submerged cell culture models of the lung 
(Table 3). One of the earliest cellular stretch devices was intro-
duced by Skinner et al.[71–74] They cultured fetal rat lung cells 
on a Gelfoam sponge with one side of it fixed to the culture 
dish and the other end elongated using an electromagnetic field 
generated by a solenoid unit (Figure 2c). However, the extent 
of cellular deformation applied by this system was nonuniform 
and difficult to quantify.[11,75]
Another early type of stretch device was used by Wirtz 
and Dobbs.[51,55] Their device consisted of a flexible 
poly(dimethylsiloxane) (PDMS, Sylgard 184) membrane, on 
Adv. Funct. Mater. 2019, 1903114
Table 1. The stretch- and permeability-related physiologic parameters of 
the native basement membrane of the human alveolar-capillary tissue.
Parameter Value Ref.





Stiffness of human alveolar tissue 1–2 kPa [36,37]
Pore diameter of alveolar-capillary 
barrier
0.5–2.5 nmd) [33]
Thickness of basement membrane !50 nm [30]
Thickness of air–blood tissue barrier 0.62 µm ± 0.04e) [30,35]
Total alveolar-capillary barrier thickness 1.1 µm ± 0.1e) [30,34]
a)normal breathing; b)deep inspiration and heavy exercise; c)pathological condi-
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Table 2. In vitro effects of (cyclic) mechanical forces on epithelial cell physiology of the lung and associated cell stretch-conditions.
Mechanical stretch Cell stretching 
device
Cell type Key results Ref.
Type Level Frequency  
[cycles per minute]
Single 16–17%  
(surface area)
27 Hydrostatic  
force unit
rATIIa) Mechanical stretch of ATIIs caused an increase in cytosolic Ca2+ 
followed by  stimulation of surfactant secretion.
[55]
Intermittent 12–18% (linear) 30 Solenoid  
stretch unit
fetal rat lung  
organotypic
Both frequency and amplitude of cyclic stretch affects production 
of prostacyclin by lung cells.
[74]
Cyclic 10% (surface area) 3 or 50 Flexcell strain 
unit
fetal rabbit ATII Mechanical stretch alters ATII  proliferation rate and may also 
affect synthesis of surfactant-related phospholipids.
[57]
Cyclic 27–30%  
(surface area)
15 Flexcell strain 
unit
ASMs Cyclic stretch resulted in proliferation of ASMs and it may con-
tribute to increased ASMs hyperplasia and airway resistance.
[42]
Cyclic 12.5% (max.), Ave. 
<5.7% (linear)





Stretch enhanced DNA synthesis of mixed cells, epithelial cells, 
and fibroblasts in 3D culture conditions.
[10]
Cyclic 12%, 24%, 37%, 




rATIIa) Deformation-induced injury is an important factor in the  
development of lung injury during mechanical ventilation.
[75]
Cyclic Max. 20–22% 
(surface area)
10–30 Flexcell strain 
unit
Calu-3, Cat tracheal  
epithelial, 1HAEo-a)
Wound healing affected by cyclic mechanical strain and wound 
closure was inhibited by both strain and compression  




21% (surface area) – Hydrostatic  
force unit
rATIIa) Mechanical stretch influenced alveolar  epithelial phenotypic 
expression in vitro, at least in part, at the transcriptional level 
(increase in the marker for the type I  phenotype (rTI40) and 
decrease in mRNA content of SFTPB, SFTPC, and no effect on 
mRNA content of SFTPA or GAPDHa).
[51]
Cyclic 5–15% (radial) 50 Flexcell strain 
unit
NCI-H441a) Cyclic mechanical stretching of H441 cells for 24 h increased 
SFTPB and SFTPA expression.
[56]
Cyclic 20–30% (surface) 20 and 40 Flexcell strain 
unit
A549 High deformation (more than 20%) can activate inflammatory 
response IL8.
[63]
Cyclic 5% (linear) 60 Solenoid stretch 
unit
Organotypic  
epithelial and  
fibroblasts
Cyclic mechanical strain differentially  regulates gene and protein 
expression of ECM molecules in fetal lung cells.
[52]
Cyclic Max. 22%  
(surface area)
3 Flexcell strain 
unit
rATIIa) Mechanical stretch can induce both  apoptosis  
and phosphatidylcholine secretion in ATII.
[61]
Cyclic 25%, 37%, and 
50% (surface area)
15 and 60 Over-distension 
injury model
rATIIa) The frequency of sustained cyclic  deformations  
(not the deformation rate during a single stretch) increased 
 deformation-induced injury.
[78]




Mechanical strain significantly increased SFTPC and tropoelastin 
mRNA expression.
[59]
Cyclic 20% (surface area) 60 Flexcell  
strain unit
NCI-H441a) Mechanical stretch induces proliferation of pulmonary  
epithelial cells. Tyrosine kinase activity is necessary to signal  
the proliferative response to mechanical strain. Activation  
of FAK via tyrosine phosphorylation does not appear to  
have a role in the strain response.
[43]
Cyclic 5% (linear) 50 Flexcell  
strain unit
fetal ATII Cyclic mechanical stretch enhances  differentiation of fetal ATIIs 








Uniform biaxial elongation inhibits epithelial  
wound closure.
[39]
Cyclic 5% and 30%  
(surface area)
30 Flexcell strain 
unit
rATIIa) Cyclic stretch induces a rapid ERK1/2 activation, which is trans-
duced via G proteins and EGFR tyrosine kinase. Stretch-induced 
MAPK/ERK pathway activation is independent of Na+ and Ca2+ 
influxes and the Grb2-SOS, Ras, Raf-1 pathway.
[200]
Cyclic 10% (surface area) 60 Flexcell  
strain unit
A549 Cyclic stretch altered the intracellular transport of plasmids to 
increase gene expression.
[62]
Cyclic 20% (surface area) 30 Flexcell  
strain unit
A549 Mechanical stretch changed cell morphology of ATII-like A549 
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Mechanical stretch Cell stretching 
device
Cell type Key results Ref.
Type Level Frequency  
[cycles per minute]
Cyclic 5% (linear) 60 Flexcell strain 
unit
fetal rATIIa) Mechanical stretch, at least in part, induces differentiation of 
fetal ATII via EGFR activation of the MAPK/ERK pathway.
[45]
Cyclic 13% and 30% 
(surface area)
40 and 60 Flexcell strain 
unit
rATIIa) Increased mechanical stretch contributes to lung injury  
by induction of apoptosis and necrosis in ATIIs.
[62]
Cyclic 5% (linear) 60 Flexcell strain 
unit
E19 fetal ATII Various integrins contribute to mechanical control of ATII  
cell differentiation on laminin substrates. Strain-induced  
differentiation of fetal ATIIs is mediated by specific  
ECM-integrin interactions.
[204]
Cyclic 5% (linear) 60 Flexcell strain 
unit
E19 fetal ATII The transcription factor-dependent protein kinase  
(cAMP-PKA-dependent) signaling pathway is activated by  
force in fetal ATIIs and participates in strain-induced  
fetal ATII cell differentiation.
[46]
Cyclic Average 10%  
(max. 20%)  
(surface area)
20 Flexcell strain 
unit
NCI-H441a), A549 Cyclic mechanical stretch induced by ventilation supports  
pulmonary epithelial proliferation by a pathway involving Src, 




5%, 10%, or 17% 
(radial elongations)
30 Flexcell strain 
unit
Fetal rATIIa) Mechanical stretch of fetal ATIIs evokes a complex network of 
signaling molecules, which diverge downstream to regulate the 
temporal expression of a unique set of early response genes.
[58]
Cyclic 25%, 50%, 75%, 




MLE-12a) The basement ECM plays a key role in both cell death and signal 
transduction in response to strain.
[205]
Cyclic 5%, 10%, and 15% 
(linear)
10–30 Flexcell strain 
unit
Primary rATIIa) Different types of mechanical strain inhibited wound closure 
of ATIIs compared with static controls. Mechanical stretch 
decreases migration of AT cells through mechanisms involving 
Tiam1, a Rac1-specific guanine nucleotide exchange factor.
[40]




rATIIa) Variable mechanical stretch may enhance surfactant secretion 
(reducing the risk of ventilator-induced lung injury).
[53]
Cyclic 38% in the 
latitudinal and up 





PCLS Stretching of PCLS on PDMS-membranes represents a  
useful model to investigate lung stretch in intact lung tissue in 
vitro for several hours.
[83]
Cyclic 5–15% (linear) 12 Human alveolar-
capillary interface 
model
A549 Studying the effects of the mechanical strain on inflammatory 
response by mimicking the lung alveolar-capillary barrier.
[94]
Cyclic 15% (surface area) 52 Flexcell strain 
unit
Primary murine ATII Cyclic stretch induces epithelial-mesynchemal transition (EMT) 
in ATIIs through production of the matrix component hyal-
uronan, which activates the Wnt/beta-catenin pathway  
downstream of MyD88 signaling.
[14]




Murine ATII, A549 Studying the combined effects of surface-tension stresses and 
cyclic stretch on AT cells
[206]
Cyclic 5% (linear) 40 Flexcell strain 
unit
Fetal mATIIa) EGFR and ErbB4 regulate stretch-induced ATIIs differentiation 
via MAPK/ERK pathway.
[207]
Cyclic 5% (linear) 40 Flexcell strain 
unit
E19 fetal ATII Mechanical strain enhances binding of alpha6beta1 integrin to 
TACEa) to promote fetal ATIIs differentiation.
[208]
Cyclic 21% (surface area) 12 Alveolar-on-a-chip 16HBE14o,  
pHPAECa)
Investigation of the effect of cyclic stretch on the metabolic 
activity and the cytokine secretion of pHPAEC using an  
alveolus-on-a-chip array.
[60]
Cyclic 6% (linear) 60 A chip to partially 
mimic OSA
rMSCsa) HIF-1! expression in rMSCs increases in response to  
intermittent hypoxia and mechanical stretch.
[96]
a)1HAEo- and 16HBE14o: airway epithelial cells, GAPDH: glyceraldehyde 3-phosphate dehydrogenase, mATII: mouse alveolar epithelial type II cells, MLE-12: mouse lung 
epithelial cells, NCI-H441: human pulmonary epithelial cell line, pHPAEC: primary human pulmonary alveolar epithelial cells, rATII: rat alveolar epithelial type II cells, 
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which primary ATIIs were cultured on the apical side and 
mechanical stretch was applied by changing the hydrostatic 
pressure below the membrane. However, this device also 
applied a nonuniform strain to the cells, which caused changes 
in cell behavior due to heterogeneous deformation. In addition, 
the amount of mechanical stress in this system was adjusted by 
altering the hydrostatic pressure manually and as a result, this 
model was not suitable for applying stable cyclic mechanical 
stretch for an extended period of time.
One of the earliest studies on equibiaxial deformation-
induced injury was carried out by Tschumperlin and Margulies 
who designed a cell-stretching device that applied a uniform, 
equibiaxial strain to AT cells cultured on a fibronectin-coated 
nonporous Silastic membranes.[75] An annular indentor was 
designed to contact the bottom of the silicone membrane 
(near the rim) and the membrane stretched by moving the 
indentor. Deformation rate and cycles are regulated by the 
motor speed (Figure 2d). The strain field (2D, equibiaxial, max-
imum applied strain 50% surface area) is unchanged during 
1 h of continuous cycling (Table 3). This method allowed applica-
tion of a predictable uniform strain to ATs resulting in more 
quantifiable investigations of the response of the alveolar epi-
thelium to cyclic mechanical stretch.
This device and other commercially available instruments 
such as the Flexcell strain unit (Flexcell International Corpora-
tion) and stretching apparatus (STREX Inc.) (Table 3) have been 
utilized by numerous researchers to study the effect of mechan-
ical stretch on ATII,[14,61,63,76–78] human pulmonary microvas-
cular endothelial,[79] and airway smooth muscle (ASM)[80] cells 
(Table 2). The general mechanism of the majority of the com-
mercially available cell-stretching devices is based on control-
ling vacuum pressure underneath the culture plates to apply 
uniaxial or uniform radial strain to the cell monolayer, which 
is cultured on a flexible silicone membrane (Figure 2e). How-
ever, the membranes used in these systems are nonporous due 
to the application of vacuum on the basal side for stretching 
the membrane and thus cells cannot be cultured under ALI 
conditions. Therefore, the in vitro devices in these studies do 
not allow the study of the lung epithelium at ALI, which limits 
their ability to recapitulate the in vivo scenario.
In addition to in vitro cell culture models, ex vivo lung 
slices have been used to investigate the effects of contraction 
on ASMs.[81] Ex vivo precision-cut lung slices (PCLS) can be 
derived from human or animal lungs. Lung tissue explants can 
be processed into lung slices of defined thickness (200–500 µm; 
a few alveolar sacs), which are viable up to 5 days.[82] In contrast 
to in vitro models, PCLS preserve cellular and structural organi-
zation of the lung tissue and maintain complex physiologic 
features not only for healthy, but also diseased lungs.[82] The 
lung slices can also be stretched to investigate the pulmonary 
responses to mechanical stretch.[83,84] For instance, the lung 
slices (PCLS/PDMS: a PDMS membrane used as a supportive 
layer) were stretched by applying pressure to the basal chamber 
(biaxial, 0.2 Hz, 4 h).[83] The average stretch was 24.9 ± 4.1% 
in alveolar perimeter (1D) at 3.5 kPa and 35 ± 8.5% at 5.2 kPa 
(Table 3).
3.2. Devices for Air–Liquid Interface Cell Culture Models
In recent years, recognition of the previously described advan-
tages of ALI as compared to submerged cell have led to an 
increase in ALI cell cultures studies with static Transwell 
Inserts,[69] where epithelial cells are cultured on a static porous 
membrane (typically PET) with air on the apical side and cell 
culture medium on the basal side (Figure 2b).[85,86] Only very 
Adv. Funct. Mater. 2019, 1903114
Table 3. Overview of cell stretch devices employed in vitro studies on the effect of mechanical stretch on cell and tissue models of the lung.
Type of device (depicted in 
Figure 2 panel c–h)
Cell culture 
conditions
Type of stretch Membrane material Ref.
Direction Max. strain applicable Material Pore size Cell growth  
area [mm2]
Thickness [µm]
Solenoid stretch unit (C) Submerged 1D, uniaxial 18% (linear) Gelfoam sponge NPa) 14 ! 10 2000 [71,72]
Stretch unit by applying  
hydrostatic pressure
Submerged 2D, biaxial 50% (surface area) Silicoelastic NP 415 230 [55]
Cell stretching device to model 
over-distension injury (D)
Submerged 2D, equibiaxial 50% (surface area) Silicone NP – 200 [75]
Flexcell strain unit (Flexcell 
International Corp., NC) (E)
Submerged 2D, equibiaxial 15% (radial) Bioflex silicone NP 420 – [57,209,210]
Strain-applying bioreactor Ex vivo  
model
1D, uniaxial "30% (longitudinally  
and latitudinally)
PCLS-PDMS – – 436b) [83]
Stretch apparatus (ST-150; 
Strex, Osaka, Japan)
Submerged 1D, uniaxial 30% (surface area) Silicone chamber NP 10 ! 10 – [79,80]
Human alveolar-capillary inter-
face model (G)
ALI 1D, uniaxial 15% (linear) PDMS 10 µmc) 0.028d) 10 [94]
Alveolar-on-a-chip (H) ALI 3D, triaxial 21% (surface area) PDMS 3 or 8 µm 2 ! 7.1 3 [60]
A chip to mimic OSA Submerged 1D, uniaxial 6% (linear) PDMS – 12.5e) 10 [96]
MALI bioreactor system (F) ALI 3D, triaxial 17% (linear) Bionate II 80A 
(PCU)
– 420 75.4 [91]
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recently, devices for stretching of ALI cell culture systems have 
become available (Table 3). Pulmonary cells are normally cul-
tured on rigid substrates (mainly plastic dishes with a stiffness 
ranging from 2 to 4 GPa), which does not recapitulate the much 
less stiff basement membranes in vivo.[87] For cell stretch under 
ALI conditions, cells should be grown on membranes which are 
not only elastic, but also porous for nutrient exchange between 
apical cells and basal cell culture medium.
To provide better culture conditions during cell seeding and 
increase the efficiency of cell culturing, bioreactor systems are 
essential. These systems, allow for tight control of temperature, 
pressure, and biomechanical stimuli as well as mass transfer 
of nutrients and oxygen by providing in vitro biomechanical 
and biochemical conditions mimicking in vivo conditions.[88,89] 
Some of these systems are now even capable of studying the 
responses of ALI cell cultures to mechanical and biochemical 
cues.[90]
Recently, the moving air–liquid interface (MALI) bioreactor 
system has been developed to study the role of mechanical 
stretching on the permeability of epithelial cells to soluble 
and airborne nanoparticles in vitro (Figure 2f). An elastic 
electrospun membrane made of polycarbonate polyurethane 
(Bionate80), where ATIIs are grown under ALI culture condi-
tions, is stretched using air regulation in the apical chamber 
to mimic natural breathing.[91] However, cell culture was 
 challenging with the Bionate membrane, even if a highly prolif-
erative lung epithelial cell line (A549) was used.
In the last decade, microfluidic cell-culture platforms 
(Figure 2g) have been introduced, which mimic the main in 
vivo physiological functions and mechanical microenviron-
ment of the alveolar epithelial barrier (Table 3). Microfluidic 
systems are able to create and regulate small amounts of 
fluid flows (10!9 to 10!18 L), and transfer nutrients and other 
biochemical cues to cells in a controlled manner.[92] In 2009, 
a continuously-perfused microfluidic system designed to cul-
ture human ATs at ALI under dynamic conditions was devel-
oped.[93] It has been reported that cells cultured using this 
platform showed a better degree of monolayer integrity, had 
higher rates of surfactant production, and lower surface ten-
sion of the lining fluid in comparison to the traditional Tran-
swell culture model. In 2010, Huh et al. designed a minia-
turized co-culture cell model with microfluidic perfusion.[94] 
This microsystem is modeled to study functions of the lung 
by integrating a co-culture of epithelial and endothelial cells 
on a stretchable, porous PDMS membrane separating the air-
filled apical from the liquid-/medium-filled basal compart-
ment of the PDMS bioreactor. Physiologic breathing move-
ments and blood flow have been mimicked by applying cyclic 
mechanical strain and constant intermittent medium flow 
on the apical and basal side of the in vitro alveolar barrier, 
respectively.[94] Although this multifunctional microdevice 
may provide superior culturing conditions for human lung 
cells rather as compared to conventional culture systems, 
it does not fulfill all of the characteristics of the alveolar-
capillary barrier in vivo, such as barrier thickness (PDMS 
membrane is 10 µm; alveolar tissue barrier <1 µm thick). 
Moreover, it does not include all of the major cell types native 
to the lung and can therefore hardly be considered as a lung-
on-a-chip, but a miniaturized version of the widely used 2D 
co-culture models of the lung. Recently, a new version of this 
device updated to regenerate a 3D cross-section of a human 
lung alveolus (co-culturing of primary human ATs (mixture 
of type I and II) with human umbilical vascular endothelial 
cells (HUVECs)); but, not subjected to cyclic mechanical 
stretch.[95]
Another simplified microfluidic device was designed to 
mimic obstructive sleep apnea (OSA) for studying cellular 
responses to cyclical hypoxia and stretch.[96] They showed that 
hypoxia-inducible factor 1" (HIF-1") is upregulated in mes-
enchymal stem cells under both intermittent hypoxia and 
cyclic stretch. The circular PDMS membrane of this device is 
stretched over a rigid post resulting in two regions with uni-
form but different strain profile. While in the center region (on 
post), there is uniform radial strain with an added circumfer-
ential strain field, the circumferential strain is small in the off-
post region (rim).[97] In fact, this is a common limitation with 
other commercial stretchable devices such as Bioflex culture 
plates (Flexcell International Corporation, Burlington, NC).[97] 
Hence, for cell experiments under identical uniform strain 
conditions only the on-post region of the membrane should be 
populated with cells.
In 2015, another microplatform was designed which sought 
to recreate the pulmonary parenchymal environment to inves-
tigate the effects of breathing movements on human primary 
cells derived from patients.[60] In this perhaps most physi-
ological lung-on-a-chip microdevice to date, the membrane 
is actuated indirectly (3D, triaxial) using a bioinspired micro-
diaphragm located at the bottom of the basolateral chamber 
(Figure 2h). Cells are seeded on a surface modified (oxygen 
plasma) and fibronectin-coated porous PDMS membrane 
(thickness is 10 µm; pore size 3 or 8 µm). After that, a cyclic 
mechanical stretch is applied to the PDMS membrane (21%, 
2D, at frequency of 0.2 Hz) by exerting a negative pressure. The 
modified version of this model enables online monitoring of 
transepithelial electrical resistance (TEER) in real-time using 
a microimpedance tomography system (at a distance of 1 mm 
from the electrodes).[98] In addition, the microfluidic device 
used in this study can be equipped with a passive medium 
exchange unit to provide long-term culture conditions under 
ALI.[99,100]
In summary, there has been substantial progress toward 
establishing an in vitro cell culture model of the lung, which 
mimics an increasing number of the core features of the lung 
including mechanical stretch and ALI conditions. A silicone-
based membrane is commonly used in commercially avail-
able devices and microfluidic studies. Even after coating with 
ECM proteins (such as collagen, fibronectin, and mixtures of 
ECM proteins such as Matrigel), epithelial cells do not always 
grow to a complete confluent cell layer on these hydrophobic 
membranes and if they do then one often finds multilayered 
regions, which are a poor model of the monolayered lung 
epithelium. In addition, other biophysical parameters of the 
membrane such as porosity and thickness are very essential 
for cell proliferation and in vivo–like permeability of the in 
vitro air–blood (alveolar-capillary) barrier. Therefore, there is 
a need to design more biomimetic membranes, which more 
closely mimic the physiological aspects of the native basement 
membrane.
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4. Alveolar-Capillary Basement Membrane  
for ALI Cell Cultures
For submerged cell culture conditions, stretchable cell support 
membranes are mainly selected based on elasticity, wettability, 
durability, biocompatibility, and availability (cost). However, 
alveolar epithelium represents the ALI with air on the apical 
side and tissue/liquid on the other basal side. ALI conditions 
can be mimicked under in vitro conditions by seeding cells 
on a permeable membrane allowing for contact with air from 
the apical side and nutrient supply with cell culture medium 
from the basal side via the permeable membrane. Therefore, 
to manufacture an appropriate membrane for ALI conditions, 
additional biophysical parameters such as porosity, perme-
ability, and multicellular compatibility should be considered. 
In addition, compatibility with optical imaging techniques (e.g., 
confocal microscopy) is a desirable, albeit not absolutely neces-
sary feature of the membrane.
Various membrane materials and manufacturing techniques 
have been assessed for lung tissue as summarized in Table 4. 
Currently, silicone-based materials such as PDMS are by far 
the most favored material type due to its high compliance with 
a Young’s modulus of !1–3 MPa (however, also values below 
1 MPa are possible depending on base to cross-linker ratio 
[101]), as well as good gas permeability, optical transparency, 
low cost, and ease of use.[102,103] However, silicone is known 
to be highly adsorptive toward many small and large mole-
cules relevant for drug testing or nourishment of the cells, 
which renders it problematic for drug transport studies and 
cytokine release monitoring in the basal compartment.[103,104] 
Alternative approaches such as electrospun membranes 
made of various materials (e.g., polycarbonate polyurethane 
(PCU),[91] polycaprolactone (PCL),[105] polydioxanone (PDS),[106] 
and poly(lactic-co-glycolic acid) (PLGA)[107]) yielded acceptable 
results in terms of stretch conditions, but often suffer from 
limitations regarding cell growth and proliferation due to the 
hydrophobic nature of these materials, which cannot be com-
pletely eliminated even after coating with ECM proteins (such 
as collagen and fibronectin[108]). As a consequence, the selec-
tion of a suitable membrane has been one of the most chal-
lenging aspects in the development of stretch-actuated, ALI 
lung bioreactors.
4.1. Membrane Properties
Ideally, the biophysical properties of membranes used for 
stretch-activated bioreactors of the lung should closely mimic 
the native basement membrane of the alveolar-capillary 
barrier, which have been summarized in Table 1. Careful 
consideration and close matching of these physiologic param-
eters is essential for membrane design yielding biomimetic 
culture conditions for pulmonary cells. Collating physiologic 
properties with technical limitations of current membrane 
technologies results in a list of membrane characteristics 
guiding the selection of membrane material and fabrication as 
summarized in Figure 3d.
As mentioned above elasticity or stiffness is among the most 
important membrane characteristic. However, compliance of 
the membrane should also be considered, i.e., the membrane 
should be elastic enough to endure prolonged cyclic mechan-
ical stretch (for at least days) with an amplitude of up to 12% 
(1D) or even 20% (pathological conditions) without experi-
encing plastic deformation, creep or rupture[109] under real-
istic cell culture conditions (contact with cell culture medium). 
Moreover, a sufficiently high degree of wettability with contact 
angles below 70° is desirable for the growth of confluent epithe-
lial and endothelial cell monolayers as encountered at the air–
blood interface. Wettability (hydrophilicity/hydrophobicity) is 
governed by surface characteristics of the membrane including 
charge, chemistry, and roughness of the membrane.[110–112] 
Membrane permeability governed by porosity and pore inter-
connectivity is also in important aspect of membrane design as 
it is essential for various processes facilitating cell growth such 
as nutrient absorption, and metabolic waste removal,[113,114] but 
also for cell–cell signaling processes.
Cells secrete signaling molecules (e.g., interleukins) and 
extracellular vesicles (EVs) (e.g., exosomes) across the base-
ment membrane under both homeostatic and pathological 
conditions, but also in response to environmental challenges 
including pathogens, gaseous irritants, cigarette smoke, and 
environmental particles.[115,116] Monitoring of these cell sign-
aling processes is vital for understanding the role of cell sign-
aling in disease development and requires the use of porous 
membrane.
Transport rates are a function of membrane porosity and 
thickness.[117] As stated above the air–blood barrier can be 
considered as a permeable membrane with submicron thick-
ness (0.62 µm) perforated with nanosized pores (<2.5 nm in 
diameter[33] (Table 1 and Figure 3c). For in vitro cell cultures, 
size and topography of the pores in the membrane need to be 
large enough to achieve desirable gas and nutrient exchange 
between apical and basal compartment (at least 10 nm diam-
eter for large biomolecules to pass through), but small enough 
to prevent inadvertent cell migration across the membrane 
(<3–8 µm depending on cell type). Hence, the most widely 
used pore size of !3 µm facilitates the formation of epithe-
lial-endothelial cell bilayers mimicking the alveolar-capillary 
barrier, while allowing transport of nutrients, growth factors 
and cell signaling molecules (e.g., cytokines, chemokines, 
and extracellular vehicles) at physiologic rates.[118–121] 
Another major factor in mimicking the properties of the air–
blood barrier of the lung is its thickness !0.6 µm in the gas 
exchange region.[35] On the other hand, the human basement 
 membrane in the alveolar-capillary region is only !0.6 µm 
thick (Table 1). Since submicron membranes, are difficult to 
handle, the majority of artificial membranes reported in the 
literature are in the 10 micron range. The increased mem-
brane thickness results in additional resistance to respiratory 
gas and macromolecular exchange and hence remains a major 
limiting factor in the design of biomimetic membranes for in 
vitro approaches to the alveolar-capillary barrier.
4.2. Membrane Fabrication
Membrane fabrication is one of the key determinants of 
membrane properties. The conventional techniques for 
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Table 4. Synthetic and natural- based polymers as candidate materials for stretchable and porous membranes.
Type Material Manufacturing 
method




























PCLa) ES 90 30 85 0.2–0.4 µm 1.74 3.55 30.08 NA HLECr) [185]
PCLb) ES NA NA 52.5 NA 0.032 0.036 129.29 NA L6 rat myoblasts [186]
P(LLA-CL) Melt spinning NA 33 and 
118c)




PET ES NA 120 83.6 NA NA NA NA NA CALU-3 and MRC5 [147]
PET ES NA 60 NA NA NA NA NA NA CALU-3, MRC5, and 
DCsr)
[148]
Silicone/PTFEr) iCVDr) NA 0.5–3e), 
20f)








Bionate II 80A (PCU) ES 121.5 75.4 NA NA 54.2 2.2 501 NA A549 [91]
Silk Casting NA 10–15 NA 0.5–5µm NA NA NA NA HLECr) [212]
Collagen ES NA 187 NA NA 1.5h), 0.7i) 52.3h), 26.1i) NA NA Aortic SMCsr) [213]








PEGdma/PLAr) PLA ES 131.8 NA NA 1836 µm2 2 64.1 275 NA VECs and VICsr) [216]
Blend ES 38.7 <50j) NA 8.27 µm2 2.1 141 4 NA
PLLA/Lung dECM ES 129.2 139 ± 53 86.75 NA NA 16.35 NA NA HBSMCsr) [171]
PGSr)/PLLA Freeze- 
drying
NA 830 92 109–141µm 0.007 0.030 NA 26.17 ADSCsr) [217]
Fibronectin grafted P(LLA-CL) ES NA 3000 60.4 1–3 µm 5.2 50k) 80 80 PEECsr) [190]
PCL/rhTEr) ES NA <100–200 NA NA 0.510 <0.3 NA <0.007 
kPa!1
HUVECs [188]










ES NA <20 NA NA NA 0.36 NA NA
PCL/Gelatinm) PCL ES 130.52 NA NA 37.6 µm 1.18 4.41 614.90 NA HUVECs [187]
Blend ES 58.18–
70.85n)
NA NA 8–12.4 µmn) 0.55–0.76n) 3.02–5.85n) 551–742n) NA
PDS/Gelatin/Elastin PDS ES NA 500 80–82 NA 5.61 17.11 216.7 NA Not studied [151]
Blend ES NA 500 80–82 NA 1.77 5.74 75.08 NA
PCL/PDS PCL ES 131.28 NA NA "23 µmj) <4j) <1j) <260j) NA In vivo vascular 
graft
[106]
PDS ES 11.54 NA NA "18 µmj) <9.5j) <4.2j) <70j) NA
Blend ES 78.06 NA NA 20.06 µm <7.1j) <2.5j) 121.3 NA
PLGA/Gelatin/ Elastin ES NA 20–1000 NA 0.6–4.74 µm2 0.130 0.770 NA NA Human EA.hy926& 
BASMCsr)
[107]
PCL/PGAr) PCL ES 118 NA 81.3 1.05 nm <1.8j) <1.5j) <10j) NA Not studied [218]
PGA ES 0 NA 90 2.3 nm <8j) <19j) <105j) NA
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porous membrane fabrication are phase separation,[122] self-
assembly,[123] freeze-drying,[124] solvent casting,[125] and electro-
spinning (ES).[126]
Thermally induced phase separation is a convenient tech-
nique for casting a wide range of polymers such as poly-L-lactic 
acid (PLLA) and PLGA into an interconnected porous film.[127] 
This method is easy to use, reproducible and obtained mem-
branes have high porosity and narrow pore size distribution. 
However, control of pore size and shape is difficult due to the 
lack of control over fiber arrangement.[127,128]
Solvent casting is a simple and inexpensive way to manufac-
ture a porous scaffold, albeit further modifications are required 
to overcome innate abnormal pore shape and interconnec-
tivity.[129] Organizing and arranging materials by molecule or 
self-assembly is another way to fabricate a porous membrane. 
With this method, the physical and structural properties of 
nanofibers can be controlled by oligopeptide composition and 
chemistry. However, limited choice of proper molecules and 
lack of control over pore size and shape are the main disadvan-
tages of this “bottom-up” approach.[130,131]
Electrospinning stands out as a powerful method in creating 
porous membranes that resemble the fibrous architecture 
of natural ECM.[132] Electrospinning is a versatile technique, 
which can be applied to virtually any polymer as well as many 
macromolecules, reshaping a rich library of materials into 
fibers with a diameter ranging from a few nanometers to 
micrometers. The nano/micro scale fibrous morphology of 
the scaffolds provides a unique high surface area to volume 
ratio,[133] which is one of the main parameters that affects the 
surface area and overall porosity of the membranes, together 
with packing density. Intricate interplay between process and 
solvent parameters such as feeding rate, voltage, concentration 
and choice of solvents, enables control over the fiber size.[132] In 
addition, membrane porosity can be further increased via salt 
leaching[134] and sacrificial polymers,[135] whereas the packing 
density of fibrous membranes can be tailored via electrostatic 
repulsion[136] and wet electrospinning.[137] It should be noted 
that the choice of the material, e.g., hydrophobic/hydrophilic, 
is to be considered in the context of fiber morphology and 
permeability analysis, which will be addressed in more detail 
below.[138] Manipulation of the shape of the electrospun fibers 
can be utilized to match the mechanical features, required by 
the lung-tissue models, such as stiffness and elasticity. Previ-
ously, lower packing  density in electrospun fibers was reported 
to decrease the bulk stiffness of the membranes.[139] Moreover, 
fabrication of coiled fibers allowed increased stretchability/
extensibility compared to straight fibers and further contrib-
uted to the contraction of cardiomyocytes.[140] Such mechanical 
actuation capacity may prove useful for the cyclic stress mim-
icry in vitro lung tissue models.
Furthermore, bioprinting technology engaging cells, growth 
factors, and biomaterials (synthetic and natural ECM) is 
another promising strategy to maximally mimic the alveolar-
capillary tissue.
In the study that is first of its kind, Horvath et al. engineered 
an air–blood barrier via layer by layer bioprinting of endothe-
lial and epithelial cells that are separated with a thin layer of 
Matrigel, which mimics the basement membrane in the native 
lung tissue.[141] Both types of printed cells exhibited high via-
bility and formed into thin confluent monolayers, which facili-
tated necessary cell–cell interactions. The authors suggested 
that the reproducible biofabrication of such air–blood bar-
rier could serve as a high-throughput screening platform for 
safety assessment and drug efficacy testing. Recently, an even 
more applied study reported bioprinting of A549 cells into 3D 
cell-laden constructs.[142] Once the printability, structural sta-
bility, and cell friendliness of the bioinks were established, the 
infection patterns were analyzed for a seasonal influenza A 
Adv. Funct. Mater. 2019, 1903114
Type Material Manufacturing 
method





















PCL/HA PCL ES 123 200 NA NA 4.1 0.68 213 NA FEK4r) [219]
PCL/HA, 5:1 ES 78 200 NA NA 10j) 0.275j) 90j) NA
PCL/HA, 5:2 ES 54 200 NA NA 11j) 0.420j) 50j) NA





3D printing NA 150 NA 400–500 µmp) 1.15 1.95q) 60 NA NOF and NOKr) [220]
a)Solvent: trifluoroethanol (TFE); b)solvent: acetic acid and dimethylsulfoxide (DMSO); c)two different solvents (acetone and 1,1,1,3,3,3-Fluoro-2-propanol (HFIP)); 
d)resembles actual arteries; e)iCVD skin layer; f)PTFE supporting membrane; g)pore size of the PTFE membrane; h)longitudinal; i)across the fiber; j)taken from graphical 
depictions; k)no creep up to 15% strain at 0.25 Hz; l)PCL (MW 14000), solvent: hexafluoro-2-propanol (HFP); m)PCL (MW 80000), solvent: HFIP; n)preparation in two 
different flow rates; o)burst pressure; p)pore size of another side of the membrane is 50–150 µm; q)dynamic tensile storage modulus is 314 kPa; r)ADSCs: human adipose-
derived stem cells, BASMCs: bovine aortic smooth muscle cell, DCs: dendritic cells, FEK4: human skin primary fibroblast cells, HBSMCs: human bronchial smooth 
muscle cells: HLEC: Human limbal epithelial cell, HPMEC: primary human pulmonary microvascular endothelial cell, HSAEC: primary human small airway epithelial cells, 
HUSMCs: human umbilical arterial smooth muscle cells, iCVD: initiated chemical vapor deposition, NCI H44: human lung carcinoma epithelial cell line, NOF: normal 
oral fibroblasts, NOK: normal oral keratinocytes, PEECs: porcine esophageal epithelial cells, PEGdma: poly(ethylene glycol) dimethacrylate, PGA: Polyglutamic acid, PGS: 
poly(glycerol sebacate), PLA: polylactic acid, PTFE: poly(tetrafluoroethylene), rhTE: recombinant human tropoelastin, SMCs: smooth muscle cells, VEC: valvular endothelial 
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strain.[142] The authors concluded that the virus was distributed 
throughout the 3D printed structure and caused a clustered 
infection pattern that is comparable to the natural infection in 
the lung tissue, which cannot be replicated with traditional 2D 
cell culture models.
Bioprinting is a rapid production technique, which provides 
powerful control over the fabrication process and patterning. 
However, it is in an early technological phase of development 
and high-resolution cell patterning and distribution are among 
its main technical challenges. In addition, selecting a tunable 
biocompatible material is another concern for bioprinting to 
achieve an appropriate resolution in a scale of the air–blood 
barrier.[143,144]
4.3. Material Selection
The type of material is another controlling factor of membrane 
features. Polymers are as the most widely used type of biomate-
rials because of their diversity in chemical groups, which allows 
fine-tuning of unique physical properties such as high surface-
to-volume ratio, high porosity, and mechanical property.[145,146] 
A wide variety of synthetic and natural-based materials and 
composite materials (natural–synthetic hybrids) has been 
employed to obtain a thin scaffold, which is appropriate for soft 
tissue applications (Table 4).
One of the most widely used synthetic-based materials is 
PCL which is a biodegradable, biocompatible, and bioresorbable 
polymer. PCL scaffold can be manufactured by various 
 fabrication methods due to its breadths in rheological and vis-
coelastic properties.[105] In addition to PCL, other synthetic-based 
polymers such as polyethylene terephthalate (PET) and[147,148] 
PCU[91] have been used to culture epithelial cells. Besides, PDS 
has been broadly used[149–151] in tissue engineering applica-
tions as a biodegradable polymer with a relatively fast degra-
dation rate. PDS shows enhancing cell infiltration and tissue 
regeneration when grafted with low-degradation rate polymers 
such as PCL in which large pore spaces created by degradation 
of PDS.[106] Synthetic-based polymers have many advantages 
including suitable mechanical properties, tunable biodegrada-
bility, easy sourcing, great flexibility in synthesis and modifica-
tion, and–last but not the least–low cost.
However, synthetic polymers lack cell affinity because of their 
low hydrophilicity and lack of surface cell recognition sites.[152,153] 
To overcome this drawback, synthetic-based materials are often 
functionalized prior to biological use. Hydrophilicity can be 
enhanced via several ways including plasma and polyvinyl 
alcohol (PVA) treatment, chemical coupling of hydrophilic poly-
mers either via copolymerization or surface grafting, surface 
patterning, and preparing hydrophobic/hydrophilic poly mer 
blends.[108,154] Membranes with appropriate hydrophilicity 
promote adsorption of ECM proteins, secreted from the seeded 
cells, without interfering with their functional/physiological 
conformation and thus render the scaffold bioactive.[155,156] 
Direct inclusion of (natural) bioactive molecules offers the 
possibilities to overcome the lack of surface cell recognition 
sites in synthetic-based polymers. The most common bioactive 
mole cules are ECM proteins, such as collagen (or gelatin as sur-
rogate), laminin, fibronectin, and elastin or other protein-based 
materials such as silk.[108] Such natural polymers can provide 
better cell–matrix interactions and biocompatibility as com-
pared to synthetic-based polymers. However, natural polymers 
tend to display poor processing ability, batch to batch variance 
and poor mechanical properties such as elasticity, stiffness, and 
durability.[157] Although mechanical features of natural-based 
polymers can be improved with an additional crosslinking pro-
cess,[158] using membranes solely composed of natural-based 
polymers is likely not suitable for long-term culturing of cells 
under mechanically challenging conditions like cyclic stress.
Instead, natural/synthetic composite materials can be for-
mulated to exploit bioactive features of biologic materials 
 combined with tunable/stable mechanical features of synthetic-
based polymers. In a recent study, an electrospun PCL/gelatin 
polymer blend was fabricated to mimic ECM and study the 
effect of ECM mechanics and topography on alveolar-capillary 
barrier permeability and cell injury during airway reopening.[159] 
In this study, a nonbiological polymer (PCL) not only provided 
elasticity and mechanical durability, but also allowed for better 
control of membrane production (various PCL/gelatin mixtures 
yielded elastic modulus: 0.36–7.20 MPa) (Table 4). The manu-
factured membranes were used to study surface tension forces 
during airway reopening. Other natural–synthetic hybrid poly-
mers such as PDS/gelatin/elastin,[151] PLGA/gelatin/elastin,[107] 
and collagen/poly(l-lactide-co-caprolactone) (P(LLA-CL))[160] 
have shown good biocompatibility, mechanical properties, and 
other physical characteristics desirable for in vitro models of 
the alveolar-capillary membrane.
Alternatively, cell adhesion peptides derived from ECM 
proteins, such as RGD (arginylglycylaspartic acid) and IKVAV 
(isoleucine-lysine-valine-alanine-valine), can be immobilized 
on synthetic polymers to create selectively bioactivated syn-
thetic membranes. Employing short peptide sequences rather 
than whole proteins offers tailor-made synthesis options and 
efficient/precise conjugation possibilities, which increase 
the overall impact of the functional epitopes.[161,162] Although 
 bioactive peptides can be directly blended with the polymers, 
chemical conjugation assures more reproducible and stable 
bioactivation. Among various conjugation methods, carbodi-
imide chemistry, Michael-addition, and photoinitiation based 
reactions are widely reported.[163–165] It has also been dem-
onstrated that covalent chemical coupling of peptides can be 
achieved in situ through the application of a reactive hydro-
philic additive to hydrophobic polyesters in the spinning solu-
tion.[166] Grafahrend et al.[166] conjugated the cell adhesion 
peptide GRGDS to a  reactive hydrophilic pre-polymer, NCO-
sP(EO-stat-PO) (star-shaped poly(ethylene oxide-stat-propylene 
oxide) with isocyanate end groups) already in the solution 
that was used for electrospinning. Subsequent co-spinning 
of bioconjugated NCO-sP(EO-stat-PO) with PLGA rendered 
electrospun fibers hydrophilic, reduced the unspecific protein 
adsorption and cultivated strong cell-substrate adhesion. In a 
similar way, Rossi et al. fabricated electrospun membranes, 
which mimicked the bipolar structure of the basement mem-
brane by conjugating ECM proteins (collagen IV, fibronectin, 
and laminin) to NCO-sP(EO-stat-PO). A bipolar membrane is 
then fabricated through subsequent spin-coating with solu-
tions, bioconjugated with  different ECM derived peptide 
sequences.[167]
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Bioactivated fibrous membranes supported the bipolar 
 co-culture of keratinocytes and fibroblast, mimicking the 
basal and reticular side of the basement membrane. A similar 
approach can be utilized for capturing the bipolar structure of 
the pulmonary epithelial barrier. Most recently, this approach 
has been extended to combine ECM-peptide bioconjugation 
with the covalent immobilization of biochemically active 
molecules such as antibodies to combine selective cell adhesion 
with, in this case, immunomodulatory effects.[168]
Furthermore, it has been shown that decellularized extracel-
lular matrix (dECM) containing essential proteins for cell attach-
ment and proliferation, could be a good candidate to improve 
the biocompatibility of copolymers.[169,170] In a recent study, 
hybrid electrospun scaffold of poly-L-lactic acid and dECM 
(derived from pig lung) for in vitro ASM model showed that 
dECM improved physical characteristics (e.g., wettability).[171]
PDMS is the most widely used membrane material for in 
vitro cell-stretching devices of the alveolar-capillary barrier 
(section 3). However, inadvertent adsorption of small molecules 
onto the surface of PDMS can affect cellular responses or 
prohibit drug transport studies. Copolymers (natural and syn-
thetic-based) have been suggested to overcome the limitations 
of PDMS-based membranes. However, relatively few studies 
are available demonstrating successful cell culturing on these 
membranes both at the ALI and under cyclic mechanical 
stretch as encountered at the alveolar-capillary barrier.
In summary, it is evident that there is a need for development 
of alternative materials suitable for manufacturing a biocom-
patible, porous, thin, and stretchable membrane  mimicking the 
physiologic parameters of the native basement membrane of 
the alveolar-capillary barrier. Moreover, the optimum choice of 
manufacturing method will also play a crucial role for obtaining 
the most biomimetic properties. The optimum material and 
processing techniques should ideally result in a final product 
that is not only bioactive enough to facilitate a fully confluent 
cell monolayer on the membrane, but also meet the high 
requirements on mechanical properties and chemical integrity 
for long-term studies with lung tissue models.
5. Future Directions: Biomimetic Models  
of the Lung
Currently, the vast majority of in vitro efficacy, toxicity, and 
pharmacokinetics studies of the lung are performed using 
static pulmonary cell models culturing a single cell type under 
submerged conditions.[172,173] While this approach is well 
established, it often lacks predictive power for in vivo/clinical 
outcome due to nonphysiologic and simplistic cell model con-
ditions and an unknown dose of the test substance delivered 
to the cells.[7,67] Recent advances in biomimetic lung models 
include ALI culture conditions (polarization of epithelial cells 
at the ALI), apical coverage of epithelial cells with lung lining 
fluid (surfactant and alveolar lining fluid), and multiple-cell 
co- culture models providing more biomimetic barrier func-
tion (epithelial and endothelial cells), immune competence 
(dendritic cells), and clearance capability (macrophage and 
mucus).[14,67] With the availability of commercial aerosol-cell 
delivery systems (e.g., VITROCELL CLOUD, Precise Inhale, 
and CULTEX technology), an increasing number of studies 
employs aerosolized drug/substance delivery for more realistic 
pharmacokinetics and dose-response measurements.[174] Any of 
these aspects enhances the biomimetic characteristics of in vitro 
cell models but depending on the endpoint of interest either all 
or only a subset of them may have to be included for adequate 
prediction of in vivo outcome. Unraveling the link between 
in vitro prediction of certain in vivo endpoints and the most 
suitable lung models will remain a field of intense research.
Moreover, there is also a trend toward microfluidic plat-
forms of in vitro lung models offering the perspective of opti-
mized process control, more efficient substance use, real-time 
monitoring systems via computer-control and automation ulti-
mately leading to high-throughput capabilities.[18] Analogous 
to standard cell culture systems and bioreactors, these micro-
platforms are also able to mimic certain aspects of the pulmo-
nary parenchymal environment such as epithelial-endothelial 
barrier, ALI, and mechanical stimulation induced by breathing 
and blood perfusion. However, these so-called lung-on-a-chip 
devices are often not easy to handle, provide a relatively small 
number of cells limiting the available amount of sample for 
biological (multiomics) analysis. This may at least partially 
explain why there are very few lab-on-a-chip devices commer-
cially available, yet.
Notwithstanding even more advanced technologies are 
already pursued such as more complex 3D organ-specific cell 
structures representing functional organ units (organoids) 
and the integration of organ-specific chips/organoids into in 
vitro organism systems. Although these methods are still in 
an early stage, they hold the promise to overcome remaining 
shortcomings of current advanced in vitro models of the lung 
such as failure of fully mimicking the complexity of the 3D 
alveolar structure, the multicell interplay in the lung (!60 dif-
ferent cell types) and inter-organ connectedness via blood 
circulation.[175,176]
In addition to these so-called bottom-up approaches, where 
biomimetic organ-specific models are built up from single-
cell structures, also top-down approaches are available, where 
the lung (or a single lobe) is cut into smaller tissue slices.[7] 
These ex vivo PCLS models, which can also be used under 
dynamic stretch conditions, represent a thin slice of the mul-
ticell 3D architecture of the lung which has been shown to 
maintain physiologic functions such as ciliary beating, mac-
rophage migration, and response to, e.g., pro-inflammatory 
stimuli.[177,178] Among other applications, PCLS have been 
used to study pathological and therapeutic measures of COPD/
emphysema in lung tissue,[82] and more recently to visualize the 
location and migration of different cell types in the lung tissue 
such as dendritic cells.[179] Lung slices with a supportive layer 
such as PDMS have been exerted to cyclic mechanical stretch 
without causing cell injury.[83] However, even this complex 3D 
multicell model of the lung can only partly reflect the proper-
ties of native lung tissue. For instance, it does not represent 
an intact epithelial-endothelial tissue barrier, ALI conditions as 
encountered in the lung and an intact immune system causing 
nonphysiological responses.[180] Moreover, these top-down 
approaches still require the use of animals or donor organs, 
while bottom-up approaches bear the potential of animal free 
drug/toxicity testing.
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All of these developments toward more biomimetic, minia-
turized, and complex models of the lung will benefit from the 
implementation of cyclic mechanical stretch as one of the fun-
damental stimuli in the lung. Until now, commercially available 
cell-stretching devices have only been available for submerged, 
but not for more physiologic ALI cell culture conditions. The 
suggested technologies for cell-stretching under ALI conditions 
mainly rely on silicone-based membranes such as PDMS,[181,182] 
which have plenty of advantages such as good compliance 
and permeability. However, due to the hydrophobic nature 
of PDMS, surface modifications or ECM protein coatings 
are required to enhance cell adhesion and biocompati-
bility.[183,184] However, the hydrophobic nature of PDMS requires 
surface modifications such as coating with ECM proteins for 
adequate cell grow. But even then, multilayered or nonconfluent 
monolayered cell regions can often not be avoided.[11] In spite of 
these efforts, PDMS membranes may adversely affect cellular 
response even for short-terms studies (1 h)[102] and silicone-
based materials are known for their adsorptive nature and hence 
their potential bias when considering transmembrane transport 
of drugs and biomolecules.[103,104] The latter is not the case for 
PET membranes implemented in the standard Transwell insert 
technology used for static ALI cell cultures. However, PET is 
not elastic and hence not suitable for mimicking cyclic stretch. 
Hence, neither PET nor silicone-based materials meet all of the 
requirements of a biomimetic basement membrane. In prin-
ciple, the next generation of ALI cell culture membranes for 
even more physiologic in vitro models of the lung should also 
mimic the curvature of the alveolar epithelium (alveolar diam-
eter: !250 µm) and the interaction between cells and ECM.
As discussed above the essential characteristics of suitable 
basement membranes include porous architecture, dimension, 
biocompatibility, stiffness, and permeability. The physiologic 
parameter range of these parameters is summarized in Table 1. A 
thin (ideally <1 µm) and porous membrane is required to mimic 
the structural and mechanical properties of the alveolar wall sup-
porting growth and maintenance of an intact epithelial mon-
olayer under ALI culture conditions. Thus, designed membranes 
should have sufficient elasticity, durability for long-term stretch 
in cell culture systems and act as cell substrate as well as allow 
for nutrient exchange between basal and apical compartment.
At this time, there is no widely accepted material meeting 
all of the physiologic requirements for the native basement 
membrane of the alveolar-capillary barrier (Table 1). However, 
there is evidence that rather than using a single material the 
application of hybrid copolymers may prove advantageous for 
representing all of the desired mechanical and biophysical 
properties. Among them, scaffolds obtained by PCL[185,186] and 
P(LLA-CL)[109] blended with natural-based polymers such as 
gelatin,[159,187] collagen,[160] and elastin[188] showed a suitable 
porosity and surface hydrophilicity. Blends of PCL/natural poly-
mers met the mechanical properties such as elasticity, reversible 
elongation and energy absorbed up to the elastic point reported 
for the basement membrane in the alveolar region. Other syn-
thetic polymers such as P(LLA-CL) also showed appropriate 
mechanical properties for soft tissue applications.[160,189,190] 
For instance, electrospun hybrid scaffolds of collagen/P(LLA-
CL) has been used for application of cardiovascular tissue 
engineering.[160] The hydrophilicity, biocompatibility, and 
mechanical properties (Young’s modulus: 1.77 ± 0.09 MPa) 
of these hybrid materials make them promising membrane 
materials for lung models, although they have not been widely 
applied in lung research, yet. dECM-derived native lung tissue, 
a biomimetic mixture of natural ECM proteins, is another 
promising natural material because of its excellent biocom-
patibility features, although it does not have sufficiently bio-
mimetic mechanical properties.[170] As this deficiency can be 
compensated by hybridization with a synthetic polymer, several 
synthetic/dECM copolymers have been recently manufactured 
for tissue engineering application.[191–193]
In addition to selecting a proper (composite) material, 
which fulfills the physiologic properties of the alveolar base-
ment membrane, fabrication methods should also be consid-
ered. Electrospinning is a simple and cost-effective technique 
which enables control over the shape, thickness, architecture, 
and biophysical characteristics of the scaffold. A tunable porous 
structure with a high surface area to volume ratio, mimicking 
natural ECM in native tissues, can be manufactured within this 
method. However, poor cellular infiltration is still the main 
limitation of electrospun scaffolds, which can be improved 
somewhat when combined with other techniques such as phase 
separation and solvent casting.[194,195]
Moreover, biofabrication is a young and vibrant field of 
research, which offers great potential for the generation of skin 
and lung tissue. This technique aims at the generation of bio-
logical functional tissue analogs either through an automated 
assembly of cell-containing building blocks, or by bioprinting 
of cells, biomaterials, and biologically active factors into 3D 
constructs.[208] Bioprinting inherently requires a bioink, a cell-
containing formulation that can be processed by a suitable 
technology.[196,197] The design and application of bioinks have 
expanded greatly in the last decade, with numerous materials–
primarily natural and synthetic hydrogels–being applied or 
developed to meet the stringent demands of bioprinting.[198,199]
Recently, an endothelium-epithelium along with basement 
membrane has been fabricated using a layer-by-layer method in 
order to mimic the pulmonary air–blood tissue barrier.[141] A 3D 
bioprinted tissue model employing cell-laden bioinks has been 
also used as a model for studying influenza infection in the 
lung.[142] These examples clearly show the potential of biofab-
rication for the engineering of functional lung tissue. However, 
many challenges still need to be overcome, such as the devel-
opment of materials and techniques that specifically suit lung 
cells forming the bipolar architecture of an air–blood barrier 
and providing mechanically tuned constructs that mimic the 
dynamic nature in native lung tissue.
6. Conclusions
Mechanical forces play a key role in proliferation, differentiation, 
function, and metabolism of lung cells. The main stretch-related 
regulatory pathways include the MAPK/ERK- and cAMP-PKA-
dependent signaling pathways triggering differentiation of ATIIs 
as well as activation of YAP/TAZ and the signaling cascade of 
Cdc42/F-actin/MAPK controlling alveolar regeneration. The 
main stretch- and permeability-related physiologic parameters 
of the native basement membrane of the alveolar-capillary tissue 
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are the level of mechanical linear (1D) strain (4-12%; up to 20% 
under pathological conditions), elasticity (1–2 kPa), thickness 
(!50 nm), and porosity (pore size <2.5 nm) and total air-blood 
barrier thickness (!0.6 µm). In addition to matching these bio-
physical conditions, suitable in vitro membranes for pulmonary 
cell-stretching also require biocompatibility, which includes wet-
tability (WCA < 70°) and conduciveness to cell growth.
Meeting all of these biophysical parameters in current in vitro 
systems is a challenge, which has not yet been fully accomplished. 
The currently available body of in vitro data on the effects of 
cyclic mechanical stretch on lung biology was almost exclusively 
obtained for nonphysiologic submerged cell culture conditions 
using nonporous silicon-based membranes (e.g., PDMS). Even 
the few currently proposed systems for pulmonary cell-stretching 
under more physiologic ALI culture conditions mainly rely on 
super-micron thick silicone membranes (even the microfluidic 
systems) with micron-sized pores. Moreover, silicone has well 
known material-specific deficiencies such as limited biocompat-
ibility (requires surface treatment) and capturing of relevant bio-
molecules and potentially applied drug molecules, which poses 
serious limitations for drug efficacy and pharmacokinetics studies.
Our review of natural and synthetic-based polymers revealed 
that natural/artificial hybrid materials combine high biocom-
patibility (natural-based polymers) with favorable mechanical 
properties (artificial polymers) for soft tissue membrane appli-
cations such as alveolar tissue models. For the lung, PCL and 
P(LLA-CL) have been identified as appropriate synthetic-based 
polymer candidates, while collagen, dECM and gelatin may 
qualify as suitable natural-based polymer components. Further 
research into the exact ratio of natural–artificial copolymers is 
required to obtain the most suitable membrane for next genera-
tion, ALI, cell-stretching bioreactors of the lung.
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